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CCA cyclohexanecarboxylic acid
COMT catechol-O-methyltransferase
DMSO dimethysulphoxide
G 6-P glucose 6-phosphate
G 6-PD glucose 6-phosphate dehydrogenase
MAO monoamine oxidase
MeS 2-[N-morpholino]ethanesulfonic acid
MMC mitomycin C
MNPCE micronucleated polychromatic erythrocytes
MNNCE micronucleated normochromatic ertythrocytes
MNNG N-methyl-N’-nitro-N-nitrosoguanidine
MTT 3-4,5, dimethyl-2,5 diphenyltetrazolium bromide
NADH nicotinamide adenine dinucleotide (reduced)
NADP nicotinamide adenine dinucleotide phosphate (oxidised)
NADPH nicotinamide adenine dinucleotide phosphate (reduced)
NET nitroblue tétrazolium
NCE normochromic erythrocytes (red blood cells)
ODC ornithine decarboxylase
PCA perchloric acid
PCE Polychromatic erythrocytes
SCE sister chromatid exchange
SOD superoxide dismutase
TPA 12-O-tetradecanoylphorbol-13-acetate
TPP thiamine pyrophosphate
UDS unscheduled DNA synthesis
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(i)
ABSTRACT
Bracken fern (Pteridium aquilinum) causes acute and chronic toxicity in animals, 
and is associated with a high incidence of stomach and oesophageal tumours in countries 
where it is consumed as food, yet the toxic constituent^ has not been unequivocally 
identified. None of the toxic constituents isolated from bracken have individually 
reproduced all the disease syndromes typical of the plant. The carcinogenicity of the plant 
has at one time or another been attributed to quercetin, shikimate and ptaquiloside.
Studies to determine whether the genotoxicity of quercetin, shikimate (and its 
metabolite cyclohexanecarboxylate), and ptaquiloside could be enhanced in combined 
application were conducted in vitro using Salmonella typhimurium and in vivo using mice 
and rats.
Quercetin was mutagenic in S. typhimurium TA98 and TA 100 both in the absence 
and presence of rat hepatic activating fractions. Induction of rat hepatic metabolising 
enzymes by pretreatment with Aroclor-1254 did not affect the enhancing effect of 
microsomal, cytosol or S9 activation. Nor did shikimate or ptaquiloside influence the 
mutagenicity of quercetin. However, cyclohexanecarboxylate, a gastrointestinal bacterial 
metabolite of shikimate significantly inhibited quercetin mutagenicity, as did norharman and 
menadione.
Ptaquiloside was mutagenic in TA98 and TA 100, but only after preincubation. Its 
mutagenicity was completely abolished by the activation system prepared from rat liver. 
Neither quercetin, shikimate nor its metabolite cyclohexanecarboxylate affected the 
mutagenicity of ptaquiloside.
Shikimate and cyclohexanecarboxylate were not mutagenic in the Salmonella 
mutagenicity test, nor were their activities influenced by norharman.
(Ü)
Quercetin, shikimate and cyclohexanecarboxylate were tested for genotoxicity in 
vivo using the micronucleus test in rats and the unscheduled DNA synthesis in rat gastric 
mucosal cells. None of these compounds were genotoxic. Simultaneous administration of 
the compounds did not influence their in vivo genotoxic activity. Plasma concentrations of 
quercetin after oral or intraperitoneal administration at 200 mg/kg bwt were below 0.1 
jig/ml suggesting that the negative in vivo results may have been due to poor bioavailability 
of the compound. Mitomycin C, which was used as a positive control in the in vivo 
studies, was strongly genotoxic.
Studies were conducted to determine the cytotoxic activity of quercetin, shikimate 
(and its major metabolite cyclohexanecarboxylate), and ptaquiloside using CHO, 3T3 and 
NRK cells. All the compounds exhibited a low order of cytotoxicity. The concentration 
which inhibited cell growth by 50% (IC50) was approximately 1 x 10-4 M and 1 x 10*3 for 
quercetin and ptaquiloside respectively. The IC50 for shikimate and cyclohexanecarboxylate 
was approximately 1 x 10"3 M and 1 x 10  ^M respectively.
The possible mechanisms involved in the mutagenicity of quercetin, inhibition of 
mutagenicity by cyclohexanecarboxylate, norharman and menadione and the possible 
implications in vivo are discussed.
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GENERAL INTRODUCTION
1
1.1 BACKGROUND INFORMATION
Almost exactly a century after the first reports by Penberthy (1893) and Storror 
(1893) which implicated bracken fern (Pteridium aquilinum) as the cause of death of 
hundreds of cattle in the British Isles during the drought of 1893, the identity of the major 
toxic constituent of the plant has yet to be unequivocally established. Success has only been 
achieved in the isolation and characterisation of a large number of constituents of which 
none has reproduced all the symptoms of typical bracken syndrome observed in domestic 
and laboratory animals. It is now postulated that the toxicity due to bracken fern might 
involve not necessarily a single constituent, but several acting collectively or synergistically 
(Pamukcu et al.91966; Evans et a/.,1982; 1983; Jones et al.t 1983), possibly in association 
with factors other than those in the plant, such as viruses (Janet, 1978; Jarret, 1982).
From time immemorial, certain species of plants have been known to be poisonous 
to animals and humans (Kingsbury, 1979; Cooper and Johnstone, 1984; Frohne and 
Pfander, 1984). Toxic plants have an enormous economic impact in the livestock industry 
particularly in range land management practices. The estimated losses due to mortalities, ill- 
health and debilitation, birth defects and infertilities have been estimated to be millions of 
US$ worldwide each year. In the US, the estimated economic loss to the livestock 
industry, due to mortality rates of 3 - 5%, amounts to more than US$ 50 million annually 
(Keeler, 1977). However, the total economic loss resulting from plant poisoning has 
always been difficult to estimate. If, for instance, adjustments were made to take into 
account the indirect losses due to reduced weight gain, management costs, loss of revenue 
due to unused toxic plant infested areas and costs in research, the losses would be much 
higher.
In Western Europe, human deaths due to plant poisoning are rare. Vale and 
Meredith (1981) reported that in a 15-year period, only 2 people died of plant poisoning in 
the whole of the United Kingdom. However, in Germany, USA and UK, after drugs and 
household chemicals, plants take third place in poisoning in children (Frohne and Pfander, 
1984). In these countries, poisoning in adults may occur by eating unknown or incorrectly
2
identified plant material, for example, during self medication with plants or the misuse of 
herbal extracts (Siegel, 1976; Anderson et a l, 1978; Dorr and Paxinos 1978).
In the least developed countries, which comprise 36 countries of the world, 
mortality rates due to plant poisoning are higher. Several possible explanations may be 
advanced to account for the higher incidence of plant poisoning in these countries: 1) 
Poverty among the population (300 million altogether) is rampant as the gross domestic 
product (GDP) is less than US$250 per person (Tetzlaff, 1991). Therefore, severe 
shortages or lack of basic medicines and expertise, coupled with low literacy, has forced a 
significant proportion of the population to rely on medicinal plants for cure of ailments 
(Van Os, 1976; Duke, 1985). Research data on many of the medicinal plants is not 
available and therefore toxicity problems remain largely unknown, particularly long term 
effects including mutagenic and carcinogenic consequences. In the short term, excessively 
high doses of such plants, poisonous or otherwise, more often results in severe side effects 
and fatal cases of poisoning and sometimes death. 2) Severe droughts like the ones which 
hit Somalia in 1985 and Tanzania in 1974 (Tetzlaff, 1991) and other natural (e.g. floods) or 
man made catastrophes (such as civil wars like those that have affected Somalia, Ethiopia, 
Mozambique, Angola, Sudan, and Liberia) result in severe food shortages and force people 
to look for alternative sources of food including wild fruits, berries, nuts, seeds and beans, 
mushrooms, leaves, stems and roots (Rugman et al., 1983).
Toxic plants contain toxins of diverse types ranging from simple small molecules 
like hydrocyanic acid (HCN), which is present as part of more complicated molecules 
(Vennessland, 1982), to more complex high molecular weight compounds such as the 
alkaloids (James, 1950). There are numerous plants containing the different toxic 
compounds and belonging to various taxonomic classes (Cooper and Johnstone, 1984; 
Frohne and Pfander, 1984). For convenience Keeler et al. (1978) grouped toxic plants 
based on the system of the animal body affected and on the chemical nature of the toxins. 
However, Shupe et al. (1978) conveniently grouped toxic plants into: 1) those that 
synthesize toxic organic compounds; 2) those that accumulate significant amounts of
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compounds such as heavy metals, selenium, fluorides, or nitrites /  nitrates; 3) those that are 
usually safe under normal conditions but can become hazardous under certain conditions, 
such as sudan grass, sorghum, alfalfa and clover; and 4) others, such as those 
contaminated (on the vegetation) with toxic substances like heavy metals, fluorides, 
herbicides or pesticides. Hence bracken fern fits into category No.l because its toxicity in 
animals has been reproduced several times by the experimental feeding of different parts of 
the plant obtained from different geographical locations (Evans and Evans, 1949; Evans et 
al.9 1972b; 1975; Evans and Mason, 1965; Hirono et al., 1973; 1983; Pamucku et al., 
1976b), an indication that a toxin is within the plant. Furthermore, milk from bracken fern 
animals is carcinogenic (Pamucku et al., 1976a; 1978), showing that a toxin is excreted 
into the milk.
1 .2  BRACKEN FERN
1.2.1 CLASSIFICATION
Bracken fern is the common name of the plant Pteridium aquilinum. The Genus 
Pteridium, originally divided into 6 species (Copeland, 1947), is currently considered to 
consist of one species with two subspecies: aquilinum, found in the Northern Hemisphere, 
and caudatum (L.) Bonap, present in the Southern Hemisphere; each subspecies consisting 
of several varieties (Cooper-Driver, 1976).
Bracken fern is a perennial plant, growing to between 1 to 13 feet high and has an 
extensive root system (rhizomes). The stem is stout and erect. The leaves, which are 
referred to as fronds, are triangular with pinnules in the apices of the pinnae.
Division: Pterophyte 
Class: Fern 
Order Fillicales 
Family: Dennstaedtiaceae 
Subfamily: Pteridorideae 
Genus: Pteridium
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1.2.2 DISTRIBUTION
The distribution of bracken fern is worldwide. The plant is abundant in Africa, 
America, Asia, Australia and Europe. In the United Kingdom alone, the area infested with 
bracken fern is estimated to be 400,000 ha (Jones, 1974; MAFF, 1978; Taylor, 1980) and 
it is estimated to be spreading at an average rate of 1% each year and up to 4% in parts of 
Scotland and Wales (Heads and Lawton, 1986).
In the UK the plant tends to prefer light acid soils in a variety of areas including 
woodlands, thickets as well as grassy places, open hillsides and burnt over areas. Its 
habitat ranges from sea level to 900 m (Atkinson, 1923; Tryon, 1941). Abandoned land 
can very easily be taken over by bracken fern due to the nature of its root system and the 
spores; the sporangium or spore case explodes to release and propel spores (31 - 32 pm 
diameter, Evans, 1985a) to large areas of land.
1.2.3 ECONOMIC IMPORTANCE
Bracken fern has had various uses in the different parts of the world. In America 
(north-eastern USA), Japan, Canada and New Zealand it is consumed as a food delicacy or 
as salad greens (Hirono et a l, 1972; Hirayama, 1979). The part of the plant normally eaten 
is the unfurled frond (referred to as fiddleheads) which is highly carcinogenic (Hirono et 
al., 1973). In other countries, bracken has provided thatching material and firewood 
(Rymer, 1976). In Tanzania, particularly in Kilimanjaro and Tanga regions, bracken is 
used as bedding material in stall fed animals. This practice might account for the high 
incidence of bracken poisoning in livestock in the two regions where high population 
density and stocking rates have meant limited forage availability for animals, forcing them 
to consume the bedding material (bracken). Whether bracken plays any significant role in 
the aetiology of the various forms of cancer in these two regions remains to be investigated.
Generally, however, plant poisoning in animals has occurred as a result of many 
other factors such as drought which favour the survival of many poisonous plants, 
overstocking, overgrazing, trecking over long distances, and poor herding procedures
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which result in a change of food availability and cause the animals to eat toxic plants, which 
are normally instinctively avoided when food supply is unlimited. Accidental contamination 
of feeds such as hay and silage as occurs when poisonous plants have spread excessively 
into the pasture or paddocks, is another source of poisoning.
1.2.4 TOXICITY IN DOMESTIC ANIMALS
Several disease syndromes have been recognised and described in animals (Tables
1.1 and 1.2).
1.2.4.1 Cattle
Three disease syndromes have been recognized:
1) ‘Acute cattle bracken poisoning’: This is a haemorrhagic syndrome resembling 
anthrax and haemorrhagic septicaemia, characterised by the elevation of temperature (41.7 
to 42.8°C), extensive intestinal damage and ulceration, anorexia, dullness and generalized 
haemorrhaging (Evans et al., 1951a; Naftalin and Cushnie, 1954). The clinical symptoms 
of this syndrome normally develop only after animals have been fed on bracken for several 
weeks, and sometimes not until they have been removed from the plant source. Death 
occurs within 48 h (Evans and Evans, 1949; Evans et al., 1954; Tusün et al., 1968) of 
onset of the first clinical signs. All parts of the plant are poisonous. Calves may develop a 
‘laryngitic’ form of the disease, characterised by oral and nasal discharge of mucus, and 
oedematous swelling of the throat, leading to difficult, noisy breathing (Evans and Evans, 
1949; Evans et al., 1954). Experimental reproduction of acute bracken poisoning has been 
demonstrated by feeding trials using fronds and /  or rhizomes. Evans et al. (1954), in such 
experiments, revealed that affected animals also developed leucopenia involving an almost 
complete disappearance of white blood cells (except the lymphocytes), marked 
thrombocytopenia with capillary fragility, a prolonged bleeding time and a defective 
clotting. Bone marrow biopsies revealed aplasia of the granulocytic and thrombocytic 
series; the erythrocytic series being occasionally affected. Based on these observations it 
has been concluded that acute bracken poisoning is a result of severe depression of mitotic
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ability in the bone marrow and other tissues (Naftalin and Cushnie, 1951; 1954; Guilhon et 
a l, 1955).
A similarity has been observed in the clinical symptoms and pathological features of 
acute cattle bracken poisoning and exposure of cattle to ionizing radiation (Evans et a l, 
1958; Heath and Wood, 1958) leading to the conclusion that the factor(s) in bracken 
responsible for the bone manow effects might be radiomimetic (Evans et a l, 1958; Schultz 
et a l, 1959). The changes recorded were characteristic of an acute systemic inflammatory 
condition: damage to the crypt cells lining the gastrointestinal tract, an increase in the 
number of tissue mast cells accompanied by extravascular increase in circulating 
lymphocytes, plasma cells and monocytes, abnormal fibrinogen and seromucoid blood 
cells, and an increase in circulating heparin and histamine levels (Evans, 1985a).
2) Chronic enzootic haematuria: This occurs several months after exposure to small 
amounts of bracken and is characterised by haematuria as a result of haemorrhages in the 
mucosa of the urinaiy bladder (Evans and Evans, 1949; Evans et a l, 1954; Rosenberger,
1971). Affected cattle experience a high mortality rate with deaths occurring a few weeks or 
months after the onset of clinical signs (Pamukcu et a l, 1967; Evans, 1984; Hirono, 
1987). Postmortem examination reveals haemorrhagic foci, up to 1 cm in diameter in the 
bladder. Histologically there is dilatation of the capillaries, angiomatous cavity formation, 
and tumours infiltrating the whole bladder wall. Bleeding occurs from the angiomatous 
capillaries. Pamukcu (1963), in an epidemiologic study, substantiated the view that bracken 
is the aetiological agent of enzootic haematuria by demonstrating that eradication of the 
plant prevented the occurrence of new cases. Moreover, cattle fed bracken fern 
experimentally developed benign (papillomas) and malignant (haemangiomas and 
transitional cell carcinoma) tumours on the wall of the bladder identical to those in 
occurring naturally in enzootic haematuria (Pamukcu et a l, 1967).
3) Digestive tract tumours: Besides tumours of the urinary bladder, bracken 
ingestion is associated with a high incidence ot tumours of the digestive system in beef
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cattle (Jarret et al., 1978; Jarret, 1982), namely squamous carcinoma in the mouth, 
oesophagus, rumen, and intestines. Papillomas have been observed in the upper alimentary 
tract and are associated with a papilloma virus. Suggestions have, therefore, been advanced 
that bracken fern suppresses the immune system thereby increasing the susceptibility of the 
body to tumour-producing viruses. Adenocarcinomas of the intestines and fibrosarcomas 
involving the jaws have also been recorded (McRea and Head, 1981).
1.2.4.2 Sheep
‘Acute haemorrhagic syndrome’ occurs in sheep that eat bracken, but to a rarer 
extent than cattle (Parker and McRea, 1965). However, the most important manifestation of 
bracken poisoning in this species is a condition referred to as ‘bright blindness’, a 
progressive degeneration of the retina of the eye (Watson et a l, 1965; Allsup and Griffiths, 
1978). In affected sheep, cloudiness of the eye, which is characteristic of other forms of 
blindness, is absent, hence the term ‘bright blindness’ (MAFF, 1978). The sheep become 
permanently blind and assume an alert attitude. Both eyes are affected and respond poorly 
to light. Histological changes mainly involve the retina. In advanced cases, the layers of the 
rods and cones of the outer nuclear layers become completely destroyed (Watson et a l, 
1972a). The condition has been reproduced in sheep in feeding experiments (Watson et a l, 
1972b). Affected sheep are known to develop thrombocytopenia and leukopenia (Moon 
and Raafat, 1951a). Like cattle, sheep may develop tumours of the gastrointestinal tract and 
the urinary bladder (Table 1.2).
1.2.4.3 Horses
In contrast to cattle and sheep, horses succumb to a different type of disease after 
feeding on bracken fern (Carpenter et a l, 1950; Evans et a l, 1951b; Evans, 1976a). 
Affected animals show incoordination, laboured breathing, rapid pulse and pronounced 
heart beat, severe muscular tremors, convulsive seizures and ultimately death (Evans et a l, 
1982). The clinical signs of this condition have given rise to the name ‘bracken staggers’; 
these are associated with lesions of the central nervous system. Administration of thiamine
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(vitamin Bl) alleviates the condition (Evans et aL> 1951b) promptly, if given soon after the 
onset of symptoms. It has therefore been suggested that the plant contains an antithiamine 
factor which inactivates thiamine. The factor has been demonstrated to be thiaminase 
enzyme (Evans et al., 1975). Thiaminase is more concentrated in the rhizome than in the 
frond, and catalyses the decomposition of thiamine by a base exchange reaction (Figure 
1.1, Evans, 1985b).
1.2.4.4 Pigs
Bracken poisoning in pigs is rare but when it does occur it is due to the antithiamine 
factor (Evans et al., 1972b). The first signs of poisoning are listlessness and anorexia. 
Terminally affected animals become recumbent and dyspnoeic. Sometimes, under outdoor 
farming conditions, early clinical signs can be missed and sudden deaths occur (Harding,
1972). Postmortem examination reveals heart lesions mainly involving enlargement, 
mottling and degenerative changes. The disease syndrome in this species has been referred 
to as ‘bracken rhizome poisoning’ (Evans et a l, 1963; 1972b; Harding, 1972).
1.2.4.5 Small laboratory animals
Although early trials with bracken involved large animals, subsequent studies have 
been conducted in small animals such as rats, mice, guinea pigs, rabbits and hamsters. 
Prolonged (64 days) feeding of bracken to rats, at a level of 34% (w/w) in the diet, caused 
development of tumours in the gastrointestinal tract particularly in the ileum (Evans and 
Mason, 1965). It was therefore concluded that bracken fern contained an agent which was 
carcinogenic in rats and that the same compound might be the cause of tumours in the 
gastrointestinal tract and the urinaiy bladder mucosa of cattle (Table 1.2).
Besides the small intestines (Pamukcu and Price, 1969; Hirono et al., 1970; 1973), 
tumours also occur in the urinary bladder and mammary glands in rats, mice, and guinea 
pigs (Evans et al., 1968; Hirono et al., 1983), as listed in Table 1.2. However, rats fed 
bracken fern without supplementation with vitamin Bl, develop a disease condition termed 
‘avitaminosis B l’, characterised by anorexia, incoordination, haemorrhages and
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polyneuritis. If treatment with vitamin Bl is not instigated, rats showing the symptoms 
invariably die (Weswig et al., 1946). Biochemical analysis reveals low blood and tissue 
thiamine levels, increased pyruvate and a disfunction of thiamine pyrophosphate dependent 
enzymes. Blood analysis reveals leucopenia and thrombocytopenia. Bone marrow damage, 
and atrophy of hair follicles, epidermis and sebaceous glands are seen at autopsy (Evans 
and Evans, 1949; Naftalin and Cushnie, 1951; Cordy, 1952).
Figure 1.1: Degradation of thiamine.
BH (co-substrate) may be primary or secondary amines, a sulfhydryl group or sulphinic acid. Thiamine (1), 
a water soluble vitamin, is also known as vitamin B l or aneurine. Its structure is comprised of substituted 
pyrimidine and thiazole rings. Thiamine is decomposed by heating under neutral and alkaline conditions, but 
in acid the compound is stable up to at least 120° C. Drying and storage do not affect the vitamin. 
Thiaminase 1, a constituent of bracken fern, induces thiamine deficiency in simple stomach animals. The 
enzyme catalyses the decomposition of thiamine by a base exchange reaction. The products formed are the 
‘pyrimidine-base’ compounds (II) and the thiazole moiety (III). In addition to bracken fern, thiaminases 
occur at high levels in several other pteridophytes such as Marsilea drummondii, Cheilanthes sieberi, and 
Pteridium esculentum (McCleary and Chick, 1977) and in some microorganisms, notably. Bacillus 
thiaminolyticum (Matsukawa et al., 1954), B.aneurinolyticus (Pill, 1967), Clostridium thiaminolyticum 
(Kimura, 1965), and C.sporogenes (Edwin and Jackman, 1974). Shell-fish, Crustacea and certain fresh-water 
fish also contain high levels of thiaminase (Fujita, 1954). Flavonoids such as isoquercitrin, astragalin and 
rutin have been shown to possess antithiamine activity (Nakabayashi, 1955), but are said to play no 
significant role in bracken induced avitaminosis Bl (Evans, 1975). Certain phenolic compounds such as 
3,4-dihydroxycinnamic acid (Beruter and Samogyi, 1967) and 5-O-caffeoylshikimic acid (Fukuoka, 1982) 
exhibit anti thiamine activity and occur in bracken fern. The biologically active forms of thiamine are 
phosphate esters. A number of phosphorylations occur at the terminal hydroxyl group. The conversion of 
thiamine to thiamine pyrophosphate (TPP) is the important reaction as TPP is the metabolically active 
form in terms of coenzyme function. TPP is the prosthetic group of three important enzymes, pyruvate 
dehydrogenase, a-ketoglutarate dehydrogenase and transketolase. It has been suggested that TPP plays an 
important role in maintenance of neuronal integrity and electrical transmission; reduced pyruvate 
dehydrogenase activity in the brain due to thiamine deficiency may interfere with cerebral energy 
metabolism, leading to observable neuronal disorders.
Nxn^ ^ C H 2-B
(H)
h 3c
+ BH H+
+
+
(I) Thiamine I
’CH3
(III)
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Table 1.1: Diseases of livestock caused by eating bracken.
Animal Disease syndrome (symptoms) Causative agent References
Cattle ‘Cattle bracken poisoning’ 
(pyrexia, haemorrhages, 
leucopenia and thrombocytopenia) 
‘Enzootic haematuria’
(bladder tumours)
Bone marrow toxin 
Carcinogen
Evans et al. (1954) 
Naftalin and Cushnie (1954) 
Guilhon et al. (1955) 
Rosenberger (1971) 
Pamukcu et al. (1967)
Horses ‘Bracken staggers’
(anorexia, ataxia, neuromus­
cular symptoms)
Thiaminase 1 Evans, (1976b) 
Evans et al. (1951b) 
Carpenter et al. (1950)
Pigs ‘Bracken rhizome poisoning’ 
(unthriftness, sudden death)
Thiaminase 1 Evans et al. (1963) 
Evans et al. (1972b), Harding (1972)
Sheep Bright blindness’
(retinal atrophy) 
Leucopenia and thrombo­
cytopenia
Unknown Watson et al. (1965; 1972a; 1972b)
Parker and McRea (1965) 
Bone marrow toxin Moon and Rafaat (195 lb)
Cattle & sheep Tumours
(alimentary cancer)
Carcinogen 
+papilloma virus ?
Grimshaw and Evans (1980) 
McRea and Head (1981) 
Jarret et al. (1978) 
Jarret (1982)
Modified from Evans et al. (1982).
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Table 1.2: The carcinogenic properties of bracken.
Animal Site (type) References
Cattle Urinary bladder Papillomas and Pamukcu (1963), Price and Pamukcu (1968) 
haemangiomas Jarret et al. (1978; 1982), McCrea and Head (1981) 
Transitional cell carcinoma Pamukcku et al. (1967)
Upper Squamous papilloma 
alimentrary tract and carcinoma
Jarret et al. (1978; 1982)
Intestines Adenoma and 
adenocarcinoma
Jarret et al. (1978; 1982)
Sheep Urinary bladder Transitional cell carcinoma 
and leiomyosarcoma
Evans et al. (1968); Harbut and Leaver (1969) 
McCrea and Head (1981)
Maxilla 
and mandibles
Fibrosarcoma Parker and McCrea (1965), Evans (1968)
Rumen, Intestines Papilloma and 
and colon adenocarcinoma
Parker and McCrea (1965), Evans (1968)
Thymus and 
Kidney
Lymphosarcoma
Thymoma
Parker and McCrea (1965), Evans (1968)
Rats Ileum Adenomas, Evans and Mason, (1965), Price and Pamukcu (1968) 
adenocarcinomas Pamukcu and Price (1969), Hirono et al. (1970; 1973; 1983) 
and sarcomas
Urinary bladder 
Mammary gland
Papilloma and Price and Pamukcu (1968), Hirono et al. (1970; 1983) 
carcinoma
Papillary carcinomas Hirono et al. (1983)
Mice Forestomach Papilloma and carcinomas Evans (1968; 1976a); Pamukcu et al. (1972)
Intestines adenomas, adenocarcinomas 
and sarcomas.
Hirono et al. (1975)
Bone marrow Lymphocytic leukemia Hirono et al. (1975), Pamukcu et al. (1972)
Lung Adenoma and adenocarcinoma Pamukcu et al. (1972)
Japanese Intestines, adenomas, adenocarcinomas, 
quail caecum and colon
Evans (1968)
Guinea
pigs
Intestines 
Urinary bladder
Adenomas, adenocarcinomas, 
and sarcomas 
Papillary carcinoma 
adenocarcinoma and 
transitional cell carcinoma
Evans et al. (1967); Evans (1968) 
Evans (1968)
Hamster Intestines Adenomas and adenocarcinomas Evans (1968)
In mice, the lymphoreticular tissue is the one primarily involved in cancer. In rats it is the gastrointestinal 
tract and the urinary bladder (Pamukcu et al., 1972).
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1.2.5 SOURCE OF EXPOSURE OF BRACKEN TO MAN
Environmental factors, both natural and synthetic, play a central role in the 
aetiology of various human cancers (Doll and Peto, 1978; Hirayama, 1979; Ames, 1986). 
Epidemiological studies have revealed that the high incidence of oesophageal and stomach 
cancer in Japan is partly associated with the bracken fern (Hirayama, 1979). Consumption 
of the plant is common in America, Canada and Japan and is suggested to be by far the 
most important means of exposure (Hirono et al., 1975; Hirayama, 1979). In places where 
bracken is not eaten as a food, indirect exposure may occur through milk because the 
carcinogenic substance is passed into the milk of cows grazing on bracken fern (Evans et 
al., 1972a). Therefore consumption of milk and other products originating from animals 
feeding on bracken might become hazardous to man, as such products have been shown to 
be carcinogenic in laboratory animals (Evans et a l, 1972a; Pamukcu et a l, 1978). 
Depending on the nature of the carcinogen, babies and foetuses may be at a greater risk 
through suckling and passage of the carcinogen across the placental barrier of women who 
have been exposed to bracken, respectively (Pamukcu et a l, 1976a). In highly infested 
areas, the toxic constituents might easily be leached into streams and rivers thereby making 
water another source of indirect exposure.
Bracken fem is a sporophyte and a single frond can produce as much as 1 g of 
spores in the summer months. Spores are shot out by the catapult mechanism of the 
sporangium. Spores caused tumours of various types in mice after oral administration 
(Evans, 1985a). In areas of high infestation there is, therefore, a possibility that large 
numbers of spores in the air might be inhaled in the same way as pollen and mould spores. 
This might present yet another important means of exposure to the carcinogen.
1.2.6 TREATMENT OF BRACKEN POISONING
Treatment of animals suffering from bracken poisoning has been extremely 
difficult. However, when it became known that in horses, pigs and other simple stomach 
animals bracken poisoning was due to an antithiamine factor (Weswig et al., 1946; Thomas
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and Walker, 1949), vitamin B1 became the treatment of choice. It was observed that 
immediate treatment at the onset of clinical signs led to better recovery (Carpenter et al., 
1950; Evans et al., 1951b; Cordy, 1952; Evans, 1976b). This treatment did not, however, 
stop other lesions such as gastrointestinal tumours developing in e.g.rats.
In cattle, vitamin B1 therapy fails to reverse the progression of the disease 
condition (Evans et al., 1982; Evans, 1984; Hirono, 1987) because the underlying cause is 
not a deficiency problem. Ruminai microflora synthesize enough vitamin B1 to meet bodily 
needs (Kon and Porter, 1954). Antibiotic therapy has been tried, but no beneficial 
therapeutic effect has been observed (Evans et al., 1958; Evans, 1984). Saito and 
Mochizuki (1986) have reported that release of histamine from mast cells might account for 
inflammation seen in acute bracken poisoning, notwithstanding that antiinflammatory 
drugs, have only produced a palliative effect (Evans et a l, 1968). B complex vitamins have 
been used as supportive therapy to stimulate appetite. Treatment of enzootic haematuria has 
involved blood transfusions and other forms of blood loss replacement therapy, although 
with minimal and temporary effect only.
1.2.7 CONTROL MEASURES
A control programme aimed at denying animals access to the plant and total 
eradication of the plant are needed to provide a long lasting solution in regions with high 
bracken infestation. Eradication methods have included burning, hand cutting, ploughing, 
and the use of herbicidal sprays. The results of all of them have been disappointing because 
the bracken rhizome system shoots easily to give new growth. Herbicides give better 
results. The herbicide asulam (methyl 4-aminobenzenesulphonyl carbamate) is effective, 
but the areas involved are too large and control becomes expensive and in many cases 
impracticable. This has been one of the major limitations to its widespread use (Biggins, 
1982; MacLeod, 1982). A biological control method which involves the use of insects 
which feed on bracken fronds has been under investigation (Heads and Lawton, 1986).
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Trials in South Africa have yielded promising results but the method has not yet been 
adopted on a large scale.
1.3 TOXIC BRACKEN CONSTITUENTS
Although bracken fem is now established as toxic to different species of domestic 
and laboratory animals, isolation and identification of the main toxic constituent^ has been 
difficult. This has probably been compounded by the fact that different disease syndromes 
are observed in different species of animals (Table 1.1). But even in cattle, it is not clear 
whether acute cattle bracken poisoning, and the other chronic forms of bracken poisoning 
are caused by the same or different bracken constituents.
Because of the carcinogenicity of the plant, extensive chemical studies have been 
carried out leading to the isolation and characterisation of a large number of constituents 
including: organic acids [shikimic acid (Evans and Osman, 1974), succinic acid, fumaric 
acid (Wang et al, 1973)], flavonoids [astragalin, isoquercitrin and rutin (Nakabayashi et 
al., 1955), kaempferol (Wang et al., 1973)], catecholamines and pteroquilines 
(Kwasniewski, 1955), sesquiterpenes (Fukuoka et al., 1972; 1978a; 1978b; Kuroyanagi et 
al., 1974; Yoshihira et al., 1978; Niwa et al., 1983a; Van der Hoeven et al., 1983), 
pterolactams (Takatori et al., 1972), tannins (Wang et al., 1976a), cyanogenic glycosides 
[prunasin (Kofod and Eyjolfsson, 1966)], and phytoecdysones (Kaplanis et al., 1967; 
Hikino et al., 1969). The various constituents of ferns have already been reviewed by Bert 
and Bottari (1968) and Cooper-Driver (1976).
Of the many constituents isolated, only a few have been shown to be of possible 
toxicological importance. These include, quercetin (Brown, 1980; Pamukcu et al., 1980), 
shikimic acid (Evans and Osman, 1974; Jones et a l, 1983), ptaquiloside (Niwa et al., 
1983a; Van der Hoeven et al., 1983), prunasin (Kofod and Eyjolfsson, 1966), and tannins 
(Wang et al., 1976a).
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1 .3 .1  QUERCETIN
1.3.1.1 Chemistry and occurrence
Quercetin (3,3\4\5,7-pentahydroxyflavone) (Figure 1.2) is a flavonoid, a group 
of naturally occurring compounds comprising more than 4000 individual members 
(Harbone, 1988). Flavonoids (Figure 1.3) are common in foods, mostly as glycosides in 
many plants. They are present in fruits, leafy vegetables, root tubers and bulbs, herbs, 
spices, legumes, cereals, tea, coffee and cocoa (Herrmann, 1976; Kuhnau, 1976, Brown, 
1980). Bracken contains quercetin at 570 to 870 mg/kg dry weight (Bryan and Pamukcu,
1982) and tea contains quercetin and kaempferol at concentrations exceeding 1% of dry 
matter (Bokuchava and Skobeleva, 1969). Table 1.3 shows quercetin content of some 
fruits and vegetables. The concentrations vary depending on many factors including 
growing conditions, stage of growth, size and degree of ripeness of fruits (Herrmann, 
1976). Quercetin is relatively stable and resists heat and dryness. Factors such as those that 
occur in food processing do not destroy the compound. However, oxidation of the 
phenolic hydroxyl side chain of ring B is known to occur to give quinones and 
semiquinones (Kuhnau, 1976).
Figure 1.2 Structure of flavonols
Kaempferol:
Quercetin:
Myricetin:
Flavonols. X = OH 
R l= H ; R2 = H
Rl=O H ; R2 = H
R l=O H ; R2 = OH
Isorhamnetin: Ri = OCHr R? = OH
3-deoxvflavonols. X = H__________
Apigenin: Rl = H; R2 = H
Luteolin: Rj = OH; R2  = H
Tricin: R% = OCH3; R2 = OCH3
Chrvsoerial: Ri = OOfo: R? = H
Flavonoids have diphenylpropane (C6C3C6) skeleton, and structural features of 2-phenyl-benzo(y)pyrane. 
The benzene rings (A and B) are linked through a heterocyclic pyrane ring C. Most flavonols, to which 
quercetin belongs, have the 3’- and 4’-positions hydroxylated, or hydroxylated only at 4 ’-position. The 
flavonoids occur mostly as glycosides. The sugars involved in the formation of glycosides are: D-glucose, 
D-galactose, L-rhamnose, L-arabinose, D-xylose, D-apiose, D-glucuronic acid and in rare instances D- 
galacturonic acid. The binding site of the sugar moieties is at 3-position. Bonding can sometimes also occur 
at 5- and 7-positions. The most common glycosides of quercetin are: 3-O-galactoside (hyperin), 3-0- 
rhamnoside (quercitrin), 3-O-glucuronide (quercituron), 3-O-glucoside (isoquercitrin), and 3-0- rhamnoside- 
galactoside (bioquercetin), 3-O-rutinoside (rutin) (Herrmann, 1976; Brown, 1980).
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Flavonols
.OH
Isoflavonol
Flavanone
Havone
OH
Chalcone
Isoflavanone
Isoflavone
Catechin
Coumarin B enzo-y-pyrone
Figure 1.3: Common classes of flavonoids and related compounds.
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Table 13: Quercetin content of some fruits and vegetables.
Sweet cherry (6-24) Apple* (98-263) (<l-3)a Brussels sprouts** (50) (25)b
Sour cherry (23-80) Pear* (28)(<0.1)a Cauliflower** (30) (l)b
Plum (<0.1-15) Quince* (180) (<0.01)a Kohlrabi** (25) (<0.1-7)b
Peach (04) Bell pepper* (63) (<1^ Kale** (35-50)
Apricot (53) Kohlrabi* (7) (<l)a Small radish** (0-30) (0-0.1)b
Raspberry (29) Small radish* (0) (0)a Radish** (35) (0)b
Blackberry (33) Horse-radish* (0) (o)a Rutabaga** (40) (0.1)b
Blackcurrant (33-68) Potato* (047) (0-0.2)a Horse-radish** (50) (0)b
Red currant (2-27) Asparagus* (0.3) (<0.1)a Scorzonera** (230) (<l)b
White currant (3-28) Potato** (770-1000) (2)b Endives*** (2.4-150)
Gooseberry (<0.1) Tomato** (155420) (2.5-7)b Cabbage*** (<0.1-6)
Billberry (32) Pea** (1580-1590) (0-130)b Broccoli*** (6)
Billbeny (cultivated) (105-160) Broad beans** (1340) (19-36)b Leek*** (10-25)
Elderberry (105-237) Lettuce*** (<l-273) Chive*** (300)
Bracken fem (570-580)°
Table modified from Herrmann (1976).
Data in brackets aie quercetin content (mg aglycone per kg of fresh weight).
* - Estimated concentration in the outer parts of the tissues (skin, peel).
** - Estimated concentration in the leaves.
*** - Estimated concentration for all the leaves of the head, 
a - Concentration in the remaining tissues, 
b - Concentration in the other parts of the same plants.
c - Concentration of quercetin as liberated aglycone in mg per kg dry weight (Bryan and Pamukcu, 1982)
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1.3.1.2 Antioxidant effect
Quercetin has been shown to possess antioxidant activity. Phenolic antioxidants act 
by donating electrons and / or breaking radical chains thereby protecting substances that can 
easily be oxidized (Shahidi and Wanasundara, 1992). In the food processing industry, they 
are of immense importance because without them compounds such as unsaturated fatty 
acids and vitamin C could very easily undergo deterioration by contact with air. When 
polyunsaturated lipids of food are exposed to light, heat, ionizing radiation, metal ions or 
metalloprotein catalysts a free radical chain reaction may be initiated as shown in Reaction 1 
to 3 below. Quercetin can interfere with this oxidation by reacting with the radical species 
as shown in Reaction 4 below, and by chelation of catalyst metals, thereby terminating the 
autoxidation of polyunsaturated lipids. [In Reactions 1 to 4 below (Shahidi and 
Wanasundara, 1992), RH is lipids; R* is alkyl radical; ROO* is peroxyradical; ROOH is 
hydroperoxide; QH2 is quercetin; QH- is quercetin semiquinone; Q is quercetin quinone 
(3’,4’-dehydroquercetin). Reaction 4 competes with reaction 3].
RH ---------------► R- + H- (1)
R" + 0 2 — ROO- (2)
ROO- + RH -►  R- + ROOH (3)
R + R"; R + ROO- ; ROO- + ROO- ^ — Form non radical speccis
QH2 Z N
ROO* ROOH
QH2
QH*
ROO* ROOH
y (4)
Quercetin reduces capillary fragility and permeability (Havsteen, 1983; Middleton, 
1984) in vivo. One of the explanations for reduced capillary fragility and permeability has 
been that the antioxidant effect protects ascorbic acid from losses through oxidation and 
hydrolysis (Parrot and Cotereau, 1946), but the current opinion is that copper chelation 
(Section 1.3.1.3) causes inhibition of hyaluranidase and may therefore enhance membrane
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stability; alternatively, tissue lysine oxidases indirectly involved in producing cross links in 
collagen and elasdn are copper enzymes and flavonoids, such as quercetin, may therefore 
assist their function and contribute to the stability of structural proteins and thereby 
reducing the fragility of capillary walls. In addition, flavonoids inhibit lysosomal 
hydrolases which degrade glycosaminoglycans and membrane bound ATPases involved in 
membrane transport (Havsteen, 1983); such inhibitory effects might, amongst other things, 
lead to reduced capillary permeability. Furthermore, inhibition of catechol-O- 
methyltransferase (COMT) (Axelrod and Tomchick, 1959; Gugler and Dengler, 1973a) 
slows the inactivation of adrenaline and noradrenaline which in turn promotes the 
andhistaminic and antiinflammatory effects of these catecholamines.
The high degree of hydroxylation of the A and B rings of quercetin affords it 
superior antioxidant properties than many other flavonoids. Quercetin possesses phenolic 
hydroxyl groups in the 3’- and 4’-positions of ring B, and the 2, 3- double bond which are 
important for the antioxidant activity (Mehta and Seshadri, 1959). Quercetin is active at 
concentrations as low as 10 |iM (Mehta and Seshadri, 1959). Unfortunately, the degree of 
hydroxylation of A and B rings (Hodnick et al., 1986) which is important in antioxidant 
effect and of beneficial effect in food preservation (Kuhnau, 1976), is also important in 
mutagenesis. Although flavonoids are the most potent antioxidative compounds of plant 
phenolics, their potential toxicity as mutagens has precluded their immediate use in food 
industry.
1.3.1.3 Metal chelating effect
Quercetin chelates many types of metal ions to form complexes. Chelation of metal 
ions such as copper, iron, magnesium, etc., is important from both nutritional and 
toxicological points of view. For example, oxidation of ascorbic acid by ascorbic acid 
oxidase is catalysed by metallic ions particularly copper ions (Clegg and Morton, 1968). 
The o-diphenol (3% 4’- dihydroxy-) grouping in ring B, and the ketol structure (3- 
hydroxyl, 4’- carbonyl couplet of the gammapyrone ring) are the copper complexing sites
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(Clark and Geissman, 1949; Shahidi and Wanasundara, 1992) and therefore essential for 
activity. Although Clementson and Andersen (1966) suggested that quercetin inhibited 
oxidation of ascorbic acid by chelating copper, it has been shown that flavonoids exert their 
antioxidant effects even in the absence of copper complexing ability (Clegg and Morton, 
1968).
Enzymes that require metal ions as cofactors for activity can be inhibited by 
quercetin. Chelation of metal ions and the subsequent inhibition of enzymic activity has 
been suggested as one of the important mechanisms for the high biological effects exhibited 
by the flavonoids (Havsteen, 1983). However, under suitable conditions, oxidation of the 
phenolic hydroxyl side chains of ring B to quinoid residues is known to take place 
(Kuhnau, 1976) and these quinones, particulaly the o-quinones, are likely to condense with 
amino acids or sulphydryl groups on enzyme proteins to form stable complexes, thereby 
inactivating the respective enzymes (Kuhnau, 1976). This mechanism is also thought to be 
involved in certain enzyme inactivation by flavonoids not apparently metal-catalysed.
1.3.1.4 Antihistaminic and antiinflammatory property
Catechol-O-methyltransferase (COMT) is a cytosolic enzyme which quickly 
metabolizes adrenaline and noradrenaline (Gugler and Dengler, 1973a). Quercetin, and 
flavonoids in general have structural similarities to catecholamines and have been shown to 
block the metabolism of adrenaline by competitive inhibition in vitro and in vivo (Axelrod 
and Tomchick, 1959). Inhibition of COMT by quercetin and by other flavonoids, 
especially those hydroxylated at 5,3’,4’- or 5,3’,4 \5 ’- positions (Gugler and Dengler, 
1973a) should result in the slowing of inactivation leading to a prolongation of duration of 
action of circulating adrenaline with subsequent enhanced antihistaminic and 
antiinflammatory effect. Increased levels of catecholamines could improve the tonus of 
precapillary sphincters and further promote stabilization of the capillary system and a 
decrease in permeability.
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Quercetin inhibits antigen induced histamine release from actively sensitised rat 
peritoneal mast cells (Fewtrell and Gomperts, 1977a; 1977b). Hope et al. (1983) have 
demonstrated inhibition of antigen induced histamine release, slow-reacting substances of 
anaphylaxis (SRS-A) release, biosynthesis of (SRS-A), and lipoxygenase activity in vitro. 
Blockade of mast cell histamine release as demonstrated by Fewtrell and Gomperts (1977a; 
1977b) has been suggested to involve inhibition of membrane transport adenosine 
triphosphatases (ATPases; specifically Ca2+ATPase). Evidence of the antiinflammatory 
nature of quercetin has been demonstrated by inhibition of the activation of 
polymorphonuclear leucocyte (Berton et al., 1980) and polymorphonuclear leucocyte 
lysosomal enzyme release (Lee et al., 1982) in vitro.
1.3.1.5 Effect on other enzyme systems
Quercetin may affect the activity of many other enzymes including cyclic nucleotide 
phosphodiesterases (Ferrell et al., 1979; Ruckstuhl and Landry, 1981), membrane bound 
enzymes such as the ATPases associated with ion transport across the plasma membrane 
(Carpenedo et al., 1969; Suolinna et al., 1974; Kuriki and Racker, 1976; Shoshan and 
MacLennan, 1981), and enzymes involved with the metabolism of lipids (Fiebrick and 
Koch, 1975a; 1975b; Baumann et al., 1980; Showed et al., 1981). The inhibitory effects 
of quercetin on so many enzymes (Gschwendt et al., 1983) including those involved in 
ATP production raises the question as to whether it can possibly be non toxic. Much 
depends on its bioavailability.
1.3.1.6 Anticarcinogenic property
In recent years flavonoids have been regarded as important food constituents 
because of their antioxidant and anticarcinogenic properties. Quercetin inhibits the induction 
of mammary cancer in rats by intragastric instdladon of 7,12-dimethylbenz(a)anthracene 
and intravenous injection of N-nitrosomethylurea (Verma et al., 1988). It suppresses 
hepatic tumour formation in Donryn strain rats treated with 0.6% (w/w) p- 
dimethylaminoazobenzene (Nagase e ta l, 1964). Feeding quercetin to C57B L/6J mice at a
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level of 4% (w/w) in feed inhibited benzo(a)pyrene induced nuclear damage in colonic 
epithelial cells (Wargovich et al., 1985). The anticarcinogenic property is not unique to 
quercetin, and is possessed by other flavonoids also.
The mechanisms involved in the anticarcinogenicity are not clear. The oxidative 
destruction of potential carcinogens by induction of the enzymes that oxidize carcinogens to 
harmless metabolites has been suggested. For example, the microsomal enzyme aryl 
hydrocarbon hydroxylase that detoxifies polycyclic carcinogens in various tissues by 
hydroxylation is induced by some flavonoids (Wattenberg etal., 1968; Wattenberg and 
Leong, 1968; 1970; Cutroneo etal., 1972; Cutroneo and Bresnick, 1973). However, only 
flavonoids that are devoid of hydroxyl groups, water insoluble and lipophilic are capable of 
inducing drug-metabolising enzymes. The synthetic flavones, 4’-bromoflavone and 5,6- 
benzoflavone (p-naphthoflavone) (Cantrell and Bresnick, 1971; Burki et al., 1973), and 
the highly methylated naturally occurring flavones such as tangeretin and pentamethyl- 
quercetin form typical examples (Wattenberg et al., 1968; Wattenberg and Leong, 1970) of 
enzyme inducers. Since attempts to induce drug metabolizing enzymes in vivo with 
quercetin have not succeeded (Brouard et a l, 1988; Sies et al., 1989), other mechanisms 
must be involved in the anticarcinogenicity of the flavonoids. Quercetin has been shown to 
inhibit 13-O-tetradecanoylphorbol-1,3-acetate (TPA) induced tumour promotion (Kato et 
al., 1983). TPA induced tumour promotion is believed to occur via induction of ornithine 
decarboxylase (Fischer et al, 1982; Kato et a l, 1983).
1.3.1.7 Fate after oral intake
Quercetin occurs in foods mostly as p-glycoside derivatives which, being 
hydrophilic and of relatively high molecular weight, cannot be absorbed easily across the 
gastrointestinal tract epithelium. Moreover, enzymes capable of splitting these glycosidic 
bonds are not secreted by the digestive system (Griffiths and Barrow, 1972). However, 
glycosidase enzymes produced by the microflora in the lower intestines (Hawksworth et 
a l, 1971; Prizant et al, 1976) cause hydrolysis of the glycosides to release the aglycone
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and the sugars (Scheline, 1968). Orally administered flavonols (3-hydroxyflavonols) are 
known to be metabolized to hydroxylated derivatives of phenylacetic acid originating from 
a fission of ring C between C-3 and C-4 (Figure 1.4) (Petrakis et a l, 1959). Phenylacetic 
acid derivatives are further dehydroxylated or methylated by microbial metabolism to yield 
several hydroxybenzoic acids (Booth et a l, 1956; Douglas and Hogan, 1958; Griffiths and 
Smith, 1972a). Flavonoids of all subgroups are known to undergo bacterial metabolism in 
the lower intestinal tract. Glycosidase action is known to proceed faster than ring cleavage 
leading to the presence of free flavonols in the lower intestines that may be absorbed. 
Bacterial metabolism of the flavonoids in the intestines is supported by the findings that 
sterilization of the gastrointestinal tract with antibiotics (Booth and Williams, 1963; 
Nakagawa et a l, 1965; Das and Griffiths, 1969; Griffiths and Smith, 1972b), or the use of 
germ-free animals completely inhibits the formation of these metabolites. The results with 
germ free animals and those of animals whose gastrointestinal tracts have been sterilized 
with antibiotics also serve to demonstrate that intestinal digestive enzymes are not capable 
of metabolizing quercetin.
Griffiths and Smith (1972a; 1977b) have demonstrated that a free hydroxyl group 
at C-5 and / or C-4 is necessary for the flavonoid to be metabolised by the microflora. 
Thus, flavonoids with a 5,4,3',4' hydroxylation pattern, which coincidentally account for a 
high proportion of food flavonoids, are subject to metabolism by gastrointestinal 
microorganisms and hence the parent compound will be absorbed only to a very limited 
degree. Flavonoids are quickly oxidised in the liver and excreted in the bile or urine as 
glucuronide or sulphate conjugates (Barrow and Griffiths, 1971; Das and Sothy, 1971). 
The fate of the A ring for many flavonoids seems to be unknown although suggestions 
have been made that it may be degraded to CO2, based on the results of labelled 
[14C]catechin, which on oral administration to guinea pigs and rats gives rise to 14CC>2 
(Das and Griffiths, 1969). It has previously been suggested that the A ring of quercetin is 
metabolized to phloroglucinolcarboxylic acid and phloroglucinol in the rat (Kallianos et al, 
1959), but Masri et a l  (1959) believe that these derivatives may be formed during the
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extraction process. Gottlieb (1975), in a review of mechanisms of oxidation and reduction 
of flavonoids, has indicated that decarboxylation of phloroglucinolcarboxylic acid occurs to 
form phloroglucinol.
Few kinetic studies of quercetin have been conducted in either man or laboratory 
animals. Those performed (Havsteen, 1983) have mainly involved analysis for urinary 
metabolites after administration of quercetin or its gycosides. In rats, oral administration of 
quercetin results in increased levels of 3,4-hydroxyphenylacetic acid and 3-methoxy-4- 
hydroxyphenylacetic acid (homovanillic acid) excretion in the urine (Murray et al., 1954; 
Booth et al., 1956; De Eds, 1968). Petrakis et al. (1959) showed that increased levels of 
homovanillic acid and m-hydroxyphenylacetic acid originated from orally administered 
quercetin. Normally, urine contains a small amount of these metabolites derived from other 
food flavonoids (Nakagawa et a l, 1965).
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Figure 1.4: The metabolic route of quercetin after oral administration to rodents.
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1.3.1.8 Antimutageniç and mutagenic enhancing effects
Flavonoids and related derivatives with phenolic hydroxyl groups inhibit the 
mutagenic activity of benzo(a)pyrene 7,8-diol-9,10-epoxide-2, the ultimate mutagen and 
carcinogenic metabolite of benzo(s)pyrene (Huang et ah, 1983; Ogawa et al., 1985). It is 
thought that the inhibition possibly results from interactions between the benzo(a)pyrene 
metabolites and the hydroxylated flavonoids (Huang et al., 1983; Ogawa et al., 1985) and/ 
or inhibition of the monoxygenase system that metabolizes the hydrocarbon (Wiebel et ah, 
1974; Buening et al., 1981; Huang et al., 1983). Many flavonoids without the phenolic 
hydroxyl or methoxy groups have been found to lack inhibitory effects. Analysis of 
structure activity relationships showed that phenolic hydroxyl groups on ring B were 
important for antimutageniç activity (Huang et a l, 1983). The reported observations thus 
indicate that the flavonoids constitute a group of natural compounds that can inactivate /  
inhibit some carcinogens and in the process, possibly, protect man and animals from their 
deleterious effects.
It is important, however, to note that quercetin and several other flavonoids such as 
kaempferol, myricetin, morin, and galangin, have a mutagenic enhancing effect for 2- 
acetylaminofluorene in Salmonella typhimurium (Ogawa et al., 1985; 1987b), both in the 
absence and presence of the activation system (Ogawa et a l, 1987c). Similarly, 
neohesperidindihydrochalcone enhances the mutagenicity of 2-acetylaminofluorene and of 
N-methyl-N’-nitro-N-nitrosoguanidine (MNNG) (Brown and Dietrich, 1979). 2- 
Acetylaminofluorene is a carcinogen belonging to a class of compounds different from that 
of benzo(o)pyrene. The effect of quercetin on mutagenic / carcinogenic amines and amides 
has also been examined. The mutagenicity of the tricyclic aromatic amines, 
aminoanthracene, and aminophenanthracene and their acetamides is enhanced by quercetin 
(Ogawa et al., 1987a). This enhancement of the mutagenic effects of compounds by 
quercetin should, therefore, be viewed seriously because of its ubiquitous nature and its 
occurrence in the toxic plant bracken fem, known to contain several other mutagenic 
compounds. Quercetin itself shows genotoxicity in different test systems (Brown, 1980).
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1.3.1.9 Mammalian carcinogenesis
Studies on quercetin carcinogenicity have produced contradicting results. Pamukcu 
et al. (1980b), in an attempt to identify the bracken carcinogen, produced evidence that 35- 
day-old male and female ‘Norwegian’ rats treated with quercetin at a level of 0.1% (w/w) in 
feed for 58 weeks developed ileal adenomas and adenocarcinomas, and urinary bladder 
carcinomas. These results prompted further similar studies by several other research 
groups. Erturk et al. (1983) demonstrated a weak carcinogenic effect of quercetin in rats, 
though Saito et al. (1980) and Hirono et al. (1981) found no effect in mice and ACI strain 
rats respectively after administration of quercetin at a level of up to 10% (w/w) in the feed 
throughout their life span. Studies conducted in mice (LACA) and rats (Fischer and 
Sprague-Dawley) by Hosaka and Hirono (1981), Takanashi et al. (1983) and Stoewsand et 
al. (1984) did not reveal any carcinogenic effect, and nor did studies in golden hamsters 
conducted by Morino et al. (1982). Interest in quercetin toxicity and carcinogenicity is not 
new. Van Duuren and Goldschmidt (1976) reported on negative results following 
application of quercetin to the skin of female ICR / Ha Swiss mice three times weekly for 
52 weeks. Urinary bladder implantation of cholesterol pellets containing quercetin did not 
induce a significant incidence of neoplasms (Boyland et al., 1964; Wang et al., 1976a). 
Ambrose et al. (1952), in a toxicity study in which rats were fed 1% (w/w) quercetin in 
feed for 410 days, observed no carcinogenic effects. However, the number of animals (3- 
5) per dose used by Ambrose et al. (1952) were too few for carcinogenicity evaluation, 
particularly for weak to moderate carcinogens.
Considering the array of biological activities, including antimutageniç and 
mutagenic enhancing effects, it is perhaps not surprising that contrasting effects should be 
reported for quercetin carcinogenicity. More information is required on factors and 
mechanisms involved in quercetin mutagenicity and carcinogenicity as this might help in 
explaining the observed differences. For example, quercetin might be an incomplete 
carcinogen, acting as either an initiator, promotor, or a cocarcinogen. Therefore, its activity
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as a carcinogen may depend on simultaneous exposure to dietary cocarcinogens / 
comutagens.
1.3.1.10 Genotoxicity
Genotoxicity studies for quercetin have been conducted using mainly the bacterial 
assay systems, the Salmonella /  mammalian microsome mutagenicity test. Quercetin, 
kaempferol and several other flavonoids are mutagenic in this system (Bjeldanes and 
Chang, 1977; MacGregor and Jurd, 1978; Brown and Dietrich, 1979; Brown, 1980; 
Nagao et al., 1981). Mutagenicity in Escherichia coli and in Saccharomyces cereviciae has 
also been reported (Hardigree and Epler, 1978). Quercetin was found to be mutagenic in 
L5178Y mouse lymphoma cells (Amacher et al., 1979; Meltz and MacGregor, 1981), V79 
Chinese hamster cells (Maruta et al., 1979) and Chinese hamster lung cells (Terada et al., 
1983). Induction of sister chromatid exchanges in cultured lymphoblastoid cells 
(Sugimura, 1979; MacGregor et al., 1983) and cultured human and Chinese hamster cells 
(Yoshida et al., 1980) has also been reported. Testing for genetic effects of quercetin in 
vivo has not received much attention. Only a handful of reports based on the micronucleus 
test are available. Sahu et al. (1981) reported that quercetin produced positive genotoxicity 
results in the micronucleus test, although others have produced contradicting reports 
(MacGregor, 1979; Aeschbacher et a l, 1982; MacGregor et a l, 1983).
Although it is not easy to determine accurately the average intake of mutagenic and / 
or promutagenic flavonol glycosides for man and animals. Brown and Dietrich (1979) are 
of the opinion that 50 mg quercetin equivalents per day would be a reasonable estimate for 
man. This intake is relatively high in chronic terms. The daily intake for grazing animals is 
likely to be higher. MacGregor (1979) examined the genetic effects of some flavonoids in 
vivo in mice and found that quercetin did not increase the normal frequency of 
micronucleated polychromatic erythrocytes (MNPCE) in the bone marrow after either oral 
or intraperitoneal administration. Sahu et al. (1981) however, in a similar study with 
Swiss mice found that quercetin administered at 200 to 800 mg/kg bwt by the
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intraperitoneal route did increase the number of MNPCE. Further studies by MacGregor et 
al. (1983) failed to reproduce the results of Sahu et al. (1981).
1 .3 .2  SHIKIMIC ACID
1.3.2.1 Chemistry and occurrence
Shikimic acid (3,4,5-trihydroxy- 1-cyclohexene-1 -carboxylic acid) (Bohm, 1965; 
Haslam, 1974) was first isolated from bracken fern by Leach et al. (1971), but its 
discovery dates back to 1885 when it was first isolated from the plant Illicium religioswn 
known to the Japanese as Shikimi-no-ki; hence the name shikimic acid (Bohm, 1965). At 
room temperature it is a white solid, freely soluble in water. Shikimic acid is an 
intermediate in the pathway leading to biosynthesis of aromatic amino acids in plants 
(Seifter et al., 1971), such as tryptophan, phenylalanine and tyrosine. Because of its 
natural occurrence in all plants including food items (Yoshida et al., 1975), it has always 
been viewed as a harmless substance. However, its isolation from bracken fem and the 
subsequent report that it is toxic and carcinogenic to mice (Evans and Osman, 1974) has led 
to the need for further studies.
1.3.2.2 Fate after oral intake
Extensive studies of shikimate metabolism in rats both in vitro and in vivo have 
been carried out by Brewster (1977). Shikimate is extensively metabolised after oral 
administration in animals with the gastrointestinal microorganisms playing a key role as 
illustrated in Figure 1.5. Gastrointestinal microorganisms of many animal species 
metabolize shikimate to a number of metabolites, some of which are excreted unchanged, 
whilst others such as cyclohexanecarboxylate (Brewster et a l, 1977a), the major metabolite 
(Brewster et a l,  1978; Wheeler et al., 1979), are absorbed. In the tissues, 
cyclohexanecarboxylate undergoes aromatization and further metabolism by mammalian 
enzymes (Fig. 1.5) to hippurate, 3,4,5,6-tetrahydrohippurate, hexahydrohippurate, benzyl- 
and cyclohexylcarbonyl-p-D-glucuronides (Brewster, 1977; 1979). Brewster et al. (1978) 
have demonstrated that shikimate is not metabolized by mammalian tissues. Following
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intraperitoneal administration of shikimate in rats almost all (>98%) of the dose is excreted 
unchanged in the urine within 6 h, with about 0.8% being excreted in the bile. After oral 
administration of radiolabelled shikimate, equal amounts of radioactivity are recovered in 
both the urine and faeces. Of the administered dose, >95% is excreted in the urine, faeces, 
and expired air within 24 h. Sterilization of the gastrointestinal tract with antibiotics before 
administration of shikimate almost completely abolished urinary excretion of the 
metabolites.
Cyclohexanecarboxylate and cis and trans 3,4-dihydroxycyclohexanecarboxylate 
are bacterial metabolites that arise through various pathways, but only 
cyclohexanecarboxylate is absorbed, the other metabolites being excreted in the faeces. 3,4- 
Dihydroxycyclohexanecarboxylates (about 60% of the dose) are major metabolites in the 
faeces. Some protochatechuic acid is also formed by bacterial action on shikimate, and 
some unchanged shikimate is excreted in the faeces. Hippurate, 3,4,5,6- 
tetrahydrohippurate and hexahydrohippurate, which are eliminated in the urine, arise from 
liver metabolism of cyclohexanecarboxylate (Brewster et al., 1977b; 1977c). Conjugated 
catechol, 3,4-dihydroxycyclohexanecarboxylates, and unchanged shikimate have also been 
identified from the urine (Brewster et al., 1978). Catechol may be formed from the 
decarboxylation of protocatechuic acid, and excreted as catechol sulphate or glucuronide 
conjugate.
1.3.2.3 Toxicity in animals
Shikimate has always been viewed as a harmless substance. Reports on acute 
toxicity are few, either in vitro in cell cultures or in vivo in experimental animals. Evans 
and Osman (1974) reported that the dose of the compound that kills 5% (LD5) of mice was 
1 g/kg of body weight by the intraperitoneal route. There is no infoimation on the cytotoxic 
effects of the compound. This is of importance considering that bracken fem causes bone 
marrow depression and shikimate is regarded as one of the causative agents (Evans and 
Osman, 1974).
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Figure 1.5: Metabolic pathways of shikimic acid after oral administration in the rat
(Modified from Tônesê7ârri983)!
* - microbial metabolites.
*** - microbial metabolite (proposed)
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O’Donovan et al. (1977) reported no teratogenic effects of shikimate although it did 
cause a reduction in blastocyte implantation in mice. However, in a similar experiment, 
Yasuda et al. (1974) showed that shikimate was teratogenic in mice, affecting the 
ossification of the stemebrae. Evans (1985a) reported that in developing quail shikimate 
caused development of beak deformities. Al-Salmani (1980) showed that shikimate caused 
a delay in ossification of the embryonic stemebrae or ribs in mice and rats, although no 
gross deformities were observed.
1.3.2.4 Genotoxicity
Shikimate is not mutagenic in the standard Salmonella / mammalian microsome 
mutagenicity test (Jacobsen et al., 1978). Its metabolite cyclohexanecarboxylate, and those 
formed after its absorption have been demonstrated to be non-mutagenic in the bacterial 
mutagenicity test without or with activation (Jones et al., 1983). Genotoxicity has however 
been demonstrated in baby hamster kidney (BHK-21) cells in which it caused 170 
transformants per 106 survivors at the LC50. Dominant lethal mutations after both oral and 
intraperitoneal administration to male mice have been reported (Evans and Osman, 1974). 
Since none of the shikimate metabolites exhibit mutagenic or cell transforming activities, 
the metabolism of shikimate might represent a detoxifying process, although Jones et al. 
(1983) propose that some undetected lactones might account for its activity. These lactones 
have been synthesised by Jones and found to be inactive (personal communication).
1.3.2.5 Mammalian carcinogenicity
Shikimate does not belong to any known groups of chemical substances with 
proven carcinogenicity in animals. However, carcinogenicity studies by Evans and Osman 
(1974) have demonstrated a carcinogenic effect in mice. Precancerous and cancerous 
lesions involving the glandular gastric mucosa, particularly the pyloric area, and leukemias, 
including the lymphatic and reticular cell types, occurred in mice treated with shikimate. 
However, Hirono et al. (1977) could not demonstrate any carcinogenic effect following 
administration of shikimate to rats, nor could Jones and Brewster, in Swiss white mice and
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Wistar albino rats (personal communication). It is important to note that animals respond 
differently to toxins depending on many factors including animal species, breed, and age. 
Hence negative results observed in rats cannot necessarily nullify findings in mice. 
Shikimate might act as a promoter, requiring initiated cells, or as a cocarcinogen.
1 .3 .3  PTAQUILOSIDE
1.3.3.1 Chemistry and occurrence
Ptaquiloside (aquilide A), an unstable norsesquiteipene glucoside (Niwa et al., 
1983a; 1983b; Van der Hoeven et al., 1983) (Figure 1.6) is a colourless, amorphous 
hygroscopic powder. The compound was independently isolated from bracken fem by 
Niwa et al. (1983a) and Van der Hoeven et al. (1983) while searching for the carcinogenic 
bracken constituent. Ptaquiloside possesses an illudane type of structure, the natural 
occurrence of which is rare (Nozoe, 1974; Ayer and MaCaskill, 1981). Other known 
members of this group (Figure 1.6) are illudin S, a toxic compound isolated from the 
mushroom Clitocybe illudens and Lampteromyces japonicus (McMorris and Anchel, 1963; 
Nozoe, 1974), illudin M (McMoiris and Anchel, 1965), and hypacrone isolated from the 
fem Hypolepis punctata (Hayashi et al., 1977b). Illudin S and M have anticancer 
properties, possibly by inhibiting DNA synthesis (Kelner et a l, 1987). The content of 
ptaquiloside in Pteridium aquilinwn ranges from 0.02 to 0.25% of the dried plant material 
depending on the season and the part of the plant (Saito et al., 1989; Van der Hoeven et al,
1983). Ptaquiloside has also been isolated from two other plants of the Pteridaceae family, 
namely Pteris cretica and Hypolepis punctata, although no reports are available for 
poisoning in animals (Saito et a l, 1989).
In a dry atmosphere, ptaquiloside is stable at room temperature for several days, 
and for more than 6 months at temperatures below 0° C. Gradual decomposition occurs if it 
is kept in aqueous or alcoholic solutions at room temperature. High temperatures enhance 
degradation, for example, at 60° C, 80% of the compound degrades in 14 days. Sunlight 
causes decomposition to 21% in 21 days (Ojika et a l, 1987).
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Acidic conditions also affect the stability of ptaquiloside. Under these conditions, 
ptaquiloside (Figure 1.7) undergoes aromatization with the liberation of D-(+)-glucose to 
form 1-indanone derivatives, pterosins B and O (Niwa et al., 1983a; 1983b; Ojika et a l, 
1987). Under slightly alkaline conditions at room temperature, ptaquiloside is transformed 
to a dienone, with release of D-(+)-glucose (Ojika et a l, 1987). In more alkaline conditions 
complete decomposition to pterosin B occurs. For example, at room temperature, the half 
life of ptaquiloside is 6.3 min and 69 sec in 10 mM sodium carbonate solution pH 10 and 
pH 11 respectively. Under acidic conditions, however, decomposition of ptaquiloside is 
reported to be gradual. At pH 4.0, for example, 50% of ptaquiloside decomposes in 7 days 
(Saito et a l, 1989).
The intermediate degradation product, the dienone, is extremely unstable, 
particularly in weakly acidic aqueous solutions at room temperature. It undergoes 
conversion to pterosin B (Ojika et a l, 1987). The half life of ptaquiloside in 0.01 M 
sulphuric acid - methanol at 22o C is about 2 h (Van der Hoeven et al., 1983).
1.3.3.2 Carcinogenic property
Rats fed a diet containing 0.027 - 0.08% (w/w) ptaquiloside developed ileal, 
bladder and mammary tumours by day 210. In the ileum, tumours were confined to the 
distal 10 cm and were of the epithelial (adenoma and adenocarcinoma) and non-epithelial 
malignant type (malignant fibrous histiocytoma). Transitional cell carcinomas, keratinizing 
squamous cell carcinomas and sarcomas developed in the urinary bladder (Hirono et a l, 
1984a; 1984c; 1987). These tumours are typical of bracken carcinogenicity.
1.3.3.3 Genotoxicity
Bacterial mutagenicity studies have been conducted using Salmonella typhimurium 
strains TA100 and TA98. Ptaquiloside (aquilide A) was mutagenic in TA 100 and TA 98 
but only after pre-incubation in an alkaline medium (Van der Hoeven et a l, 1983; Nagao et 
al, 1989). The mutagenicity of ptaquiloside is due to the dienone so formed (Matoba et a l, 
1987), the cyclopentane ring being necessary for mutagenicity.
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Ptaquiloside induces sister chromatid exchange (SCE), HGPRT-deficient mutants 
in V79 Chinese hamster cells, and unscheduled DNA synthesis in hepatocyte primary 
cultures (Mori et al., 1985). Furthermore, it induces type III transformed foci in C3H 
10T1/2 cells (Van der Hoeven et al., 1983). Ptaquiloside produced chromosomal 
aberrations in Chinese hamster lung cells (line CHL) at concentrations as low as 11.3 JIM. 
The clastogenic effect was pH dependent. The same activity was observed at 90-fold higher 
dose at pH 5.3 in the culture medium compared with the activity at pH 7.4 or pH 8.0.
1.3.3.4 Reactions with amino acids, nucleosides and nucleotides
Ptaquiloside and its intermediate metabolite, the dienone, act as alkylating agents 
towards different types of nucleophiles. Ojika et al. (1987) have proposed that ptaquiloside 
is a direct acting carcinogen and that the dienone formed under alkaline and neutral 
conditions is the ultimate carcinogen and that the cyclopropane ring of the dienone is the 
reactive part of the molecule.
The dienone alkylates thiol and sulphide groups in amino acids in vitro. It also 
alkylates purines and pyrimidines. Adenosine is alkylated at the position of adenine and 
at the 5’-OH position of the ribose moiety; guanosine at the 0& and N-7 positions of 
guanine; uridine at the N-3 and positions of uracil; and cytidine at the N-3 position of 
cytosine. The nucleotides 5’-guanylic acid (5'-GMP) and 5’-adenylic acid (5’-AMP) are 
alkylated at the phosphate groups (Ojika et al., 1987).
Interactions between ptaquiloside and macromolecules in vitro have important 
implications if extrapolated to the in vivo situation, in that alkylation of genetic material may 
be the mechanism involved in ptaquiloside mutagenesis and carcinogenesis.
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Figure 1.6: The chemical structures of ptaquiloside, illudin S and M, and hypacrone.
Eludin S and M cause acute toxicity in rats, about 150 times that of ptaquiloside. An oral 
dose of illudin S (200 mg) caused acute and fatal toxicity to a 3-month old calf within 12 
hours (Evans, 1985b). The illudins have not been isolated from bracken fern although 
Evans (1985b) suggests that illudane precursors might be synthesized by the plant.
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Figure 1.7: Route of degradation of ptaquiloside.
(Modified from Ojika et al., 1987; van der Hoeven et a l, 1983).
Pterosin B and pterosin O contain the 1-indanone nucleus. More than 30 individual 
sesquiterpenoids containing the 1-indanone nucleus have been isolated from bracken fern 
and characterised (Fukuoka et al., 1972; 1978a; 1978b; Kuroyanagi et al., 1974; Yoshihira 
et al., 1978; Niwa et a l, 1983a; Van der Hoeven et a l, 1983). Sesquiterpenoids are widely 
distributed in plants and microorganisms and occur as glycosides called pterosides, and 
their aglycones the pterosins. From the biogenetic view point, ptaquiloside is thought to be 
the precursor of pterosins (Niwa et al., 1983a). The pterosins are designated A - Z 
depending on the nature of the side groups attached to the side chains at carbon 12. Their 
glycosides are also designated pterosides A - Z. In bracken fern, pterosin B and O are the 
most abundant and highest levels are found in the leaves and rhizomes, respectively 
(Fukuoka et al., 1972; Saito et al., 1975). Although the pterosins and pterosides are known 
to be toxic to HeLa-cells (Saito et al., 1975), they cause no acute toxicity or carcinogenic 
effects in rats, mice or guinea pigs, or mutagenic effects in either bacterial or mammalian 
cells (Yoshihira et al., 1978; Evans et a l, 1983).
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1.3.3.5 Fate after oral intake
The fate of ptaquiloside after oral administration has not been determined. 
However, based on the available knowledge regarding its instability in vitro, degradation 
and /  or metabolic pathways after oral intake may be proposed.
Differences in pH exist in the various compartments of the gastrointestinal tract. In 
the ruminant animal, the pH of the oesophageal contents is about the same as that of the 
saliva (pH in cattle is 8.1 - 8.2). The ruminai contents are acidic, about pH 6.0 - 6.5, while 
the contents of the abomasum are acidic, pH 2.0 - 2.2. The intestinal contents are alkaline 
in both the ruminant and the monogastric animals. The contents of the intestines are more 
alkaline in the lower part of the intestines than in the upper parts. In the mouth and 
oesophagus, the alkaline environment causes ptaquiloside to degrade to the dienone, the 
mutagenic /  carcinogenic intermediate. In the rumen, however, the acidity may favour the 
degradation of ptaquiloside to the ‘harmless’ products, pterosin B and pterosin O. The 
rumen contains many types of microbial organisms that may enzymatically degrade 
ptaquiloside. The fraction that survives degradation in the upper parts of the alimentary tract 
reaches the abomasum whose acidic contents may cause inactivation of the compound to 
pterosin B and pterosin O. Under acidic conditions, glycosidic bonds normally undergo 
hydrolysis. For ptaquiloside, aromatization to the dienone occurs prior to hydrolysis of the 
glycosidic linkage (Kigoshi et al., 1989). Hence, the aglycone is not formed. Depending 
on the amount of plant material consumed and the retention time, some ptaquiloside may 
reach the intestines where the high pH may subject some of the remaining ptaquiloside to 
transformation to pterosins via the dienone intermediate product. Relatively high amounts 
of the dienone should be formed in the lower portion of the intestines where the pH is more 
alkaline than the upper. As the lower intestine (colon) contains many types of bacterial 
flora, enzymatic hydrolysis of some ptaquiloside to its aglycone, ptaquilosin, may take 
place. However, since in vitro studies have shown that under enzymatic hydrolysis, 
transformation of ptaquiloside to the dienone occurs prior to the hydrolysis of the glycoside 
(Kigoshi et a l, 1989), it seems unlikely that the aglycone appears in the lumen of the
39
intestine. Alternatively, if the amounts ingested, and the in vivo conditions are such that 
some ptaquiloside appear in the lumen, its unstable nature may result in insignificant 
amounts reaching the systemic circulation. It has previously been suggested that no 
absorption of ptaquiloside, as such, may occur from the gastrointestinal tract because of its 
molecular weight (398 Dalton) and its hydrophilic nature (Van der Hoeven et al, 1983).
Bracken fern causes oesophageal, intestinal (particularly distal 20 cm ) and bladder 
tumours in cattle. These sites parallel the proposed sites of formation of the dienone, the 
reactive intermediate of ptaquiloside, and lends support to the suggestion that ptaquiloside 
may be the carcinogenic constituent of the plant. For bladder tumours (Hirono et al., 
1984a), and suppression of bone marrow activity in cattle (Hirono et al., 1984b), the 
aglycone and / or the dienone, if absorbed at all, must survive drug metabolizing enzyme 
systems in the intestines and the liver (first pass effect). In the alkaline urine of herbivores 
(pH 7.5 - 8.5 in cattle), the reactive metabolite may be formed and so induce bladder 
tumours. However, Evans (1985a) suggests that ptaquiloside is unlikely to persist and 
cause bladder tumours or suppress the bone marrow. The data produced by Hirono et al. 
(1984b) using a calf supports this view.
Hirono et al. (1984b) reported the induction of ‘acute bracken poisoning* in a calf 
6 months old on administration of ptaquiloside at 400 mg/day for 24 days followed by 800 
mg / day for 14 days and then 1600 mg / day for 4 days. Evans (1985a) after a detailed 
analysis of the data produced by Hirono et al. (1984b) concludes that in spite of the high 
doses administered the calf developed no clinical symptoms of acute cattle bracken 
poisoning; there was no complete leucopenia affecting all cell types, or thrombocytopenia. 
Histologically, the bone marrow was not grossly aplastic. Ptaquiloside only simulated, in a 
mild form, an early stage of ‘cattle bracken poisoning’. Perhaps, the doses administered 
were too low in view of the unstable nature of the compound, or the carcinogen has low 
activity in eliciting the acute poisoning syndrome (Evans, 1985a). Thus, ptaquiloside does 
not suppress bone marrow activity significantly, which may indicate that it is not the sole 
toxic bracken constituent. Ptaquiloside carcinogenicity could be more fully understood if
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data on factors affecting absorption, distribution and urinary excretion of the compound 
were available.
1 .3 .4  OTHER TOXIC BRACKEN CONSTITUENTS
1.3.4.1 Prunasin
Prunasin, O-p-D-glucuropyranocyl-D-mandelonitrile, a cyanogenic glycoside 
which occurs in many species of Angiospermae and Gymnospermae, has been isolated 
from bracken fern (Kofod and Eyjolfsson, 1966; Bennet, 1968). In bracken fern, the 
highest concentrations are found in the young fronds at the equivalent of 50 mg of HCN 
per 100 g dry matter. Nevertheless, the content of prunasin varies widely depending on 
season and in most cases is much lower, ranging from 1 to 50 mg per 100 g dry matter 
(Moon and Rafaat, 1951a).
The oral LD5o for prunasin in ACI rats is 750 mg/kg. Cyanogenic glycosides 
require gut microorganisms for their metabolism (Figure 1.8). Upon ingestion, prunasin 
(Figure 1.9) is hydrolysed to mandelonitrile by bacterial P-glucosidases in the 
gastrointestinal tract. Mandelonitrile is further degraded by hydroxynitrile lyase or by 
spontaneous decomposition to cyanide and benzaldehyde (Frakes et al., 1986). 
Benzaldehyde is oxidized to benzoic acid, and then to hippuric acid (Dorr and Paxinos, 
1978), and excreted in the urine. Prunasin as such may be absorbed, but is excreted 
unchanged in the urine. The cyanide released is the toxic metabolite of prunasin.
Following absorption, cyanide ions react readily with ferric ion of cytochrome 
oxidase, to form a stable cyanide cytochrome oxidase complex. As iron is in the trivalent 
state, electron transport stops and the chain of cellular respiration is brought to a halt 
leading to cytotoxic anoxia. Oxygen, in haemoglobin, cannot be released to the electron 
transport system and, in sufficient doses, prunasin can lead to sudden death of affected 
animals (Vennesland et al., 1982). However, with the possible exception of very young 
plants, the prunasin content of bracken is considered insufficient to be a cause of acute 
poisoning. Prunasin has no carcinogenic effect in animals (Hirono et a l, 1980).
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Figure 1.8: The hydrolysis of cyanogenic glycosides.
At times of drought, animals may consume plants containing high contents of cyanogenic 
glycosides, such as sorgum, arrow grass (Triglochin spp.), elderberry (Sambucus spp.), 
wild cherry {Prunus spp.) (Oehme, 1977). In humans, cyanide poisoning results from 
dietary sources such as cassava (Manihot utilissima) (Osuntokun, 1968) or therapeutic 
preparations such as nitroprusside, a hypotensive compound, and succinonitrile, an 
antidepressant drug. Other sources of exposure include insecticides based on organic 
thiocyanates, industrial processes for the manufacture of steel, paint and aluminium 
(Solomonson, 1981; Way, 1981).
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Figure 1.9: Enzymatic degradation of prunasin in animals.
* - Bacterial metabolism; ** - enzymic metabolism. Following absorption, cyanide 
detoxification involves conversion to thiocyanate, a reaction catalysed by the enzyme 
rhodanese (thiosulphate sulphur transferase) which occurs in most tissues but with highest 
concentration in the liver (Cosby and Sumner, 1945; Himmwich and Saunders, 1948). 
Vitamin B12 and cystine in the thyroid also play some role in the detoxification of cyanide 
(Wood and Cooley, 1956).
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1.3.4.2 Tannins
Tannins, hydrolysable or condensed, are complex polyphenolic esters of sugar or 
polyhydiic alcohols or polymeric flavonoids, with molecular weights ranging from about 
300 to 3000, depending on the source. They constitute a large group of substances which 
occur widely in plants. High concentrations are found in the barks of trees such as oak, 
wattle and hemlock (Haslam, 1966).
Tannins occur in bracken and their involvement as a cause of toxicity in animals 
was suggested by Long (1924) and later by Shearer (1945). It was suggested that the 
tannin ‘pteritannic acid’ in the plant was the toxic agent. Although "tannic acid” failed to 
induce neoplasia after oral administration, induction occurred after subcutaneous injection 
(O’Gara et al., 1974; Pamukcu et al., 1980a) and implantation in the bladder (Wang et al., 
1976a; 1976b). Tannins have been considered to play insignificant role in bracken toxicity, 
after demonstration that the tannin free fraction of bracken fern retains the carcinogenic 
property (Pamucku et al., 1980a). Furthermore, tannins fail to depress bone marrow 
activity (Evans et al., 1982). Nevertheless, tannins could act as promoters of 
carcinogenesis. In bracken fern, the concentration of tannins is 2.45 g per kg dry weight.
1.3.4.3 Phytoecdysones
The major insect ecdysones, a-ecdysone and 20-hydroxyecdysone have been 
isolated from bracken fern (Kaplanis et al., 1967). Alpha-ecdysone was administered to 58 
Egyptian toads (Bufo regularis) by force feeding. Neoplastic lesions were induced in 10 
. toads (El-Mofty et al., 1987) suggesting that the phytoecdysones may contribute to the 
carcinogenicity of bracken fern. There are no further reports yet on the carcinogenicity of 
these compounds in other animals.
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1.4 AIMS AND OBJECTIVES
The isolation and characterisation of bracken fern constituents has extensively been 
conducted but it seems that the chemical identity of the toxic agent(s) is not conclusive. 
Only shikimate (Evans and Osman, 1974), quercetin (Pamukcu et al., 1980b) and 
ptaquiloside (Hirono et al., 1984a; 1984b; 1984c; 1987) have reproduced some aspects of 
bracken fern poisoning in experimental animals. It seems that, singly, these compounds are 
incapable of reproducing all the toxic properties of the plant. There is therefore a possibility 
that two or more of these compounds may act together in the toxicity of the plant.
The chronic form of the disease which is characterised by tumours in various 
organs of the body in different species of animals might result from certain constituents 
acting as initiators and others as promoters, but they might also act as cocarcinogens. The 
hypothesis of initiation / promotion has already been studied by Ogunbiyi (1987). In 
cocarcinogenesis, two carcinogens may act synergistically to induce tumours whereas each 
on its own cannot (Wynder et a l, 1978; Wynder and Hoffman, 1979).
Further studies on the bracken constituents are justified because of the toxicity in 
animals and the public health importance of the plant. The aims and objectives of this study 
were to determine,
1. whether quercetin (Bjeldanes and Chang, 1977; MacGregor and Jurd, 1978; Brown and 
Dietrich, 1979; Brown, 1980; Nagao et al., 1981), shikimate (and its major metabolite 
cyclohexanecarboxylate) (Jones et a l, 1983), and ptaquiloside (Niwa et al., 1983a; Van 
der Hoeven et al., 1983; Matoba et al., 1987; Saito et al., 1989) demonstrate comutagenic 
effects in the Salmonella / mammalian microsome mutagenicity test.
The Ames test (Ames et al., 1975; Maron and Ames, 1983) is established as one of 
the most sensitive genotoxicity tests available for in vitro studies. Although not all 
mutagenic compounds are carcinogenic and vice versa, it has nevertheless, been established 
that a good correlation exists between mutagenicity and carcinogenicity (Ames, 1979; 
McCann et al., 1975a; 1975b; Sugimura et al., 1976; Straus, 1981).
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2. the genotoxicity of quercetin, shikimate and cyclohexanecarboxylate in vivo in 
the bone marrow of mice and the gastrointestinal mucosa cells in the rat. Furthermore, the 
genotoxicity of these compounds in vivo was determined after simultaneous administration. 
The two in vivo methods were chosen because previous studies with quercetin have used 
only one method, the bone marrow micronucleus test (Schmid, 1976; Jenssen and Ramel, 
1980), and had produced conflicting results (Sahu et al., 1981; MacGregor et al., 1983). 
The bone marrow micronucleus test in mice and the unscheduled DNA synthesis (UDS) 
using the gastric mucosa cells in the rat (Burlinson, 1989; Burlinson et al., 1991) are good 
indicators of genotoxicity. The micronucleus test which is an important test, is only of 
relevance to compounds which are bioavailable after administration. The GI mucosa may 
therefore offer the extra advantage of being the most exposed tissue after oral intake of 
compounds in food or medicinal preparations.
3. the cytotoxic effect of quercetin, shikimate, cyclohexanecarboxylate and 
ptaquiloside in Chinese hamster ovary (CHO), fibroblast (3T3) and normal rat kidney 
(NRK) established cell lines, in culture. This study was conducted in order to relate the 
mutagenic /  genotoxic properties of the compounds to the general cytotoxicity which is a 
feature in bracken poisoning of animals.
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CHAPTER 2
MUTAGENICITY STUDIES OF QUERCETIN USING SALM ONELLA  
TYPHIMURIUM  IN THE PRESENCE OF RAT HEPATIC ACTIVATION
SYSTEMS
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2.1 INTRODUCTION
The genotoxicity of quercetin has been demonstrated in mutagenicity studies 
employing Salmonella typhimurium strains TA1537, TA1538, TA98 and TA100 
(Bjeldanes and Chang, 1977; Brown et al., 1977; Sugimura et al., 1977b; Elliger et al., 
1984; Stoewsand et al., 1984; De Flora et al., 1984). These bacterial tests were conducted 
using a technique based on that described by Ames et al. (1975) and Maron and Ames 
(1983) in which liver fractions (S9), normally from rodents, are employed to metabolise 
precarcinogens /  premutagens to their active proximate and /  or ultimate forms because 
bacteria lack many of the mammalian metabolising enzymes. Since S9 enhances quercetin 
mutagenicity in the bacterial mutagenicity tests (Hardigree and Epler, 1978; MacGregor and 
Jurd, 1978; Brown and Dietrich, 1979), it has been inferred that reactive metabolites may 
be involved in its mutagenicity.
Pretreatment of rats with certain chemicals including barbiturates (loannides and 
Parke, 1975), polychlorinated biphenyls (e.g. Aroclor-1254) and 3-methylcholanthrene 
(Ryan et al., 1977) increases mixed function oxidase (MFO) activity. Aroclor-1254 
induces, by about equal amounts, the major forms of cytochrome P-450 associated with 
induction by phenobarbitone (cytochrome P450 IIB) and 3-methylcholanthrene 
(cytochrome P450 1A) (Ryan et al, 1977), hence the common practice of determining 
quercetin mutagenicity using Aroclor-1254 induced S9 (Brown et al., 1977; Hatcher and 
Bryan, 1985; Rueff et al., 1986; Vrijsen et al, 1990). However, Hardigree and Epler 
(1978) and Brown and Dietrich (1979) have indicated that induction of rat liver enzymes by 
Aroclor-1254 fails to significantly enhance the effect of S9 on quercetin mutagenicity.
The purpose of this study was to optimise the mutagenicity of quercetin by 
modifying the nature of the activation systems. A preincubation step was incorporated since 
this has been shown to enhance the mutagenicity of weak mutagens such as N,N- 
dimethylnitrosamine (Yahagi et al., 1977). The mutagenicity of quercetin is enhanced by 
both cytosolic and microsomal factors (Bjeldanes and Chang, 1977; Brown et al., 1977; 
Sugimura et al., 1977b; De Flora et al., 1984; Elliger et al., 1984; Stoewsand et al., 1984;
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Hatcher and Bryan, 1985; Rueff et al.y 1986; Vrijsen et al., 1990) which are possibly 
protein in nature.
The cofactor requirements of the cytosolic and microsomal systems were 
determined to enable the identification of the enzyme system(s) that may be involved in 
modulating quercetin mutagenicity and to determine whether the microsomal and cytosolic 
activation systems share similar properties. Moreover, the cytosolic fraction was subjected 
to dialysis in order to investigate the involvement of metal ions or small molecular weight 
compounds on quercetin mutagenicity.
2.2 MATERIALS AND METHODS
2.2.1 CHEMICALS
Quercetin, L-histidine, biotin, ampicillin, nicotinamide adenine dinucleotide 
phosphate (oxidized) tetrasodium salt (NADP) grade H, nicotinamide adenine dinucleotide 
phosphate (reduced form) (NADPH), nicotinamide adenine dinucleotide (reduced form) 
(NADH), glucose 6-phosphate (G 6-P), glucose 6-phosphate dehydrogenase (G 6-PD) 
type XXIII, proteinase K, norharman, menadione, dicoumarol, 2-aminoanthracene, 2- 
nitrofluorene and Folin-Ciocalteau phenol reagent were all purchased from Sigma Chemical 
Co. (Poole, Dorset); sodium dithionite was purchased from BDH Chemicals Ltd (Poole 
Dorset); dimethylsulphoxide (DMSO) was purchased from FSA (Loughborough, Liecs) 
and Aroclor-1254 from The Robens Institute of Environmental and Industrial Health and 
Safety (Guildford, Surrey); Lab MC 2 agar was purchased from London Analytical & 
Bacteriological Media Ltd (Salford, Lancs); Oxoid No. 2 nutrient broth from Oxoid Ltd. 
(Basingstoke, Hants), Vogel Bonner E plates with minimal agar were obtained from 
Becton Dickinson Ltd (Cowley, Oxford) and sterile plastic disposable tubes from Sterilin 
Ltd (Teddington, Middlesex).
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2.2.2 THE BACTERIAL TESTER STRAINS
Salmonella typhimurium tester strains TA97, TA98, TA100, TA 102, and TA104 
were all generous gifts from Prof. Bruce N. Ames (University of Califonia, Berkeley, CA, 
USA). The tester strain TA98 was selected for the present studies because this strain was 
found to be the most sensitive to quercetin (Tables 2.3 and 2.4). It was stored at -80° C as 
nutrient broth cultures in aliquots of 2 ml containing 0.8% (v/v) DMSO as a 
cryopreservative. Master plates were prepared from the frozen cultures by inoculating 
nutrient broth with cultures using a platinum loop (Section 2.2.3). Overnight cultures for 
mutagenicity tests were made from master plates.
2.2.3 PREPARATION OF MASTER PLATES
Fresh nutrient broth (approximately 10 ml) containing ampicillin (25 |ig/ml) was 
inoculated from frozen bacterial culture and incubated for 13 h at 37° C in a shaking water 
bath. The overnight culture was then serially diluted in three sets of tubes each containing 
10 ml of nutrient broth, by transferring aliquots of 0.1 ml in each step to give a final 
dilution of approximately 1:10^. An aliquot of the dilution (0.1 ml) was mixed with 2 ml of 
top agar containing 0.1 ml of 0.1 M L-histidine and 0.5mM biotin and poured on to minimal 
agar (Vogel Bonner E) plates. When the agar solidified, the plates were incubated at 37° C 
for 24 h and then stored at 4° C. These served as a routine source of bacteria for 
preparation of overnight cultures for mutagenicity tests. Master plates were discarded after 
4 weeks.
2.2.4 PR EPA R A TIO N  OF O V ER N IG H T  CU LTU RES FOR 
MUTAGENICITY TESTS
One or more colonies of the appropriate strain were transferred from the master 
plate into a 25-ml sterilin tube containing 10 ml oxoid nutrient broth solution (25 mg/ml) 
with added ampicillin (25 Jig/ml) and incubated in a shaking water bath at 37° C for 13 h.
50
2.2.5 TESTS FOR GENOTYPE
Strains were tested for the presence of their genotype each time master plates were 
prepared prior to their use in the mutagenicity experiments. This was done as follows:
2.2.5.1 Histidine requirement:
The His- character of the tester strains was confirmed by demonstrating bacterial 
growth in the presence of histidine on minimal agar plates. Biotin, which is also required 
by the tester strains because the uvrB deletion extends through the bio gene, was also 
incorporated in the minimal agar plates. A solution containing 0.1M L-histidine and 0.5mM 
biotin (0.1 ml), was added to each plate and spread out using a sterile right angled glass 
spreader. The plates were then inoculated with the bacteria. Control plates, containing no 
added histidine, were similarly inoculated with the bacteria. Plates were incubated at 37° C 
overnight. Growth was observed only on histidine-biotin plates confirming that the strains 
required histidine for growth.
2.2.5.2 Presence of deep rough (rfa) mutation:
To molten test agar (2 ml) supplemented with 0.1M L-histidine and 0.5mM biotin 
(0.1 ml), was added 0.1 ml of an overnight bacterial culture. This was then mixed and 
plated on Vogel Bonner E plates. When the agar solidified, a sterile filter paper disc (10 
mm in diameter) was placed at the centre of the plate onto which was pipetted 40 jil of 
Crystal Violet solution (1 mg/ml). Plates were inverted and incubated at 37° C overnight. A 
clear zone of inhibition around the disc indicated the presence of the rfa mutation. The deep 
rfa mutation results in the loss of lipopolysaccharide coat in the bacterial surface, permitting 
compounds of large molecular weight, such as Crystal Violet, to enter the bacterial cell and 
inhibit growth and multiplication.
2.2.5.3 Presence of R-factor:
The strains TA98 and TA 100 contain a plasmid pKMlOl (R-factor) which confers 
bacterial resistance to ampicillin. The plasmid contains muc genes (mutagenesis: UV and 
chemical) which enhance UV light and chemically induced mutagenesis, and the bla gene
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that codes for a [3-lactamase that inactivates ampicillin making the cells resistant to the 
antibiotic (Langer et ah, 1981). The plasmid pKMlOl is unstable and may be lost.
To 2.0 ml molten test agar containing 0.1M L-histidine and 0.5mM biotin (0.1 ml), 
was added an overnight bacterial culture (0.1 ml). This was mixed and plated on Vogel 
Bonner E plates. After solidification of the agar, a sterile filter paper disc (10 mm in 
diameter) was placed at the centre of the plate and 40 fil of an ampicillin solution (8 mg/ml 
in 0.02M sodium hydroxide) pipetted on to the disc. Plates were inverted and incubated at 
37° C overnight. The absence of a zone of inhibition indicated resistance to ampicillin and 
therefore, the presence of the plasmid.
2.2.5.4 Tests for bacterial viability:
The viability of bacterial cells was determined as follows: The overnight culture 
(0.1 ml) was serially diluted in three tubes each containing 10 ml nutrient broth to achieve a 
final dilution of approximately 1:106. An aliquot (0.1 ml) of this dilution was mixed with 
molten test agar (2 ml) containing 0.1M L-histidine and 0.5mM biotin (0.1 ml), and plated 
on Vogel Bonner E plates. When the agar solidified, the plates were inverted and incubated 
at 37° C for 24 h. Bacterial colonies were counted and numbers of between 100 and 300 
indicated that each 0.1 ml of the overnight broth contained 1 - 3 x 10  ^cells.
2.2.5.5 Determination of spontaneous reversion rates:
Spontaneous reversion rates were determined each time a mutagenicity test was 
performed. To 2 ml of test agar was added 0.1 ml of the solvent (DMSO or water), the 
overnight bacterial culture (0.1 ml) and phosphate buffer pH 7.4 or the activation system 
(0.5 ml) and plated.
2.2.6 INDUCTION OF RAT LIVER ENZYMES
Rat liver enzymes were induced as described by Maron and Ames (1983). Male 
Wister albino rats, weighing approximately 200g, were purchased from the Experimental 
Biology Unit, University of Surrey. They were housed in cages with saw dust bedding.
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Food (Spratts Animal Diet No.l) and water were given ad libitum. A 12 h light-dark cycle 
was in operation (from 07.00 h to 19.00 h light) and the temperature was maintained at 
22±1° C.
Rats were administered Aroclor-1254 in com oil (200 mg/ml) at a dose of 500 
mg/kg bwt by the intraperitoneal route. Control animals were not treated. Rats were 
sacrificed by cervical dislocation 5 days post-treatment and their livers removed asepdcally 
immediately.
2.2.7 PREPARATION OF LIVER HOMOGENATE
Liver homogenates were prepared as described by loannides and Parke (1975). All 
steps were carried out at 0 - 4° C using cold sterile solutions and cold apparatus. The livers 
were transferred to beakers containing 3 volumes of 0.15M KC1 (3 ml/g wet liver), minced 
with scissors and homogenized using a motor driven Potter-Elvehjem glass teflon 
homogenizer. The homogenate was centrifuged at 9000g (11200 ipm) for 20 min using a 
JA17,14 x 50 ml aluminium angle head rotor in a Beckman J2-21 centrifuge. Cell debris, 
nuclei, mitochondria and lysosomes sedimented to the bottom of the tube. The supernatant 
(S9 fraction), which contained microsomes (endoplasmic reticulum) and the soluble 
fractions of the cell, was decanted and stored at -20° C in 1 - 5 ml aliquots in small plastic 
Nunc tubes until required. The S9 fraction was kept for a maximum period of 3 months.
2.2.8 PREPA RA TIO N  OF M ICRO SO M AL AND CY TO SO LIC 
FRACTIONS
Liver fractions were prepared as described by loannides and Parke (1975). Aliquots 
of S9 were thawed over ice and centrifuged in a Beckman L7-65 ultracentrifuge at 
105,000g for 1 h at 4° C. The supernatant (cytosol) was decanted and the pellet re- 
suspended to the original volume in phosphate buffer containing 20% (v/v) glycerol, using 
a hand homogeniser. Aliquots of the microsomal suspension (0.5 -1.0 ml) were stored at - 
20° C for protein and cytochrome P-450 determination.
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2.2.9 DETERMINATION OF PROTEIN CONCENTRATION OF THE 
MICROSOMAL FRACTION
Protein was determined by the method described by Lowry et a l  (1951) using a 
standard curve prepared with bovine serum albumin. The principle involved is that the 
phenolic group of tyrosine molecules present in a protein reacts with Folin-Ciocalteau 
reagent to produce a blue colour with a characteristic maximum absorbance at 720 nm.
The copper reagent was prepared immediately before use and consisted of copper 
sulphate (0.5 ml of a 1% [w/v] solution), potassium sodium tartrate (0.5 ml of a 2% [w/v] 
solution) and sodium carbonate (50 ml of a 2% [w/v] solution in 0.1M NaOH). Aliquots 
(0.1 ml) of a 25% (w/v) microsomal suspension were diluted with 0.5M NaOH (1.9 ml) 
solution. Appropriate volumes of bovine serum albumin solution (500 |ig/ml) were diluted 
in 0.5M NaOH to give a range of protein standard solutions of (0 - 250 pg/ml). All 
samples were run in triplicates.
To 0.5 ml of the standards, blanks and test samples, was added 0.5M NaOH (0.5 
ml) followed by the copper reagent (5 ml) and the mixture allowed to stand for 10 min. 
Folin-Ciocalteau phenol reagent (0.5 ml), diluted 1: 2 with distilled water, was added to 
each tube, immediately mixed and then left to stand for 30 min. The absorbance was 
recorded at 720 nm using a Kontron Uvikon spectrophotometer.
2.2.10 CYTOCHROME P-450 DETERMINATION
Microsomal cytochrome P-450 was determined using a method based on that 
described by Omura and Sato (1964) and involved measurement of the difference spectrum 
of the reduced P-450-CO bound complex against reduced P-450. The difference spectrum 
was recorded between 390 and 500 nm.
Aliquots (0.5 ml) of microsomal suspension (25% [w/v]) were diluted with 2.5 ml 
of 0.1 M potassium phosphate buffer, pH 7.6. Sodium dithionite crystals (approximately 
30mg) were added and the samples divided between two 1.5-ml disposable cuvettes. The
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auto-zero was set and the baseline for the reference and test cuvettes was recorded at 390 - 
500 nm using a Kontron Uvikon 860 spectrophotometer. Carbon monoxide was then 
bubbled through the sample cuvette for approximately 30 seconds and the difference 
spectrum was recorded between 350 and 500 nm. The concentration of cytochrome P-450 
was calculated from the absorbance difference between 450 and 500 nm, employing an 
extinction coefficient of 91 mM~l cnr 1.
2.2.11 PREPARATION OF THE ACTIVATION SYSTEMS
Hepatic S9, microsomal and cytosolic liver fractions were prepared as described in 
section 2.2.7 - 2.2.8. Activation systems, unless otherwise stated, were prepared as shown 
in Table 2.1. This activation system is referred to as a 10% (v/v) activation system.
Table 2.1: Composition of activation system.
Component* Volume (ml)
Potassium phosphate buffer pH 7.4 (0.2M) 0.25
Magnesium chloride (0.08M) 0.05
Potassium chloride (0.33M) 0.05
G-6-P (0.025M)& NADP (0.02M) 0.10
Liver fraction 0.05
TOTAL VOLUME 0.50
* - When the composition of the activation system was changed to 5%, 20%, or 30% (v/v), 
the amount of the liver fraction was 0.025 ml, 0.10 ml or 0.15 ml respectively, and the 
amount of buffer was increased or decreased correspondingly so that the total volume of 
the system remained 0.5 ml. When microsomal suspension was used as the liver fraction, 1 
unit of G 6-PD in 1 pi of 0.2M potassium phosphate buffer, pH 7.4 solution was added to 
the system
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2.2.12 TEST AGAR
Top agar was prepared by autoclaving distilled water containing 0.6% (w/v) Lab 
MC 2 agar and 0.5% (w/v) NaCl at 121° C for 20 min. Aliquots (100 ml) of the agar were 
stored at room temperature in 250 ml bottles with rubber lined plastic screw caps. Before 
use, caps were loosened and the agar melted in steam baths, and maintained at 45° C to 
avoid solidification.
2.2.13 TOXICITY TEST
The method used to test the toxicity of test compounds to the Salmonella strains 
was that described by Hatcher and Bryan (1985). An overnight nutrient broth culture was 
serially diluted in 0.9% (w/v) phosphate buffered saline (pH 7.4) to 1:106. Test 
compounds, at different concentrations, were transferred to test agar (2 ml), containing 
0.1M L-histidine and 0.5mM biotin (0.1ml). Aliquots (0.1 ml) of the diluted culture were 
transferred to the top agar, mixed using a swirl mixer and plated. Tests were conducted in 
triplicates for each sample. Colonies formed from surviving bacteria were scored after 48 h 
of incubation at 37° C.
2.2.14 THE PLATE INCORPORATION TEST
Top agar aliquots (2 ml) containing histidine-biotin (10 ml of a sterile solution of 
0.5 mM L-histidine hydrochloride and 0.5 mM biotin per 100 ml top agar) were transferred 
to 13 x 100 mm screwcapped sterilin tubes maintained at 45° C in a water bath. Solutions 
(0.1 ml) of the test compound(s), the overnight culture (0.1 ml) and phosphate buffer, or 
the activation system (0.5 ml) were quickly transferred to the tubes, mixed and plated on 
Vogel Bonner E plates (Table 2.2). The plates were inverted after solidification and 
incubated at 37° C for 48 h. The histidine revenant colonies were counted manually using a 
colony counter (Gallenkamp).
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Table 2.2: Constituents of complete mutagenicity system.
Constituent (ml) + Activation - Activation
Top agar 2.0 2.0
Solution of test compound(s) or 
vehicle or positive control
0.1 0.1
Bacterial suspension 0.1 0.1
Activation system 0.5 -
Potassium phosphate buffer pH 7.4 - 0.5
TOTAL VOLUME 2.7 2.7
2.2.15 THE PREINCUBATION METHOD
The preincubation test was conducted as described by Yahagi et al. (1977). Test 
compound(s), potassium phosphate buffer or activation system (0.5 ml) and the overnight 
culture (0.1 ml) were transferred into 13 x 100 mm screw capped sterilin tubes on dry ice. 
Tubes were then incubated in a shaking water bath at 37° C for various time periods before 
adding test agar (2 ml) and plating. Plates were incubated at 37° C incubator for 48 h.
2.2.16 SCORING OF PLATES AND STATISTICAL ANALYSIS
After 48 h, the plates were scored for the number of histidine independent colonies 
(i.e. histidine revenants, revenant colonies) after confirming the presence of a background 
lawn. The faint background lawn arises from the bacterial cells, after undergoing several 
divisions as a result of the trace amounts of histidine added to the top agar. Test samples 
were considered to give a positive response (mutagenic) if there was concentration 
dependent increase in the number of revenants which was at least more than double the 
spontaneous reversion rate. Positive controls were conducted for each assay and unless 
otherwise stated were 2-aminoanthracene at 5 p.g per plate for TA98 in test systems which 
employed activation, and 2-nitrofluorene at 5 pg/plate in test system without the activation.
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Negative controls contained the bacteria, buffer or activation system, and solvent to 
establish the number of revenant colonies that arise spontaneously.
Data were evaluated by using the student’s t-test. Where significant differences are 
referred to without qualification, the level of significance is at the 5% level.
2 .3  RESULTS
2.3.1 M U TA G EN ICITY  OF Q U ERCETIN  IN 5 STRAINS OF 
SALMONELLA TYPHIMURIUM
Quercetin was tested for mutagenicity in Salmonella typhimurium strains TA97, 
TA98, TA100, TA 102 and TA104. Table 2.3 shows that quercetin, in the absence of 
activation system, is mutagenic only in strain TA98 at all dose levels tested. The 
mutagenicity in TA 100 occurred only at the highest dose of 80 fig/plate. The liver post- 
mitochondrial fraction from untreated rats significantly influenced the mutagenicity of 
quercetin. Potentiation of quercetin mutagenicity in strains TA97, TA98 and TA100 
occurred following incorporation of rat liver fraction (S9), as shown in Table 2.4. Strain 
TA98 was the most sensitive in the presense of rat liver S9 activation.
Table 2.3: Mutagenicity of quercetin in 5 strains of Salmonella typhimurium in the 
absence of an activation system.
Strain
Number of histidine revenants per plate induced by the stated concentrations
0 p.g** 10 tig 40 tig 80 tig
TA97 91±16 106±19 88±26 95±15
TA98* 23±5 88±7 181±11 269+14
TA100* 145±20 149±19 178±38 Î92+Î5
TA102 246±37 240+41 238+4O 280±4
TA104 534±35 584+43 587±33 647+56
*- Significant mutagenic effect of quercetin.
** - Quercetin (concentrations in pg/plate) was used as a solution in 100 pi of DMSO. 
Results are presented as mean±SD of triplicate samples.
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Table 2.4: Mutagenicity of quercetin in 5 strains of Salmonella.typhimurium in the 
presence of a rat liver S9 activation system.
Strain
Number of histidine revenants per plate induced by the stated concentrations
0 pg** 10 pg 40 pg 80 pg
TA97 118±16 349+31* 467+83* 546±92*
TA98 24±2 280±30* 611±52* 987+6! *
TA100 Î48+Î5 187+18 26Î+24* 348±40*
TA 102 259+35 289+43 268+H 293±40
TA104 580±71 685+64 576±21 610+67
*- Significant mutagenic effects.
** - Quercetin (concentrations in pg/plate) was used as a solution in 100 pi of DMSO. 
Results are given as mean±SD of triplicate samples.
Rats were pretreated with Aroclor-1254 to determine whether the cytochromes P- 
450-induced could enhance the mutagenicity of quercetin. The results in Table 2.5 show 
that such pretreatment does not significantly increase the mutagenicity of quercetin when S9 
preparations are used as activating systems.
Table 2.5: Activation of quercetin to mutagens by Aroclor-1254-induced rat liver 
preparations.
Number of histidine revenants per plate in the presence of the stated activation
Quercetin
(pg/plate) No activation Aroclor-1254 induced S9 Uninduced S9
0 14±5 19±1 28+3
12.5 71±6 408±11 411121
25.0 113±13 702126 686147
50.0 Î36+Î5 822118 887+102
100.0 176±44 1220+49 1179167
Mutagenicity was determined using bacterial strain TA98 and 10% (v/v) activation systems. 
Quercetin was dissolved in DMSO so that 100 pi of the solvent was added to each plate. 
The results are presented as mean±SD of three samples. 2-aminoanthracene (5 pg/plate) 
was used as a positive control and caused a reversion rate of 3409+98; Quercetin at 0 
pg/plate represents spontaneous reversion rates.
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2.3.2 CONTRIBUTION OF M ICROSOM AL AND CYTOSOLIC 
FRACTIONS IN QUERCETIN MUTAGENICITY
The ability of the cytosolic (S100) fraction from Aroclor-1254-induced rats to 
enhance the mutagenicity of quercetin was compared with microsomal fraction in order to 
determine the contribution that each makes in the S9 fraction. As shown in Table 2.6., 
SI00 was consistently more effective than the microsomal fraction in potentiating quercetin 
mutagenicity, when compared with quercetin alone without activation. Hepatic fractions 
from uninduced rats gave similar results (Table 2.7). The data presented in Tables 2.6 and
2.7 are from experiments conducted concurrently and reveal no significant difference when 
corresponding results are compared. Hence, uninduced rat liver activation system was used 
in all subsequent experiments.
Quercetin mutagenicity mediated by microsomal fractions may have resulted from 
residual levels of cytosol, since the latter has a greater potency (Tables 2.6 and 2.7). The 
microsomal fraction was, therefore, twice recentrifuged following homogenisation in 
0.15M KC1 solution, and aliquots from each centrifugation were used in the activation 
system. The results of this experiment are presented in Table 2.8 and clearly indicate that 
recentrifugation did not significantly change the mutagenic response to quercetin showing 
that microsomal activation of quercetin mutagenicity was not due to residual cytosol.
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Table 2.6: Quercetin mutagenicity mediated by various hepatic fractions from rats 
pretreated with Aroclor-1254.
Quercetin
(pg/plate)
Number of histidine revenants per plate in 
stated activating system
the presence of the
No activation Microsomal Cytosol
0 16±3 20±3 32±3
12.5 67±7 165±34 316±12
25.0 109±11 216+31 501+10
50.0 140±14 269±28 666+46
100.0 165±33 307±33 ÎO88+7Î
Mutagenicity was determined using bacterial strain TA98 and 10% (v/v) Aroclor-1254 
induced activation systems. Quercetin was dissolved in DMSO so that 100 pi of the solvent 
was added to each plate. The results are presented as mean±SD of three samples. Quercetin 
at 0 pg/plate represents spontaneous reversion rates.
Table 2.7: Potentiation of quercetin mutagenicity by different liver fractions from control 
rats.
Number of histidine revenants per plate in the presence of the 
stated activating system
Quercetin* No activation Microsomal Cytosol
0 22±3 19±4 31±2
12.5 75+5 Î59+2O 300+15
25.0 Î2Î+Î5 230+22 550+18
50.0 144+19 278+3! 732+3!
100.0 170±20 28&+18 1004±50
* - Quercetin concentrations in jig per plate.
Mutagenicity was assayed using bacterial strain TA98 and 10% (v/v) uninduced activation 
systems. Quercetin was dissolved in DMSO so that 100 pi of the solvent was added to each 
plate. The results are presented as mean±SD of three samples. Quercetin at 0 pg/plate 
represents spontaneous reversion rates.
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Table 2.8: Microsome- and cytosol-mediated quercetin mutagenicity in Salmonella
typhimurium TA98, after repeated centrifugation of the microsomal pellet
Number of 
centrifugation
Number of histidine revenants per plate in 
stated activating system
the presence of the
Microsomes Cytosol
1 409+37 605±78
2 349+29 750+144
3 363+3! 581±58
Uninduced microsomes and cytosol (centrifugation 1) were twice further centrifuged at 
105000g for 1 h. Quercetin (25 p.g dissolved in 100 pi of DMSO), bacteria (TA98), and 
microsomal or cytosolic activation systems were used. The spontaneous reversion rate of 
17±3 has already been subtracted. The results are presented as mean±SD of triplicate 
samples.
2.3.3 DEPENDENCE OF QUERCETIN M UTAGENICITY ON S9 
CONCENTRATION IN ACTIVATION SYSTEM
The effect of varying the amounts of rat liver S9 fraction in the activation system on 
the mutagenicity of quercetin was investigated to determine whether concentrations higher 
than the commonly used level of 10% (v/v) could further enhance the mutagenicity. 
Increasing the concentrations of S9 in the activation system, as shown in Figure 2.1, 
resulted in increase of quercetin mutagenicity, which, however, reached a maximum at a 
concentration of S9 of 10 - 15% (v/v). As a result, an S9 concentration in the activation 
system of 10% (v/v) was used in all subsequent studies.
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Figure 2.1: Effect of concentration of S9 fraction in the activation system on quercetin 
mutagenicity in Salmonella typhimurium TA98. Mutagenicity was carried out using 
bacterial strain TA98 and uninduced activation systems at 0 - 30% (v/v) concentration. 
Quercetin was dissolved in DMSO so that 100 jil of the solvent was added to each plate. 
The results are presented as a plot of mean of three samples. Data represented by 0% S9 
activation system is mutagenicity of quercetin without activation.
* - Quercetin concentrations in p.g per plate.
2.3.4 EFFECT OF PREINCUBATION ON QUERCETIN MUTAGENICITY
Preincubation of premutagens with an activation system sometimes result in 
increased mutagenicity (Yahagi et al., 1977). Preincubation exposes the tester strain, for a 
brief period, to concentrations of the test compound and activation system much higher 
than those that occur in the top agar overlay, thus facilitating the metabolism of the 
premutagen and its interaction with bacterial DNA. The results presented in Table 2.9 show 
that preincubation of quercetin with microsomal or cytosolic activation systems results in 
significant, albeit small increase in the mutagenicity.
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Table 2.9: Microsomal and cytosolic potentiation of quercetin mutagenicity in Salmonella
typhimurium TA98 after preincubation.
Preincuba­
tiontime
(min)
Number of histidine revenants per plate in the presence of the stated activation
Microsomes Cytosol
0 272±5 416+25
15 282±21 442±15
30 300+17* 463+25*
45 337+2O* 485+17*
60 368+27* 494±2*
Quercetin (25 |ig dissolved in 50 |il of DMSO), bacteria and S9 activation system were 
preincubated for up to 60 min at 37° C in a shaking water bath, and then agar (2 ml) 
quickly added and plated. Results are presented as mean±SD of three samples. The 
spontaneous reversion rate of 13±4 has already been substracted.
* - Statistically significant effect (P < 0.05).
2.3.5 Q U ER C ETIN  M U TA GENICITY IN TH E PR ESEN CE OF 
DIFFERENT AMOUNTS OF DIMETHYLSULPHOXIDE
Organic solvents, such as DMSO, have been shown to influence the mutagenicity 
of certain mutagens (Yahagi et aL, 1977). DMSO is a scavenger of hydroxyl radicals and 
may modulate the mutagenicity of compounds mediated by such radical species (Rueff et 
al., 1989; Puppo, 1992). Since quercetin undergoes autoxidation and in the process 
superoxide and hydroxyl radicals are produced (Ueno et aL, 1983; Kostyuk and 
Potapovich, 1989; Rueff et aL, 1989) the effect of DMSO on quercetin mutagenicity was 
therefore evaluated. The results are as presented in Table 2.10. DMSO, up to a 
concentration of 100 pi, caused no significant effect on quercetin mutagenicity. In all the 
experiments the amount of DMSO was, therefore, maintained at a maximum of 100 pi per 
plate.
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Table 2.10: Effect of dimethylsulphoxide on quercetin mutagenicity in TA98.
DMSO
(pl/plate)
Number of histidine revenants per plate induced by quercetin in the presence 
of the stated activation systems
No activation Microsomes Cytosol S9
10 100+24 227120 499+4 514164
20 93±24 233116 513122 75816
40 102128 22312 . 448+6 76112
80 102+9 215125 434161 69619
100 96±8 265120 503+50 690122
Quercetin (25 jig dissolved in the indicated amounts of DMSO) was mixed with the bacteria 
and potassium phosphate buffer pH 7.4 or the appropriate activation system. The 
spontaneous reversion rate of 13±2 has already been substracted. Results are mean±SD of 
triplicate samples.
2.3.6 COFACTOR REQUIREMENT FOR QUERCETIN MUTAGENICITY
The results, as presented in Table 2.11, show that in the absence of added 
cofactors, the cytosolic activation system enhanced quercetin mutagenicity, by about 2- 
fold. However, addition of G-6-P and NADP further increased the enhancing effect of 
cytosolic activation system to 3.5-fold. There was no significant difference between 
NADPH and NADPH-generating system on quercetin mutagenicity. Quercetin 
mutagenicity mediated by rat liver microsomal fraction was also significantly enhanced by 
NADPH and the NADPH-generating system. NADH, did not significantly affect cytosolic 
mediated quercetin mutagenicity. NADP caused a significant increase in the cytosolic 
mediated quercetin mutagenicity, but the effect was less marked than NADPH. A similar 
pattern of activity was observed with the microsomal fraction.
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Table 2.11: Cofactor requirement for quercetin mutagenicity in Salmonella typhimurium 
TA98
Hepatic fraction Co-factors (mM) Histidine revenants per plate induced in the 
presence of the stated activation system
Microsomes G 6-P (2.5) + NADP (2.0) 244+29*
Microsomes G 6-P (2.5) 163±4*
Microsomes NADPH (4.0) 279+26*
Microsomes NADP (2.0) 193+13*
Microsomes NADH (4.0) 164±25*
Microsomes NONE 169±17*
Cytosol G 6-P (2.5) + NADP (2.0) 444+17*
Cytosol G 6-P (2.5) 320+10*
Cytosol NADPH (4.0) 427±4*
Cytosol NADP (2.0) 409+4*
Cytosol NADH (4.0) 33Î+Î6*
Cytosol NONE 298+10*
No activation G 6-P (2.5) + NADP (2.0) 127+11
No activation G 6-P (2.5) ÎO4+6
No activation NADPH (4.0) Î34+8*
No activation NADP (2.0) 108+5
No activation NADH (4.0) 102+12
No activation NONE 98+12
Test systems contained quercetin (25 fig/plate), bacteria (TA98), and uninduced rat liver 
activation systems without or with the indicated amounts of co-factors. Spontaneous 
reversion rate of 28±4 has already been subtracted. Results are mean±SD of triplicate 
samples of a representative experiment.
* - Significantly higher reversion rates in comparison with tests without activation or 
cofactors.
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2.3.7 EFFECT OF DIALYSING THE CYTOSOL ON QUERCETIN 
MUTAGENICITY
Cytosolic mediated quercetin mutagenicity was further investigated by dialysing the 
hepatic fraction. The results of this experiment are presented in Table 2.12. In the absence 
of cofactors, the mutagenicity of quercetin potentiated by dialysed cytosolic fraction was 
not significantly different from that due to quercetin alone. A small, but significant increase 
in quercetin mutagenicity occurred when dialysed cytosolic fraction was incorporated into 
the activation system at 20% (v/v). In the presence of cofactors dialysed cytosolic fraction 
potentiated quercetin mutagenicity to the same extent as the undialysed fraction. The effect 
of dialysis of the rat liver cytosolic fraction on potentiation of 2-aminoanthracene 
mutagenicity is evident from Table 2.13. In the absence of cofactors, neither dialysed nor 
undialysed activation system activated 2-aminoanthracene to its mutagenic species. In the 
presence of cofactors, however, both dialysed and undialysed cytosolic fractions activated 
2-aminoanthracene, although the observed mutagenicity was significantly lower than that 
caused by S9 activation system. It is also apparent that in the presence of cofactors, the 
mutagenicity of 2-aminoanthracene mediated by undialysed cytosolic fraction was 
significantly higher than that due to dialysed fraction.
Table 2.12: Effect of dialysis of cytosol fraction on the activation of quercetin 
mutagenicity in Salmonella typhimurium TA98.
Number of histidine revenants per plate induced by quercetin in the
presence (+) or absence (-) of cofactors
Activation* Dialysed Undialysed
(%) + Cofactors - Cofactors + Cofactors - Cofactors
0 54+7 62±4 59+8 61±11
5 199+11** 56+8 156+15** 61+5
10 299+19** 67+9 256+14** 95+15
20 387+58** 87±9 343±13** 170+5**
* - Uninduced cytosolic rat liver fraction. Quercetin (20 |ig dissolved in 50 fil of DMSO), 
bacteria (TA98), activation systems containing the indicated cytosolic fraction at 0 - 20 % 
(v/v) were used in the presence or absence of cofactors. The spontaneous reversion rate of 
16±2 has already been subtracted. ** - Marked mutagenic effect.
67
Table 2.13: Effect of dialysis of cytosol fraction on the activation of 2-aminoanthracene 
mutagenicity in Salmonella typhimurium TA98.
Activation
(%)
Number of histidine revenants per plate induced by 2-aminoanthracene 
the presence (+) or absence (-) of cofactors
Dialysed 
+ Cofactors - Cofactors
Undialysed 
+ Cofactors - Cofactors
5 6+3 0 17±1 2+1
10 33+5 0 45+4 5+2
20 113+8 0 172±25 4+3
* - Uninduced cytosolic rat liver fraction.
2-Aminoanthracene (2.5|ig/plate), bacteria (TA98), activation systems containing the 
indicated cytosolic fraction at 0 - 20 % (v/v) were used in the presence or absence of 
cofactors. The spontaneous reversion rate of 16±2 has already been subtracted.
2.3.8 EFFECT OF PROTEINASE TREATMENT ON THE RAT LIVER- 
MEDIATED QUERCETIN MUTAGENICITY
Hepatic fractions were incubated with proteinase K enzyme (activity 10-20  units 
per mg protein) for 1 hat 37° C, before being used to prepare the activation systems for the 
mediation of quercetin mutagenicity. It is evident, from the data in Table 2.14 that, in the 
presence of cofactors, treatment with proteinase K did not affect the mutagenicity of 
quercetin induced by S9. The table also shows that 2-aminoanthracene mutagenicity was 
completely abolished after treatment of rat liver fraction with proteinase K, possibly 
indicating a high sensitivity of the activating enzyme to the proteolytic agent
The effect of proteinase K treatment was further examined following incubation 
with microsomal and cytosolic fractions, as shown in Table 2.15, to determine whether the 
rat liver fractions displayed similar responses to this treatment. No significant effect was 
observed in the proteinase-treated microsomes’ ability to activate quercetin. Similarly, there 
was no marked effect arising from treatment of the cytosolic rat liver fraction with the 
proteinase, showing that the enzyme neither affected microsomal nor cytosolic quercetin
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mutagenicity. Proteinase treated microsomal and cytosol fractions did not activate 2- 
aminoanthracene to mutagenicity, in agreement with the results of Table 2.14.
Table 2.14: Effect of proteinase K treatment of S9 fraction on quercetin mutagenicity.
Number of histidine revenants per plate induced by quercetin and 
2-aminoanthracene in the presence (+) or absence (-) of cofactors
Proteinase K Quercetin 2-Aminoanthracene
(mg/ml)* + Cofactors - Cofactors + Cofactors - Cofactors
0 559±18 412+18 1480+112 4±0
2 531±20 536±13 15±8 14±4
4 490±33 463±34 22+7 23+2
* - Proteinase K (activity 10 - 20 units per mg protein) was added to hepatic S9 fraction at 
0 - 4  mg/ml and incubated for 1 h in a shaking water bath at 37° C. Activation systems 
contained S9 hepatic fractions which have been pre-incubated with proteinase K. Quercetin 
was used at 25 |ig (dissolved in 50 jil of DMSO) per plate; 2-aminoanthracene was used at 
3 fig per plate. Mutagenicity was assayed using bacterial strain TA98. Results are presented 
as meardzSD. The spontaneous reversion rate of 17±2 has already been subtracted.
Table 2.15: Influence of proteinase K treatment of rat liver microsomal and cytosolic 
fractions on potentiation of quercetin and 2-aminoanthracene mutagenicity.
Number of histidine revenants per plate induced by quercetin and 
2-aminoanthracene in the presence of microsomal or cytosol activation
Proteinase Quercetin 2-Aminoanthracene
(mg/ml)* Microsomes Cytosol Microsomes Cytosol
0 334+30 762+33 2847+43 226±21
1 397+51 778+47 0 0
2 376±6 695+6! 0 0
4 375±44 652±54 0 0
8 401 ±24 669±43 0 0
* - The indicated concentrations of proteinase K (activity 10-20 units per mg protein) were 
added to uninduced hepatic fractions and incubated for 1 h at 37° C. The fractions treated in 
this way were used to prepare activation systems. Quercetin, as a solution in 50 Jil DMSO, 
was used at 50 fig per plate. 2-aminoanthracene was used at 5 fig per plate. The 
mutagenicity test was carried out using bacterial strain TA98. The results are presented as 
mean±SD of triplicate samples. Spontaneous reversion rates of 15±4 have already been 
subtracted.
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2.3.9 QUERCETIN MUTAGENICITY FOLLOWING HEAT TREATMENT 
OF THE RAT LIVER FRACTIONS
The present study was undertaken to establish whether the microsomal and 
cytosolic enzymes activating quercetin are heat labile. Heat-treated rat liver microsomes 
could not significantly enhance quercetin mutagenicity (Figure 2.2). The results of heat 
treatment of the cytosolic rat liver fraction on the activation of quercetin mutagenicity are 
presented in Figure 2.3. Heat treatment inhibited cytosolic activation of quercetin 
mutagenicity.
□  Heat-treated 
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Figure 2.2: Quercetin mutagenicity in Salmonella typhimurium TA98 mediated by heat- 
treated rat liver microsomal fraction. Uninduced microsomal fraction heated for 20 min at 
60° C in a shaking water bath was used for preparation of activation systems. Quercetin at 
25 jxg or 50 fig was dissolved in DMSO so that 50 pi of the solvent was added to each 
plate. The results are presented graphically as mean±SD of triplicate samples. The 
spontaneous reversion rate of 17±2 has already been subtracted.
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Figure 2.3: Quercetin mutagenicity in Salmonella typhimurium TA98 mediated by heat- 
treated rat liver cytosolic fraction. Uninduced cytosolic fraction heated for 20 min at 60° C 
in a shaking water bath was used for preparation of activation systems. Quercetin at 25 jig 
or 50 jig was dissolved in DMSO so that 50 jil of the solvent was added to each plate. 
Cofactors were not used in the cytosolic activation. The results are presented graphically as 
mean±SD of triplicate samples. The spontaneous reversion rate of 17±2 has already been 
subtracted. Quercetin alone caused a reversion rate of 125±18.
2.3.10 MODULATION OF RAT LIVER MEDIATED QUERCETIN 
MUTAGENICITY BY NORHARMAN
Norharman is known to enhance the mutagenicity of mutagenic (Nagao et al., 
1977a; 1977c; Wakabayashi et a i, 1981) and otherwise nonmutagenic compounds such as 
aniline and o-toluidine (Nagao et aL, 1977c). The modulation by norharman of quercetin 
mutagenicity enhanced by rat liver fractions was therefore determined using microsomal, 
cytosolic and S9 activation systems. Surprisingly, rather than potentiation, norharman 
inhibited microsomal, cytosolic and S9-mediated enhancement of quercetin mutagenicity, 
as shown in Figure 2.4.
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Figure 2.6: Inhibition of hepatic activation of quercetin mutagenicity in Salmonella 
typhimurium TA98 by norharman. Quercetin (25 |ig dissolved in 50 (il DMSO), the 
indicated amounts of norharman (dissolved in 50 jil DMSO), bacteria, and activation 
systems consisting of microsomal, cytosol and S9 rat liver fraction were mixed and 
plated. Results are presented as mean±SD of triplicate samples. The spontaneous reversion 
rate of 19±3 has already been subtracted. Under these conditions, norharman elicited no 
positive mutagenic response.
It appears that inhibition was most marked in microsomal rather than in either 
cytosol- or 89-mediated quercetin mutagenicity. The cytosol-mediated quercetin 
mutagenicity was the least sensitive to norharman inhibition. A concentration-dependent 
relationship exists in the inhibitory effect of norharman on quercetin mutagenicity mediated 
by the three activation systems.
The inhibitory effect of norharman on quercetin mutagenicity was further evaluated 
using rat liver S9 fraction to determine whether it was 89-dependent as previously seen in 
the case of N-2-fluorenylacetamide, Trp-P-1, and Trp-P-2 (Nagao et aL, 1978). The 
results of this experiment are illustrated in Figure 2.5. Norharman inhibited quercetin
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mutagenicity at all S9 concentrations in the activation system. Increasing S9 concentration 
in the S9-mix did not significantly alter the inhibitory effect of norharman. Furthermore, 
norharman inhibited quercetin mutagenicity at a range of mutagen concentrations, as shown 
in Figure 2.6.
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Figure 2.5: Inhibitory effect of norharman on quercetin mutagenicity in Salmonella 
typhimurium TA98 in the presence of increasing concentrations of rat liver S9. Assay 
system comprised of quercetin (25 |ig dissolved in 50 jil of DMSO), norharman (200 jig 
dissolved in 50 jil of DMSO), bacteria (TA98) and S9 activation system, at the shown 
concentrations. Each point represents MearrizSD of triplicate samples for quercetin alone, 
and quercetin plus norharman.
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Figure 2.6: Inhibition of the mutagenicity of quercetin at various concentrations by 
norharman in Salmonella typhimurium TA98. Assay systems comprised of quercetin at the 
shown concentrations (dissolved in 50 Jil of DMSO), norharman (200 jig dissolved in 50 
jil of DMSO), bacteria (TA98), and S9 rat liver fraction. Each point represents the 
mean±SD of triplicate samples for quercetin alone or quercetin plus norharman.
2.3.11 M ODULATION OF Q U ERCETIN  M U TA GENICITY BY 
MENADIONE AND DICOUMAROL
Studies with menadione and dicoumarol were conducted to further determine 
whether these compounds affected rat liver fraction-mediated quercetin mutagenicity. 
Menadione is known to undergo autoxidation with generation of free radical species such 
as superoxide radicals. It has been proposed that superoxide radicals cause degradation of 
quercetin (Ochiai et aL, 1984). Furthermore, in the process of autoxidation, menadione 
utilises NADPH which may be depleted from solution. Autoxidation of menadione is a 
faster reaction than that of quercetin. Dicoumarol was used as a probe to determine whether 
DT-diaphorase plays any significant role in cytosolic potentiation of quercetin mutagenicity. 
DT-diaphorase [NAD(P)H quinone oxidoreductase], is a cytosolic enzyme that catalyses a 
two-electron reduction of quinones. Dicoumarol is a potent and specific inhibitor of the
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enzyme (Emster, 1967). The pathway leading to activation of quercetin mutagenicity has 
been proposed by MacGregor and Jurd (1978) to involve quinone and semiquinone 
intermediate species.
The results of the study of the effect of menadione on quercetin mutagenicity, using 
rat liver microsomal and cytosolic activation systems, are presented in Table 2.16. 
Menadione caused a decrease (36% - 38%) in quercetin mutagenicity, both in the presence 
and absence of cofactors. Inhibition of cytosolic mediated quercetin mutagenicity also 
occurred significantly by 13% and 36%, in the absence and presense of cofactors, 
respectively. Similarly, microsomal mediated quercetin mutagenicity was inhibited by 
menadione, by about 30% in the absence of cofactors, and by about 88% in the presence of 
cofactors. Incorporation of higher concentrations of menadione in the test systems resulted 
in an even greater inhibition of quercetin mutagenicity. However, at these concentrations 
menadione was toxic to bacteria complicating interpretation of data. These results, using the 
different rat liver fractions, seem to suggest that microsomal-mediated quercetin 
mutagenicity is more sensitive to inhibition by menadione than cytosolic-mediated 
mutagenicity, and that this inhibition is more marked when cofactors are incorporated into 
the activation system.
From data in Table 2.17, in the presence of cofactors, dicoumarol caused a slight 
but significant decrease in cytosolic activation of quercetin mutagenicity. In the absence of 
cofactors, however, no significant decrease was observed. Moreover, dicoumarol caused a 
significant but modest decrease in the mutagenicity of quercetin mediated by the 
microsomal activation system in the presence of cofactors. Microsomal mediated quercetin 
mutagenicity, in the absence of cofactors was, however, unaffected except at high doses, 
which were also toxic to bacterial cells.
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Table 2.16: Inhibition of quercetin mutagenicity in Salmonella typhimurium TA98 by
menadione in the absense or presence of cofactors.
Activation NADPH-generating
system
Menadione Number of histidine revertants per 
plate in the presence (+) or absence 
(-) of the stated factor
Microsomes - - 151+23
Microsomes - + 104±6 (54±4; 21+3)
Microsomes + - 319+10
Microsomes + + 38+1 (18+3; 14±1)
Cytosol - - 344±2
Cytosol - + 299+Î2 (168±27; 110±33)
Cytosol + - 483+45
Cytosol + + 308+20 (Î84+44; 112±18)
Buffer* - - 155111
Buffer* - + 98+21
Buffer* + - 183110
Buffer* + + 112117
Assay systems consisted of quercetin (25 |ig dissolved in 50 gl of DMSO), bacteria 
(TA98), and the indicated rat hepatic fractions, with or without cofactors, in the presence or 
absence of menadione (50 gl of a 1.8 mM solution in DMSO). Results are presented as 
meardzSD of triplicate samples. The spontaneous reversion rate of 10±1 has already been 
subtracted. Data in parenthesis is reversion rates when 50 gl of 3.8 mM and 7.2 mM 
menadione solution respectively were used.
+, denotes presence of menadione or NADPH-generating system in the mutagenicity test 
-, denotes absence of menadione or NADPH-generating system in the mutagenicity test.
* - potassium phosphate buffer pH 7.4 containing 80 mM magnessium chloride and 330 
mM potassium chloride (as in Table 2.1), each at 10% (v/v).
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Table 2.17: Inhibition of quercetin mutagenicity in Salmonella typhimurium TA98 by 
dicoumarol.
Number of histidine revertants per plate mediated by the stated system 
activation in the presence (+) or absence (-) of the indicated cofactors
Dicoumarol Microsomes Cytosol No activation
(pg/plate) + cofactors -cofactors + cofactors - cofactors + cofactors - cofactors
0 299+5 Î98+8 520+3 375±24 178+11 140±15
6.8 242+21* 187+10 495+8 389+30 166+7 Î4Î+Î2
13.6 211+41* 171+6* 478+4 342+17 Î57+Î8 149+3
27.2 206+14* 152±2* 457+25* 355±13 154±5 160+4
54.4 189±30* 13Q±9* 464+Î8* 359±3O Î35+Î5* 120+3
Quercetin (25 pg), dicoumarol (dissolved in 50 pi of DMSO), bacteria (TA98), and the 
activation system or buffer without or with cofactors were tested. The microsomal 
activation system containing cofactors was supplemented with G 6-P DH (1 unit per plate). 
The spontaneous reversion rate of 13±2 has already been substracted. Results are presented 
as mean±SD of triplicate samples. Dicoumarol was not mutagenic under the present 
conditions.
+, denotes the presence of the indicated fator in the mutagenicity test 
-, denotes the absence of the indicated factor in the mutagenicity test.
* - Significant decrease in reversion rates compared with tests without dicoumarol.
2.4 DISCUSSION
The mutagenicity of quercetin was investigated in the presence of microsomal, 
cytosol or S9 hepatic fractions from Aroclor-1254-treated or untreated rats, in the absence 
or presence of cofactors. Furthermore, the effect of preincubation, and incorporation of 
menadione, norharman, dicoumarol and ptoteinase enzyme in the mutagenicity tests was 
examined to further elucidate the mechanisms involved in the mediation of mutagenicity by 
the hepatic fractions.
Quercetin was found to be mutagenic to Salmonella typhimurium strains TA97, 
TA98 and TA100 when the activating systems from rat liver were used, but only in TA98 
and TA 100 in the absence of the activating systems. The activity was not significantly
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enhanced by pretreatment of rats with Aroclor-1254. Investigations showed that while both 
the cytosolic and microsomal fractions enhanced activity, the cytosol was more effective (> 
2-fold) than the microsomal fraction in potentiating quercetin mutagenicity.
Failure of Aroclor-1254-induced rat liver microsomes and S9 to cause potentiation 
of quercetin mutagenicity higher than controls indicates that the major forms of cytochrome 
P-450 (cytochrome P-450 LA and P-450IIB) inducible by this agent (Ryan et aL, 1977) are 
not involved in quercetin mutagenicity.
The present results indicate that NADPH is one of the cytosol factors that enhances 
quercetin mutagenicity, and that an NADPH-generating system consisting of NADP and G 
6-P produces the same effect. An NADPH-dependent enzyme activity in the cytosol, which 
is sensitive to heat (60° C), seems to be involved in mediating quercetin mutagenicity. The 
present results have also demonstrated that NADPH alone or NADPH-generating system 
can enhance the mutagenicity of quercetin in the absence of microsomal and cytosol 
fractions, although to a significantly smaller extent than that resulting from hepatic fractions 
supplemented with cofactors. Reducing agents such as NADPH have been shown to be 
capable of reducing orr/zo-quinones to orr/zo-dihydroxyphenols (Kertesz and Zito, 1962), 
suggesting that transformation of quercetin to its orf&o-quinone is an antimutagenic 
pathway.
The mutagenicity of quercetin, with and without activation, was markedly inhibited 
by menadione. Menadione can undergo a two-electron reduction pathway catalysed by DT- 
diaphorase to the hydroquinone menadiol, or one-electron reduction, through the action of 
flavoproteins, to semiquinone free radicals which can participate in oxidation /  reduction 
cycles in the presence and expense of molecular oxygen, to form superoxide radicals, and 
regenerate the quinone (Kappus and Sies, 1981). The regenerated quinone re-enters the 
flavoprotein catalysed redox cycles with molecular oxygen to generate large amounts of 
superoxide radicals and the oxidation of reduced nucleotides. The enzymic or spontaneous 
dismutation of superoxide radicals yields hydrogen peroxide and molecular oxygen
78
(McCord and Fridovich, 1969). In the presence of certain metal ions, such as iron, the 
reaction between superoxide radicals and hydrogen peroxide forms hydroxyl radical and 
singlet oxygen (Beauchamp and Fridovich, 1970; Hassan and Fridovich, 1979). 
Therefore, redox cycling of quinones leads to a condition of oxidative stress, in which 
partially reduced oxygen products are involved, and the oxidation of reduced pyridine 
nucleotides (Smith et aL, 1982). Two mechanisms may, therefore, be involved in the 
inhibition of quercetin mutagenicity by menadione. The first possible mechanism may be 
through depletion of reduced pyridine nucleotides, that is, there is a decrease of NADPH. 
The NADPH-generating system cannot cope with the rate at which NADPH is used. The 
second possible mechanism, may involve facilitated degradation of quercetin by superoxide 
radicals generated by menadione. Superoxide radical formed during autoxidation of 
quercetin (Ueno et aL, 1983; 1984; Hodnick et aL, 1986; Kostyuk and Potapovich, 1989; 
Rueff et aL, 1989) (Figure 2.7a) or from xanthine and xanthine oxidase system (Ueno et 
aL, 1983) has been shown to degrade quercetin. Although the second mechanism may be 
more important both are likely to proceed simultaneously. Figure 2.7 shows generation of 
semiquinone, quinone and superoxide radicals by autoxidation of quercetin. Flavonols 
having a pyrocatechol grouping in ring B are known to undergo oxidations with quinones, 
and quercetin forms quercetinquinone (Gottlieb, 1975). The quercetinquinone pathway is 
thus antimutagenic.
The inhibitory effect of menadione on quercetin mutagenicity was more marked in 
microsomal- than in cytosol-mediated mutagenicity. Microsomal NADPH-cytochrome P- 
450 reductase (lyanagi and Yamazaki, 1970; Powis and Appel, 1980; Thor et aL, 1982) is 
known to catalyse degradation of menadione to semiquinone and superoxide radicals. Since 
this enzyme system does not occur in the cytosolic fraction, it is possible that the marked 
inhibition of microsomal mediated mutagenicity results from a higher turnover of 
superoxide radicals. Degradation of menadione in the cytosol is possibly only autocatalytic 
with a low turnover of free radicals.
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Although proteinase treatment of the microsomal fraction abolished the activation of 
2-aminoanthracene, potentiation of quercetin mutagenicity was not significantly affected. 
One possible explanation is that the microsomal systems that activate quercetin mutagenicity 
are insensitive to proteinases, whereas the enzymes that activate 2-aminoanthracene have a 
high sensitivity to proteolysis. The second explanation may be that, in the case of 2- 
aminoanthracene, proteinase treatment causes release of important components of the 
microsomal enzyme system such as NADPH-cytochrome P-450 reductase and its specific 
cytochrome P-450 (Hutson, 1975), thereby disrupting electron transport, whereas 
activation of quercetin mutagenicity may involve microsomal enzymic systems not affected 
in this way. Proteolysis of microsomal vesicles releases glucuronyltransferases trapped 
within the vesicles. Glucuronyltransferases are known to affect the activation of 
arylhydroxylamines (Weisburger and Williams, 1982).
It has previously been suggested that the mutagenicity of quercetin might be via 
some quinone intermediate product(s) (Figure 2.7) formed from the interaction of quercetin 
with molecular oxygen, either spontaneously or by processes involving cytosolic and 
microsomal enzymes (MacGregor and Jurd, 1978). DT-Diaphorase is an Aroclor-1254- 
inducible cytosolic enzyme (Prochaska and Talalay, 1986) which catalyses a 2-electron 
reduction of quinones to hydroquinones without the formation of semiquinone radical 
intermediates (lyanagi and Yamazaki, 1970; Powis and Appel, 1980; Lind et a l,  1982). 
For quercetin, therefore, if the mechanism of mutagenicity involved oxidation of ring B 3’- 
and 4’- hydroxyls to quinones, such quinones would be subjected to a 2-electron reduction 
(catalysed by DT-Diaphorase) to generate quercetin or 1-electron reduction with formation 
of semiquinone (Figure 2,7). Inhibition of DT-diaphorase by dicoumarol, a potent and 
specific inhibitor of the enzyme (Emster et aL, 1962; Hollaender and Emster, 1975; 
Hosoda et aL, 1974) would, therefore, cause either enhanced or reduced mutagenic effect, 
depending on whether quercetin or its quinone intermediate products are important for 
activity. In the present study dicoumarol did not cause a significant concentration- 
dependent effect on cytosolic-mediated quercetin mutagenicity. It is therefore deduced that
80
'H + Q2
HO O 
Quercetin
(a) Oxidation of quercetin by oxygen
Semiquinone
HO O
Quercetin Semiquinone
(b) Oxidation of quercetin by superoxide radical H2O2
HO O 
3',4'-Dehydroquercetin Semiquinone
(C) Reduction of dehydroquinone by superoxide 
Figure 2.7: Formation of quinone and semiquinone products of quercetin mediated by 
oxygen and superoxide radical. Quercetin may exist in its quinonoid form (ketone groups at 
positions 2 and 3). Oxidation of the 3'- and 4'-hydroxyl groups on ring B of quercetin (or 
its quinonoid form) form the B ring quinonoid intermediates. These intermediates may exist 
in their tautomeric forms (MacGregor and Jurd, 1978).
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DT-diaphorase probably plays little or no significant role in quercetin mutagenicity and a 2- 
electron reduction of quinone intermediate product may possibly not constitute a mutagenic 
pathway. Interestingly, tyrosinase has been shown to strongly inhibit quercetin 
mutagenicity (Hatcher and Bryan, 1985). Tyrosinase catalyses the oxidation of catechols to 
orr/zo-quinones (Vanneste and Zuberbuhler, 1974). Since quercetin contains a catechol, the 
presence of tyrosinase presumably causes quercetin to oxidize at the 3’- and 4’-hydroxy 
groups to form the orr/zo-quinone 3 \4 ’ -dehydroquercetin. This further indicates that 
transformation of quercetin to orf/zo-quinone is probably an antimutagenic event.
A 1-electron reduction of quercetin by autoxidation has already been shown to 
inhibit mutagenicity (Ochiai et al., 1984; Ueno et aL, 1984; Hatcher and Bryan, 1985; 
Rueff et aL, 1989). Superoxide radicals possibly cause degradation of the compound 
(Table 2.15; Ueno et aL, 1983).
Norharman inhibited the mutagenicity of quercetin in the Ames test. Such inhibition 
by norharman has not previously been reported. This finding was unexpected because 
norharman enhances the mutagenicity of the non-mutagenic compounds such as aniline, o- 
toluidine (Nagao et aL, 1977c; Nagao et aL, 1978), 1- (2-methylphenyl) azo-2- 
naphthaleneamine (yellow OB) (Sugimura et aL, 1977a) and diphenylamine (Sugimura et 
aL, 1982; Nagao et aL, 1986), and enhances or inhibits the mutagenicity of N-2- 
fluorenylacetamide, Trp-P-1 and Trp-P-2 (Nagao et aL, 1978; Wakabayashi et aL, 1981), 
depending on the concentration of the metabolic activation system. Norharman is a p -  
carboline which occurs in cigarette smoke condensate, some alcoholic beverages, and 
various foods, especially charred parts of proteinaceous foods (Sugimura et aL, 1976; 
Adachi et aL, 1991). The mechanisms involved in the potentiation or inhibition of 
mutagenicity of the compounds by norharman are largely speculative. Firstly, norharman 
intercalates into double stranded DNA (Hayashi et aL, 1977a), an event which may 
increase the susceptability of DNA to damage by mutagens. Secondly, norharman inhibits 
the metabolism of benzo(o)pyrene (Fujino et aL, 1978) and reduces its mutagenicity (Levitt
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et aL, 1977). In addition, inhibition of aryl hydrocarbon hydroxylase enzyme by 
norharman has been demonstrated. Since this enzyme is responsible for detoxification of 
aniline, the mutagenicity of aniline in the presence of norharman has been suggested to be 
due to inhibition of its detoxification (Nagao et aL, 1977c). Furthermore, norharman (Ho, 
1972) and related compounds (Mclssac and Estevez, 1966) inhibit the activity of 
monoamine oxidase (MAO), and enhances that of superoxide dismutase (SOD) (Nagao et 
aL, 1986). SOD has been shown to enhance the autoxidation of some hydroquinones and 
to inhibit that of others (Brunmark and Cadenas, 1989), thereby affecting their activity 
depending on whether the hydroquinone or the quinone /  semiquinone is the active form.
The mechanism by which norharman inhibits quercetin mutagenicity mediated by 
rat hepatic fractions is unlikely to involve aryl hydrocarbon hydrolase enzyme as this is an 
Aroclor-1254-inducible enzyme and induction plays insignificant role in quercetin 
mutagenicity mediated by rat hepatic fractions (Section 2.3.2). The inhibitory effect is also 
unlikely to involve MAO because this enzyme catalyses the oxidative deamination of 
catecholamines and a wide range of other amines to form the corresponding aldehyde 
derivatives. There are no amino groups in the quercetin molecule. Increasing or decreasing 
S9 concentration, which results in either enhancement or inhibition by norharman of Trp-P- 
1 and Trp-P-2 mutagenicity (Nagao et aL, 1978) does not influence the inhibitory effect of 
norharman on quercetin mutagenicity. Since SOD has already been isolated from the 
cytosolic fraction (Ochiai et aL, 1984) and shown to enhance quercetin mutagenicity, 
possibly by dismutation of superoxide radicals (Ochiai et aL, 1984; Hatcher and Bryan, 
1985), it would seem likely that norharman inhibits quercetin mutagenicity by a process 
that modulates the concentration of superoxide radicals. That is, norharman may facilitate 
the oxidation of quercetin. Metal salts such as MnCla, CuClz, FeS04  and FeClg also inhibit 
the mutagenicity of quercetin in Salmonella typhimurium, possibly by facilitating the 
catalytic oxidation of quercetin (Hatcher and Bryan, 1985). Alternatively, since norharman 
is a base it is possible that it may cause opening of ring C of quercetin (Figure 3.6). 
Degradation products formed by opening of ring C are non-mutagenic (Friedman and
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Smith, 1984). Another possible mechanism of inhibition of quercetin mutagenicity by 
norharman may involve intercalation into DNA. Quercetin, being a planar molecule, may 
intercalate into DNA helix. It is also possible that it causes mutation in bacteria by acting 
this way. Norharman may, therefore, competitively inhibit this intercalation and reduce the 
mutagenic activity of quercetin.
In quercetin mutagenicity studies, a preincubation step (Table 2.9) does not seem to 
increase the mutagenic response sufficiently to warrant routine application. The small 
increase observed is probably a result of the mechanism of action involved in quercetin 
mutagenicity. In this case, brief periods of high concentrations of quercetin or activation 
system during preincubation appear not to be important, but rather the persistence of 
quercetin. This is in agreement with the suggestion that a metabolic intermediate is probably 
not involved in the mutagenicity.
It is therefore possible to postulate that the cytosolic fraction enhances mutagenicity 
by inhibiting the autoxidation and degradation of quercetin. More quercetin would therefore 
be available in the test mixture to interact with DNA, possibly by intercalation, causing 
mutation.
The ability of a hepatic microsomal-NADPH system (pH 7.45) to redox cycle 
previously oxidised quercetin was studied by Canada et al. (1990) in which reduction of 
the oxidized quinone to the parent reduced form was demonstrated. It would therefore 
appear that in the Ames test, microsomal mediated quercetin mutagenicity utilizing NADPH 
may involve facilitated reduction of quercetin oxidation products to the parent compound.
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2.5 CONCLUSION
In conclusion, the study demonstrates that quercetin is a direct-acting mutagen in 
the Salmonella typhimurium strains TA100 and TA98 but is not mutagenic in S. 
typhimurium TA97, TA 102 or TA 104. The positive mutagenic response seen in TA98 and 
TA 100, as previously reported by others (Bjeldanes and Chang, 1977; MacGregor and 
Jurd, 1978; Brown and Dietrich, 1979), and in TA 97 with activation, indicates that the 
compound is a frameshift and a base-pair substitution mutagen. The critical sites for 
reversion in these strains occur at the G-C base pairs (Ames et aL, 1975; Levin et al., 
1982a; 1982b; Maron and Ames, 1983).
The major forms of cytochrome P-450 enzymes inducible by Aroclor-1254 (P-450 
LA and P-450 IIB) do not seem to be involved in the mediation of quercetin mutagenicity 
because their induction by pretreatment of rats with Aroclor-1254 does not increase the 
mutagenicity of quercetin.
Superoxide and hydroxyl radicals generated by autoxidation of quercetin (Ueno et 
aL, 1983; 1984; Hodnick et aL, 1986; Rueff et aL, 1989) are unlikely to mediate 
mutagenicity. Dimethylsulphoxide, which scavenges free hydroxyl radicals had no effect 
on quercetin mutagenicity.
A 2-electron reduction pathway appears not to contribute to cytosolic mediation of 
quercetin mutagenicity because mutagenicity was not influenced when DT-diaphorase was 
selectively inhibited with dicoumarol. Since menadione is known to cause toxicity via 
semiquinone radical formation (Thor et aL, 1982) and inhibition of quercetin mutagenicity 
occurred when it was incorporated in the test systems in the presence or absence of 
activation, it seems likely that oxygen species facilitate degradation of quercetin. Hence
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menadione may cause inhibition of quercetin mutagenicity via 1-electron reduction by 
spontaneous autoxidation which is enhanced by microsomal preparations. Thor et al. 
(1982) have already demonstrated that 1-electron reduction of quinones is catalysed by 
NADPH-cytochrome P-450 reductase.
Events that cause oxidation of quercetin appear to be antimutagenic. It is therefore 
reasonable to conclude that the cytosolic fraction enhances mutagenicity by inhibiting 
autoxidation. This may be through scavenging of free radicals by enzymes such as SOD 
(Ochiai et al., 1984).
Since NADPH significantly enhanced quercetin mutagenicity, and since NADPH 
and microsomes - NADPH are known to cause reduction of orr/zoquinones to ortho- 
dihydrophenols (Kertesz and Zito, 1962; Canada et al., 1990) it is concluded that 
microsomal enzymes possibly enhance the mutagenic activity of quercetin by catalysing this 
reaction.
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CHAPTER 3
CO M U TA G EN ICITY  STUDIES OF Q U E R C E T IN , SH IK IM A TE , 
C Y C L O H E X A N E C A R B O X Y L A T E  AND P T A Q U IL O S ID E  IN 
SALMONELLA TYPHIMURIUM
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3.1 INTRODUCTION
Although a large number of compounds have been isolated from bracken and 
subsequently identified, not one is able to reproduce the full spectrum of lesions produced 
by the plant itself (Evans, 1985a). However, several of the compounds have been 
suspected of having carcinogenic properties (Evans, 1984; Hirono, 1987). Shikimate 
(Evans and Osman, 1974; Jones et ah, 1983; Morino et a l, 1982; Matsuoka et al., 1989), 
quercetin (Bjeldanes and Chang, 1977; Sugimura et a i, 1977b; Hardigree and Epler, 1978; 
MacGregor and Jurd, 1978; Brown and Dietrich, 1979; Brown, 1980; Nagao etaL, 1981) 
and ptaquiloside (Niwa et aL, 1983a; Van der Hoeven et al., 1983) are all genotoxic and 
the carcinogenicity of bracken fern has, at one time or another, been associated with each of 
these compounds (Evans and Osman, 1974; Pamukcu et al., 1980b; Hirono et aL, 1984a; 
1984b).
It is feasible that these compounds might collectively account for the carcinogenicity 
of the plant by acting cooperatively as cocarcinogens. For example, it has been suggested 
that the effect of tobacco smoke in humans is due to the cocarcinogenicity of polycyclic 
aromatic hydrocarbons, a -  and (J- carbolines, catechol and other phenolic compounds 
found in the smoke (Wynder et aL, 1978; Wynder and Hoffman, 1979). In 
cocarcinogenesis, it is thought that certain compounds (comutagens) affect the metabolism 
of genotoxic mutagens by increasing the amount of the ultimate carcinogens formed or by 
decreasing the detoxification and elimination processes. It has further been suggested that 
comutagens may sensitize the target tissue of genotoxic mutagens by stimulating 
proliferation. Alternatively, comutagens may interfere with DNA repair mechanisms (Van 
Duuren, 1976; Hennings e ta i, 1983; Schulte-Hermann, 1985; Yuspa and Poirier, 1988).
Because of the long latent period normally encountered in chemically induced 
tumorogenesis, carcinogenicity studies must involve administration of compounds to 
animals for a considerable proportion of its normal life span (2 years in mice and rats, 5 
years in cattle, Pitot, 1986). Because of the time involved and the high costs incurred, short 
term in vivo and in vitro assays have been developed to screen compounds for mutagenic
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and genotoxic activity. The Ames test has been used to screen chemicals for potential 
carcinogenicity by determining their mutagenic properties (Maron and Maron, 1983). 
Available reports show that there is a good correlation between mutagenicity in the Ames 
test and carcinogenicity for the majority of carcinogens (McCann et a l, 1975a; Sugimura et 
aL, 1976; Purchase et aL, 1976; Bartsch et aL, 1980., Rinkus and Legator, 1979; 1981; 
Ames and McCann, 1981).
The purpose of this study was to determine whether comutagenicity exists between 
quercetin, shikimate (and its major metabolite cyclohexanecarboxylate) and ptaquiloside by 
using the Salmonella typhimurium tester strains TA 100 and TA98 in the Ames test. 
Shikimate and cyclohexanecarboxylate were also tested for mutagenicity in strains TA97, 
TA 102 and TA 104 to determine whether mutagenicity can be detected in these strains.
A preincubation step was incorporated since this has been shown to enhance the 
mutagenic responses of certain weak mutagens such as N,N-dimethylnitrosamine (Yahagi 
et aL, 1977).
In the present studies, norharman was incoiporated in the test systems because it 
has been shown to enhance the mutagenicity of some mutagenic (Nagao et aL, 1977a; 
1977b; Wakabayashi et aL, 1981) and non-mutagenic compounds such as aniline and o- 
toluidine (Nagao et aL, 1977b).
3.2 MATERIALS AND METHODS
Unless otherwise stated, the procedures and methods used in the present study are 
the same as those described in Section 2.2.
3.2.1 CHEMICALS
Shikimate, cyclohexanecarboxylate, 2-nitrofluorene, and N-methyl-N’-nitro-N- 
nitrosoguanidine (MNNG) were obtained from Sigma Chemical Co. Ltd (Poole Dorset); 
Ptaquiloside was obtained as a gift from Professor K.Yamada of Nagoya University,
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Japan. All other chemicals and reagents were obtained from sources presented in Section 
2 .2 . 1.
3.2.2 THE BACTERIAL TESTER STRAINS
The Salmonella typhimurium tester strains TA98 and TA 100 were used for 
comutagenicity studies. These strains are the most sensitive to reversion induced by 
quercetin (MacGregor and Jurd, 1978; Brown and Dietrich, 1979; Tables 2.3 and 2.4) and 
ptaquiloside (Matoba et aL, 1987). TA98 detects frameshift mutagens and TA 100 detects 
base pair substitution mutagens. The characteristics of the strains, as well as storage and 
handling techniques are as described in Section 2.2.2.
3.2.3 COMUTAGENICITY TESTS
Top agar aliquots (2 ml) containing histidine-biotin (10 ml of a sterile solution of 
0.5 mM L-histidine hydrochloride and 0.5 mM biotin per 100 ml top agar) were transferred 
to 13 x 100 mm screwcapped sterilin tubes maintained at 45° C in a water bath. Solutions 
(50 |il or less) of either quercetin, shikimate, cyclohexanecarboxylate or ptaquiloside 
singly, or in combinations (norharman was added if required), the overnight culture (0.1 
ml) and phosphate buffer, or the activation system (0.5 ml) were quickly transferred to the 
tubes, mixed and plated on Vogel Bonner E plates. The plates were inverted after 
solidification and incubated at 37° C incubator for 48 h. The histidine revenant colonies 
were counted manually using a colony counter (Gallenkamp).
3.2.4 PREINCUBATION TEST
Preincubation test was conducted as described in Section 2.2.15. Test compound(s) 
(dissolved in 50 |il DMSO), potassium phosphate buffer or activation system (0.5 ml) and 
the overnight culture (0.1 ml) were transferred into 13 x 100 mm screwcapped sterilin 
tubes on dry ice. Tubes were then incubated in a shaking water bath at 37° C for time 
periods before adding test agar (2 ml) and plating. Plates were incubated at 37° C in an 
incubator for 48 h.
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3 .3  RESULTS
3 .3 .1  MUTAGENICITY IN SALM O NELLA TYPH IM U RIU M  TESTER 
STRAINS TA97, TA98, TA100, TA102 AND TA104
Shikimate and cyclohexanecarboxylate were tested for mutagenicity, alone or in the 
presence of S9 activation system in the five Salmonella typhimurium tester strains. The 
results are as shown in Tables 3.1 and 3.2 respectively. No significant mutagenicity due to 
shikimate or cyclohexanecarboxylate was observed in any of the strains either in the 
absence or presence of activation system.
Table 3.1: Mutagenicity of shikimate in five strains of Salmonella typhimurium.
Strain
Number of histidine revenants per plate induced by the 
stated concentrations of shikimate
0\ig 10 gg 100 \ig 1000 jig
Without S9 activation
TA97 89±17 93±21 94+10 90+5
TA98 52±4 53+1 60+8 56+7
TA100 133±14 139±4 141±11 154±16
TA 102 229±21 23O+Î5 242+7 248+23
TA 104 540±31 535+16 542±33 550±34
With S9 activation
TA97 92±14 ÎO9+ÎO 114±18 102±7
TA98 55±4 49+6 47±11 52+8
TA100 144±12 140±13 139±14 Î38+Î8
TA 102 238±14 232+2 221+15 205±18
TA104 569±22 566±18 571±18 554±32
Shikimate was used at the indicated concentrations per plate dissolved in 100 fil distilled 
water. The test was carried out in the absence or presence of Aroclor-1254-induced rat liver 
S9 activation system. Results are presented as mean±SD of triplicate samples.
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Table 3.2: Mutagenicity of cyclohexanecarboxylate in five strains of Salmonella
typhimurium.
Number of histidine revertants per plate induced by the 
stated concentrations of cyclohexanecarboxylate
Strain 0|^g lO^ig 100 |ig 1000 jig
Without S9 activation
TA97 94±3 97110 99114 109115
TA98 49±3 5112 5615 60112
TA100 155115 148113 14913 157113
TA102 209119 236118 228114 219119
TA104 589142 582126 559138 566133
With S9 activation
TA97 90110 88114 95113 10016
TA98 4415 48112 4214 5316
TA100 15819 150116 142111 149111
TA102 265115 25119 254117 232115
TA104 542119 539130 547129 575134
Cyclohexanecarboxylate was used as a solution in 100 jil of DMSO. The test was carried 
out in the absence or presence of Aroclor-1254-induced rat liver S9 activation system. 
Results are presented as mearrizSD of triplicate samples.
3.3.2 COMUTAGENICITY OF QUERCETIN W ITH SHIKIMATE AND 
CYCLOHEXANECARBOXYLATE
The results of the comutagenicity studies using quercetin and shikimate in 
Salmonella typhimurium strain TA98 in the absence and presence of the rat liver S9 
activation system are shown in Tables 3.3 and 3.4 respectively. As expected, quercetin 
alone was mutagenic in both test systems, though this was not significantly affected by
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shikimate at any of the concentrations used. Shikimate alone also showed no significant 
mutagenic effect
The results of the effect of shikimate on quercetin mutagenicity in TA 100 in the 
absence or presence of rat liver S9 activation system are presented in Tables 3.5 and 3.6 
respectively. The mutagenicity of quercetin was not significantly affected by the presence 
of shikimate.
Comutagenicity studies between quercetin and cyclohexanecarboxylate were also 
conducted and the results are as presented in Figures 3.1a and 3.1b. The mutagenicity of 
cyclohexanecarboxylate was not enhanced by quercetin either in the absence or presence of 
S9 activation system. At high concentrations (>100 p.g/plate), however, 
cyclohexanecarboxylate caused a significant decrease in the mutagenicity of quercetin.
Comutagenicity studies between cyclohexanecarboxylate and quercetin in 
Salmonella typhimurium TA100 were carried out in the absence or presence of Aroclor- 
1254-induced rat liver S9 activation system as presented in Figure 3.2. There was 
significant inhibition of quercetin mutagenicity by cyclohexanecarboxylate at concentrations 
greater than 100 |ig/plate. High concentrations of cyclohexanecarboxylate were not lethal to 
bacteria as judged by the presence of the background lawn in the test plates after 48 h 
incubation. However, a toxicity test, as previously described in Section 2.2.13, was 
carried out to determine whether inhibition of quercetin mutagenicity resulted from bacterial 
lethality due to cyclohexanecarboxylate. The results are as demonstrated in Table 3.7. The 
number of bacteria surviving after incubation with 1000 gg cyclohexanecarboxylate per 
plate was not significantly different from that of the controls, suggesting that the test 
compounds had no lethal effect on the bacteria.
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Table 3.3: Effect of shikimate on quercetin mutagenicity in Salmonella typhimurium
TA98.
Number of histidine revertants per plate induced in 
of the stated concentrations of shikimate
the presence of
Quercetin
(jig/plate)
Ogg* 10 Jig* 100 jig* 1000 gg*
0 22±2 27+4 28±4 29±6
25 15Q±15 158±28 Î47+Î4 Î34+7
50 317±20 310+15 303+11 275±16
100 477±39 488±36 484±30 432±30
* - Shikimate (jig/plate).
Assay systems consisted of quercetin (dissolved in 50 p.1 of DMSO) alone or with 
shikimate dissolved in 50 |il distilled water. TA98 was used as the tester strain. Results are 
presented as mean±SD of triplicate samples.
Table 3.4: Effect of shikimate on quercetin mutagenicity in Salmonella.typhimurium 
TA98 in the presence of rat liver S9 activation system.
Number of histidine revertants per plate induced in the presence of 
the stated concentrations of shikimate
Quercetin
(gg/plate)
Ogg* 10 gg* 100 gg* 1000 gg*
0 49±17 54116 59110 54+13
25 811±44 826154 848159 904+39
50 1182150 1165190 1214+93 1222160
100 1784+98 1814+80 1923+118 1805+97
* - Shikimate (|J.g/plate). Assay systems consisted of quercetin (dissolved in 50 p.1 of 
DMSO) alone or with shikimate (dissolved in 50 |il of distilled water). TA98 and Aroclor- 
1254-induced rat liver S9 activation system were used. Results are presented as mean±SD 
of triplicate samples.
94
Table 3.5: Effect of shikimate on quercetin mutagenicity in Salmonella typhimurium
TA 100.
Quercetin
(pg/plate)
Number of histidine revertants per plate induced in the presence of 
the stated concentrations of shikimate
Opg* 10 pg* 100 pg* 1000 pg*
0 160±15 150120 156110 14318
25 218±7 228115 232115 208112
50 308122 289121 295115 282118
100 369120 351124 358118 347123
* - Shikimate (jig/plate).
Quercetin was dissolved in DMSO (50 jj.1) and shikimate in distilled water (50 (il). TA 100 
was used as the tester strain. Results are presented as mean±SD of triplicate samples.
Table 3.6: Mutagenicity of quercetin in Salmonella typhimurium TA 100 in the presence 
of rat liver S9 activation system and shikimate.
Number of histidine revertants per plate induced in the presence 
of the stated concentrations of shikimate
Quercetin
(pg/plate)
Opg* 10 pg* 100 pg* 1000 pg*
0 162120 159112 159111 15719
25 399124 410128 387130 378131
50 487121 500125 489116 469117
100 629140 635139 600125 610127
* - Shikimate in pg/plate.
Quercetin was dissolved in DMSO (50 pi) and shikimate in distilled water (50 pi). TA 100 
and Aroclor-1254-induced rat liver S9 activation system were used. Results are presented 
as mean±SD of triplicate samples.
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Table 3.7: Mean survival rates of Salmonella typhimurium TA 100 in the presence of 
cycohexanecarboxylate (CCA) and quercetin.
Tester
strain
CCA
(pg/plate)
Number of surviving colonies 
+ Quercetin - Quercetin
TA98 0 113±3 116±10
10 115±8 111±7
100 112±15 ÎO8+Î5
500 107±11 11617
1000 113±5 96113
TA100 0 130±12 13519
10 133±6 124113
100 Î29+9 126110
500 132±8 131111
1000 128±5 13717
Assay systems contained cyclohexanecarboxylate (dissolved in 50 p.1 of DMSO), quercetin 
(100 p.g dissolved in 50 pi of DMSO), bacteria (TA98 or TA 100), and Aroclor-1254- 
induced rat liver S9 activation. Results are presented as mean±SD of triplicate samples.
+, Denotes presence of quercetin.
-, Denotes absence of quercetin.
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Figure 3.1: Inhibition of quercetin mutagenicity by cyclohexanecarboxylate in
Salmonella typhimurium TA98. Test systems contained quercetin (dissolved in 50 jil of 
DMSO) and cyclohexanecarboxylate (dissolved in 50 jil of DMSO) at the shown 
concentrations, TA98, and phosphate buffer (a) or Aroclor-1254-induced rat liver S9 
activation system (b). Each point represents meartizSD of triplicate samples.
97
400 H
(a)
□  0 Cyclohexanecarboxylate (jig/plate) 
M 10 
M 100 
H 1000
2
J2 600
*a.
j2
I  400a»
%
ve
« 200 
32
(b)
□  0 Cyclohexanecarboxylate (gg/plate) 
® 10 
M 100
m moo
0
0 25 50 100
Concentration of quercetin (pg/plate)
Figure 3.2: Inhibition of quercetin mutagenicity by cyclohexanecarboxylate in Salmonella 
typhimurium TA 100. Test systems consisted of quercetin (dissolved in 50 pi of DMSO) 
and cyclohexanecarboxylate (dissolved in 50 |il of DMSO) at the shown concentrations, 
TA100, and potassium phosphate buffer (a) or Aroclor-1254-induced rat liver S9 
activation system (b). Each point represents mean±SD of triplicate samples.
9 8
3.3.3 EFFECT OF PREINCUBATION ON COM UTAGENICITY OF 
QUERCETIN, SHIKIMATE AND CYCLOHEXANECARBOXYLATE
A preincubation step at 37° C for 40 min was incorporated in the mutagenicity test 
to determine if comutagenicity of quercetin and shikimate in TA98 could be enhanced. The 
results of this experiment are illustrated in Figure 3.3. Preincubation did not cause any 
significant effect on the comutagenicity of quercetin and shikimate. Shikimate was 
nonmutagenic in this system.
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Figure 3.3: Comutagenicity of quercetin and shikimate in Salmonella typhimurium TA98 
with preincubation. Test systems contained quercetin (dissolved in 50 |il of DMSO), 
shikimate (dissolved in 50 pi of distilled water) and TA98. Each point represents the mean 
of triplicate samples.
The results of the effect of shikimate on quercetin mutagenicity in the presence of 
Aroclor-1254-induced rat liver S9 activation system, with preincubation, are as illustrated 
in Figure 3.4. The mutagenicity of quercetin was not significantly affected by shikimate at 
any concentration. Shikimate demonstrated no significant mutagenicity in this system.
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Figure 3.4: Effect of shikimate on quercetin mutagenicity in Salmonella typhimurium 
TA98 in the presence of S9 activation and preincubation. Test systems consisted of 
quercetin (dissolved in 50 p.1 of DMSO) alone or with shikimate at the shown 
concentrations (dissolved in 50 |il of distilled water), bacteria (TA98) and Aroclor-1254- 
induced rat liver activation system. Each point represents meartizSD of tripplicate samples.
Figures 3.5a shows the results of a comutagenicity study of quercetin and 
cyclohexanecarboxylate using the preincubation technique, in the absence of activation. 
Preincubation did not enhance the mutagenic activity of cyclohexanecarboxylate. The 
presence of quercetin did not activate cyclohexanecarboxylate to mutagenicity. As observed 
previously quercetin mutagenicity was significantly inhibited by high concentrations of 
cyclohexanecarboxylate.
The effect of incorporation of rat liver S9 activation system and preincubation on 
comutagenicity of quercetin and cyclohexanecarboxylate are as shown in Figure 3.5b. No 
significant activation of cyclohexanecarboxylate to mutagenic intermediates occurred. 
However, the mutagenicity of quercetin was significantly inhibited by 
cyclohexanecarboxylate at 1000 pg/plate.
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Figure 3.5: Inhibition of quercetin mutagenicity by cyclohexanecarboxylate in Salmonella 
typhimurium TA98 after preincubation. Test systems contained quercetin (dissolved in 50 
pi of DMSO) and cyclohexanecarboxylate (dissolved in 50 pi of DMSO) at the indicated 
concentrations, bacteria (TA98), and 0.2M potassium phosphate buffer pH 7.4 (a) or 
Aroclor-1254-induced rat liver S9 activation system. Each point represents mean±SD of 
triplicate samples.
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3.3.4 COMUTAGENICITY STUDIES WITH PTAQUILOSIDE
The comutagenicity of ptaquiloside with quercetin, shikimate or 
cyclohexanecarboxylate was determined using both the standard and the preincubation 
methods. The results of the standard method using TA 100 are as presented in Table 3.8. 
Ptaquiloside was not mutagenic using the standard method, and its mutagenicity was not 
enhanced by any of the compounds. However, after preincubation in 0.2M phosphate 
buffer pH 7.4 at 37° C for 40 min (Table 3.9), ptaquiloside demonstrated significant 
mutagenicity in TA100.
The results of a comutagenicity study, involving mixed application of ptaquiloside 
with either quercetin, shikimate or cyclohexanecarboxylate, with preincubation, are 
presented in Table 3.9. Mixed application of either quercetin, shikimate or 
cyclohexanecarboxylate with ptaquiloside did not significantly enhance mutageniciy though 
the mean number of revertants due to quercetin (12.5 pg/plate) and ptaquiloside (338) was 
higher than the sum of their separate reversion rates (293). Likewise, at higher 
concentrations of quercetin, the mean number of revertants due to combined application 
was not significantly different from the sum of their separate effects, showing that there 
was no synergism in the mutagenicities of the two compounds.
Since prolonged preincubation of ptaquiloside with Salmonella typhimurium is 
known to potentiate its mutagenicity (Matoba et aL, 1987), a comutagenicity trial was 
conducted using TA 100 and a preincubation period of 4 h in 0.2M phosphate buffer pH 
7.4. The results of this study are presented in Table 3.10. The mutagenicity of ptaquiloside 
was markedly enhanced when compared with that produced following preincubation 
periods of 40 min (Table 3.9). The sum of the reversion rates due to quercetin and 
ptaquiloside after separate applications was not significantly different from the reversion 
rates of these compounds after combined application, indicating that there was no inhibitory 
or synergistic effect resulting from the combination. Shikimate and cyclohexanecarboxylate 
were not mutagenic, even after combined application with ptaquiloside.
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Table 3.8: Comutagenicity of ptaquiloside with quercetin, shikimate or
cyclohexanecarboxylate (CCA) in Salmonella typhimurium TA 100.
Number of histidine revertants per plate in the 
presence (+) and absence (-) of ptaquiloside
Compound Concentration (pg/plate) + -
Quercetin* 0 136*13 149110
12.5 167±15 15919
25 272117 268115
50 301121 28918
Shikimate 0 151121 155118
50 153111 152113
500 149114 146116
1000 156119 13817
CCA 0 153119 14519
50 148122 144118
500 147113 137112
1000 136110 14018
Test systems contained ptaquiloside (20 jig) alone, or with the indicated concentrations of 
either quercetin, shikimate, or cyclohexanecarboxylate, and bacteria (TA 100). Results are 
presented as mean±SD of six samples.
*- Significant mutagenic effect at 25 and 50 pg/plate.
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Table 3.9: Mutagenicity of ptaquiloside with quercetin, shikimate and
cyclohexanecarboxylate (CCA) in Salmonella typhimurium TA100 with preincubation.
Number of histidine revertants per plate in the 
presence (+) or absence (-) of ptaquiloside
Compound Concentration (pg/plate) + -
Quercetin* 0 360±16 (217) 14317 (0)
12.5 481±52 (338) 21917 (76)
25 477±49 (334) 251126 (108)
50 454±14 (311) 278115 (135)
Shikimate** 0 380128 147123
50 357118 13616
500 369111 145115
1000 37415 151112
CCA** 0 373119 150115
50 366142 146110
500 415129 135116
1000 312117 129113
Assay systems contained ptaquiloside (20 gg) alone or with the indicated concentrations of 
either quercetin, shikimate or cyclohexanecarboxylate, and bacteria (TA 100), with a 
preincubation step at 37° C for 40 min. Plates contained no more than 50 pi of DMSO. 
Results are presented as mean±SD of six samples.
* - The reversion rate due to ptaquiloside at 20 pg/plate is significantly higher and more 
than 2-fold the spontaneous reversion rate. Data in parenthesis is net revertants per plate 
(the spontaneous reversion rate of 143 has been subtracted).
** - Significant increase in the number of revertants, more than 2-fold the spontaneous 
reversion rate, only in test systems containing ptaquiloside.
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Table 3.10: Comutagenic activity of ptaquiloside with quercetin, shikimate and 
cyclohexanecarboxylate (CCA) in Salmonella typhimurium in TA 100 after prolonged 
preincubation.
Number of histidine revertants per plate in the 
presence (+) or absence (-) of ptaquiloside
Compound Concentration (gg/plate) + -
Quercetin* 0 488+48 (366) 12117 (0)
12.5 548+42 (427) 168116 (47)
25 557+53 (436) 212113 (91)
50 535132 (414) 280116 (157)
Shikimate** 0 503124 13518
10 497+22 139111
100 495134 142+9
1000 512131 123116
CCA** 0 493117 13816
10 516126 143112
100 486+25 134118
1000 513+17 149115
Assay systems contained ptaquiloside (20 gg) alone or with the indicated concentrations of 
quercetin, shikimate or cyclohexanecarboxylate, and bacteria (TA98) and no more than 50 
gl of DMSO which was used as solvent. A preincubation step was carried out at 37° C for 
4 h. Results are presented as mean±SD of six samples.
* - The reversion rate due to ptaquiloside is significantly higher and more than 2-fold the 
spontaneous reversion rate. Data in parenthesis is net revertants per plate (the spontaneous 
reversion rate of 121 has been subtracted).
** - Significant increase in the number of revertants, more than 2-fold the spontaneous 
reversion rate, only in test systems containing ptaquiloside.
105
The mutagenicity of ptaquiloside has been suggested to be potentiated by high pH 
(Matoba et aL, 1987). Comutagenicity studies of ptaquiloside with quercetin, shikimate and 
cyclohexanecarboxylate were, therefore, carried out at an elevated pH of 8.2, with 
incubation at 37° C for 40 minutes. As shown in Table 3.11, the mutagenicity of 
ptaquiloside was markedly enhanced at the elevated pH, to more than 6-fold the 
spontaneous reversion rate. Quercetin was not mutagenic in this system up to 50 pg/plate 
tested although there was a consistent increase in reversion rates with increasing 
concentrations of the compound.
Table 3.11 also shows that there was no significant difference between the 
reversion rates due to ptaquiloside alone and ptaquiloside in combination with quercetin. 
Shikimate and cyclohexanecarboxylate were not mutagenic in this system, signifying that 
the compounds are not activated by alkaline conditions. The mutagenicity of ptaquiloside 
was not affected by either shikimate or cyclohexanecarboxylate.
Since the mutagenicity of quercetin is potentiated by S9 liver fraction, and that of 
ptaquiloside enhanced by preincubation, a comutagenicity study of the compounds must 
attempt to optimise these factors. A study was therefore conducted with preincubation at 
pH 7.4 in the presence of S9 activation system. Mutagenicity was not tested at pH 8.2 
because this pH is too high for the optimal activity of S9 rat liver fraction. The results are 
presented in Table 3.12 for TA100, and Table 3.13 for TA98. Ptaquiloside caused no 
significant mutagenic effect in either test system. Quercetin, as expected, was mutagenic at 
all dose levels.
Neither quercetin, shikimate nor cyclohexanecarboxylate could potentiate 
ptaquiloside mutagenicity. It is, therefore, evident that the S9 activation system abolishes 
the mutagenic effect of ptaquiloside. It is likely that a factor in the S9 activation system 
renders ptaquiloside non-mutagenic. Shikimate and cyclohexanecarboxylate were not 
mutagenic in this assay system, again asserting that preincubation, even in the presence of 
S9 activation system, does not potentiate their mutagenicity.
106
Table 3.11: Comutagenicity of ptaquiloside with quercetin, shikimate and
cyclohexanecarboxylate (CCA) in TA100 with preincubation in phosphate buffer pH 8.2.
Number of histidine revertants per plate in the 
presence (+) and absence (-) of ptaquiloside
Compound Concentration (jig/plate) + -
Quercetin* 0 10991130 (940) 159122 (0)
12.5 898170 (739) 195135 (36)
25 817179 (658) 214142 (55)
50 837168 (678) 221149 (62)
Shikimate** 0 12691209(1101 168145
50 12561316(1113) 143150
500 12071216 (1032) 175142
1000 10651268 (890) 175148
CCA** 0 9751220 (830) 145113
50 9141272 (778) 136112
500 9681239 (831) 13719
1000 9471279 (807) 140115
Assay systems contained ptaquiloside (20 gg) alone or with the indicated concentrations of 
either quercetin, shikimate or cyclohexanecarboxylate, TA 100, and 0.2M phosphate buffer, 
pH 8.2. A preincubation step at 37° C for 40 min was carried out. The results are presented 
as mean±SD of triplicate samples.
* - Reversion rate caused by ptaquiloside significantly higher and more than 2-fold the 
spontaneous reversion. Data in parenthesis is net revertants per plate (the spontaneous 
reversion rate of 159±22 has been subtracted).
** - Significant increase in the number of revertants, more than 2-fold, occurred only in 
test systems containing ptaquiloside.
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Table 3.12: Comutagenicity of ptaquiloside with quercetin, shikimate and
cyclohexanecarboxylate (CCA) in Salmonella typhimurium TA 100 with preincubation in
the presence of S9 activation.
Number of histidine revertants per plate in the 
presence (+) and absence (-) of ptaquiloside
Compound Concentration (gg/plate) + -
Quercetin* 0 173±23 (0) 169±3 (0)
25 304±4 (135) 298+10 (129)
50 396+16 (227) 411±38 (242)
100 547+31 (378) 518+23 (349)
Shikimate 0 196±25 172±22
50 196±19 178±18
500 199±16 166+23
1000 2O6+24 Î75+Î4
CCA 0 178±5 181+9
50 165+14 160±11
500 174±29 158+16
1000 160+21 146±26
Assay systems contained ptaquiloside (20 jig) alone or with the indicated concentrations of 
either quercetin, shikimate or cyclohexanecarboxylate, bacteria (TA 100) and Aroclor-1254- 
induced rat liver S9 activation. Not more than 50 |il of DMSO solvent was used per plate. 
A preincubation step at 37° C for 40 min was performed. Results are presented as 
mean±SD of six samples.
* - Significant mutagenic effect at 25 to 100 jig quercetin/plate. Data in parenthesis is net 
revertants per plate due to quercetin (the spontaneous reversion rate has been subtracted).
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Table 3.13: Comutagenicity of ptaquiloside with quercetin, shikimate and 
cyclohexanecarboxylate (CCA) in Salmonella typhimurium TA98 with preincubation in the 
presence of S9 activation.
Number of histidine revertants per plate in the 
presence (+) and absence (-) of ptaquiloside
Compound Concentration (pg/plate) + -
Quercetin* 0 21±2 (0) 23±3 (0)
25 554+33 (543) 521+32 (498)
50 804±39 (783) 862±45 (839)
100 1233+48(1212) 1336+54 (1313)
Shikimate 0 21±4 24±1
50 29±6 23+2
500 25±3 24+7
1000 28+4 18+1
CCA 0 24±2 25+2
50 18+4 22+4
500 22+4 22±1
1000 23+3 23±4
Assay systems contained ptaquiloside (20 p.g) alone or with the indicated concentrations of 
either quercetin , shikimate or cyclohexanecarboxylate, bacteria (TA 100) and Aroclor- 
1254-induced rat liver S9 activation. Plates contained not more than 50 pi of DMSO used 
as solvent. A preincubation step was carried out at 37° C for 40 min. Results are presented 
as mean±SD of six samples.
* - Significant mutagenic effect at 25 to 100 pg quercetin/plate. Data in parenthesis is net 
revertants due to quercetin (the spontaneous reversion rate of 23 has been substracted).
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3 .3 .5  S H IK IM A T E  AND C Y C L O H E X A N E C A R B O X Y L A T E  
MUTAGENICITY IN THE PRESENCE OF NORHARMAN
The mutagenicity of shikimate and cyclohexanecarboxylate was further investigated 
by incorporation of norharman in the test systems. Norharman has been shown to enhance 
the mutagenicity of certain non-mutagenic compounds (Nagao et aL, 1977c). Table 3.14 
shows the results of this experiment, in the presence of Aroclor-1254-induced rat liver S9
Table 3.14: Mutagenicity of shikimate, and cyclohexanecarboxylate (CCA) in 
Salmonella.typhimurium in the presence of norharman and S9.
Number of histidine revertants per plate in the 
presence (+) and absence (-) of norharman
TA100 TA98
Compound Concentration 
(pg/plate)
+
Norharman Norharman
+
Norharman Norharman
Quercetin* 0 116±6 119+12 34±10 4Î+Î4
12.5 206±21 231±13 166±39 343±29
25 271 ±7 349+ÎO 275+59 395±64
50 345±28 467+6 401±60 85Î+98
Shikimate 0 119±9 118±11 33±3 29±7
50 123+10 119±12 35+5 29+8
500 119±11 H6+ÎO 29+7 32±12
1000 126±8 Î25+9 32+10 34±11
CCA 0 118+7 119±5 33+8 38±8
50 141±35 Î25+14 49+22 37+6
500 117+11 123+12 38±10 38±7
1000 124±12 116±11 38+8 41±9
Assay systems contained norharman (200 |ig) alone or with either quercetin, shikimate or 
CCA; TA 100 or TA98, and Aroclor-1254-induced S9. Plates contained not more than 100 
pi of DMSO used as solvent. Results are presented as mean±SD triplicate samples.
* - Significant differences in the number of reversion rates at all concentrations.
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activation. Norharman, in the presence of the activation system, did not enhance the 
mutagenicity of either shikimate or cycloheaxanecarboxylate. These compounds were tested 
at concentrations up to 1000 jig per plate.
Evidence has already been presented in Section 2.3 on the inhibition of quercetin 
mutagenicity by norharman in Salmonella typhimurium TA98. In this study, norharman 
also inhibited quercetin mutagenicity in strain TA 100, as shown in Table 3.14. These 
results are evidence that norharman is antimutagenic for base pair and frameshift 
mutagenesis resulting from quercetin in the S. typhimurium strains.
3. 4 DISCUSSION
The comutagenic effect of three lexicologically important bracken constituents 
(quercetin, shikimate and its metabolite cyclohexanecarboxylate, and ptaquiloside) were 
investigated using S. typhimurium strains TA 100 and TA98. The data obtained 
demonstrate that only quercetin and ptaquiloside were mutagenic under the conditions 
adopted and that cyclohexanecarboxylate significantly inhibited quercetin mutagenicity.
Shikimate was not mutagenic in any of the strains, either in the absence or presence 
of the activating system, in agreement with other studies. This perhaps is not surprising 
because mammalian enzymes are incapable of metabolizing shikimate (Brewster, 1977). 
Similarly, cyclohexanecarboxylate was not mutagenic either in the absence or presence of 
the activation system. This compound is the major bacterial metabolite of shikimate which 
undergoes rapid further metabolism by mammalian enzymes (Brewster, 1977). Further to 
the observations of Jones et <2/. (1983), the present results are additional evidence that 
cyclohexanecarboxylate, and hence shikimate metabolites, are not mutagenic in the S. 
typhimurium  tester strains TA97, TA98, TA 100, TA 102 and TA 104 even after 
preincubation and incorporation of norharman which are known to mediate the 
mutagenicity of some otherwise non-mutagenic compounds (Nagao et al., 1986).
I l l
Shikimate has previously been tested in TA 1535 and TA 1537, using the standard Ames 
method, and shown to be without mutagenic effect (Jacobsen et al, 1978).
It is not clear how cyclohexanecarboxylate (Figure 1.5) modulates quercetin 
mutagenicity. It is unlikely, though, that inhibition results from any toxic effects on 
bacterial cells since the antibacterial lethality test (Table 3.7) produced negative results. The 
first possible mechanism of inhibition may involve a chemical interaction between quercetin 
and cyclohexanecarboxylate. Quercetin is hydroxylated at 3, 3\  4’, 5, and 7-positions. In 
the flavonoids (Figure 1.2), estérification occurs readily at these positions. The 
hydroxylation pattern is important in the mutagenicity of quercetin. If for example the free 
hydroxyl groups on the B ring are removed, as in galangin or kaempferol (Figure 7.1), 
there is an absolute requirement for hepatic activation to exhibit mutagenicity (Brown and 
Dietrich, 1979). Méthylation of quercetin at C-5 position of ring A forms 5-0- 
methylquercetin which has little mutagenic activity in comparison to quercetin. Méthylation 
at C-7 position is not important for mutagenic activity of quercetin because rhamnedn (7-0- 
methylquercetin) is mutagenic. Removal of the hydroxyl at C-3 to form luteolin abolishes 
the mutagenic activity even in the presence of hepatic activation. Furthermore, derivatives 
of quercetin such as the esters 3-0-methylquercetin and rutin, with methyl or sugar 
molecules (rutinose, rhamnose) attached at C-3, are non-mutagenic (MacGregor and Jurd, 
1978; Brown and Dietrich, 1979). Since esters are formed when acids react with alcohols 
and since quercetin has the chemical features of an alcohol, and cyclohexanecarboxylate is a 
carboxylic acid, it is possible that ester linkages between quercetin and 
cyclohexanecarboxylate at the hydroxylated positions of quercetin may occur, especially at 
C-3 position. It would therefore appear that as the molar ratio of cyclohexanecarboxylate to 
quercetin increases so would more of the ester be formed at the hydroxylated positions. 
Consequently the mutagenicity of quercetin would decrease because, as explained above, 
blockade or removal of the hydroxyl groups of quercetin, especially at 3,3’,4’, and 5- 
posidons inhibits mutagenicity.
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The second possible mechanism of inhibition of quercetin mutagenicity by 
cyclohexanecarboxylate may involve enhancement of degradation of quercetin. It is already 
known that esterified flavonoids degrade easily (Gottlieb, 1975). However, this may not 
represent the only possible mechanism of degradation of quercetin in the presence of 
cyclohexanecarboxylate.
The third possible mechanism may involve interaction between 
cyclohexanecarboxylate and enzymic systems involved in the mediation of quercetin 
mutagenicity. A review by Murray and Freidy (1990) on the inhibition of mammalian 
cytochromes P-450 by chemicals indicate that 1-ethynyl-cyclohexanol inactivates P-450 
during oxidation. Although cyclohexanecarboxylate structurally has some semblance to 1- 
ethynyl-cyclohexanol, it may not possess the same mechanism of inhibition because the 
latter is believed to act via the acetylene moiety.
Norharman did not affect the mutagenicity of either shikimate or 
cyclohexanecarboxylate in any of the systems used. However, it caused a significant 
decrease in the mutagenicity of quercetin in both TA 100 and TA98. Although the effect of 
norharman in increasing or decreasing the mutagenicity of some compounds is well known 
(Nagao et a l, 1978; Wakabayashi et al, 1981; Nagao et al., 1986), its effect on quercetin 
and on the other bracken constituents has not previously been fully investigated. The 
present results therefore, emphasize the significant role that norharman, and possibly also 
other related compounds, such as harman, 3,4-dihydronorharman and 1,2,3,4- 
tetrahydronorharman, might play in modulating, as antimutagens, the genotoxicity of 
quercetin in vivo. Taken together with the inhibitory effect of cyclohexanecarboxylate, the 
present study demonstrates the possible presence of multiple factors in the environment that 
may act as antimutagens towards quercetin, and therefore the importance of antimutagens in 
the whole question of mutagenesis / carcinogenesis.
A low mutagenic effect for quercetin at pH 8.2 compared with that at pH 7.4 is 
consistent with previous studies (Friedman and Smith, 1984; Hatcher and Bryan, 1985).
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There are two possible explanations for this. Alkaline conditions cause degradation of 
flavonols (Gottlieb, 1975). Quercetin is a flavonol and degradation under alkaline 
conditions may occur as shown in Figure 3.6. The ease with which the hydroxyl ion 
degrades the flavonols was shown to depend on the strength of the partial positive charge 
on C-2 position. Although in quercetin this partial positive charge is reduced by the 
presence of an oxide ion at C-3 (created by the strong base from the free 3-hydroxyl) 
(Gottlieb, 1975) degradation would still occur if the pH of the medium is raised sufficiently 
(Friedman and Smith, 1984) as in the present case. Hence, quercetin degradation may 
result in a decrease in mutagenic response because this transformation is an antimutagenic 
process since there is a decrease in the concentration of the active species, as proposed in 
Figure 2.8. Secondly, increased ionization of quercetin at the hydroxylated carbon 
positions under alkaline conditions, such as at pH 8.2, results in a lower proportion of 
quercetin existing in the unionized form that can penetrate bacterial cells to cause mutation.
The mutagenicity of ptaquiloside was enhanced only after preincubation at 37° C 
for 40 min. The longer the preincubation period the greater the mutagenic response, as 
demonstrated by a significantly greater effect after preincubation for 4 h. Preincubation may 
have influenced mutagenicity by briefly exposing bacteria to relatively high concentrations 
of ptaquiloside and its reactive intermediate species, the dienone. The mutagenic response 
was higher at pH 8.2 than at pH 7.4. This is in agreement with the results of Matoba et al. 
(1987) who also noted that pH affected ptaquiloside mutagenicity. Under alkaline 
conditions it is possible that relatively high concentrations of the reactive intermediate 
species are formed (Van der Hoeven et al., 1983).
The mutagenicity of ptaquiloside was completely eradicated in the presence of rat 
liver S9 fraction. It is likely that enzymes in the hepatic fraction caused rapid metabolic 
inactivation of ptaquiloside to inert compounds such as pterosin B and pterosin O (Niwa et 
al., 1983a; Van der Hoeven et al., 1983). Alternatively, ptaquiloside and /  or its reactive 
intermediate species, the dienone (Van der Hoeven et al., 1983), may have reacted with 
protein and other substances in the 89-mix. The rapid inactivation by the hepatic fractions
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has important implications in vivo in the target animals such as ruminants. Given that 
inactivation by hydrogen ions also takes place (abomasal pH is about pH 2.2), ptaquiloside 
may not survive to account for bladder tumours, and suppression of bone marrow activity, 
as in ‘cattle bracken poisoning’ (Evans, 1985a). Appropriate data on the pharmacokinetics 
and pharmacodynamics of ptaquiloside are not yet available to dispel doubts (Evans et al., 
1985a) cast about its toxicity. Nevertheless, because the toxicity of bracken is cumulative 
(Pamukcu et a l, 1976b), the small concentrations of the compound that may survive 
degradation might be effective after a continuous exposure and therefore still play a role in 
the toxicity of the plant.
The fact that quercetin mutagenicity is inhibited by a metabolite of a naturally 
occurring compound raises the question of the protective role of natural food components 
in mutagenesis and carcinogenesis. Risk assessment of quercetin in mutagenesis, and 
possibly also in cancer causation, should take into consideration, not only the amount of 
the mutagen consumed, but also the amount of antimutagens. This is emphasized by the 
observation that oxygen, alkaline pH, tyrosinase, and metal salts such as MnCla, CuCla, 
FeS04  and FeClg (Friedman and Smith, 1984; Hatcher and Bryan, 1985) inhibit the 
mutagenicity of quercetin by facilitating catalytic oxidation.
The present results clearly show that the bracken constituents quercetin and 
ptaquiloside have the capacity to interact with environmental factors which in turn may 
modify their mutagenic / carcinogenic potential. Surprisingly, however, besides the few 
bone marrow micronucleus studies conducted using quercetin (Sahu et al., 1981, 
MacGregor, 1979; MacGregor et al., 1983), not much is known about the genotoxicity of 
these compounds including shikimate and its metabolite cyclohexanecarboxylate in various 
organs of the body in vivo. Further studies using short term in vivo assays therefore are 
warranted and is the subject of the next study.
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OH OH
HO kO  
(I) Quercetin
COOH
(HI) 1,3,5-Trihydroxybenzene-2( 1 -ketoethanol)
OH 
HO
(IV) Protocatechuic acid
Figure 3.6 Alkaline degradation of quercetin. Trihydroxyacetophenone contains ring A 
and part of ring C whilst protocatechuic acid contains ring B and part of ring C.
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3.5 CONCLUSION
In conclusion, the studies demonstrate that quercetin, shikimate, 
cyclohexanecarboxylate and ptaquiloside are not comutagenic in the Salmonella / 
mammalian micro some mutagenicity test.
It is further concluded that shikimate and its metabolite cyclohexanecarboxylate are 
not mutagenic in the Salmonella typhimurium tester strains TA97, TA98, TA 100, TA102 
and TA104, and that incorporation of hepatic fractions from Aroclor-1254-induced rats, 
norharman, alkaline pH, or pre-incubation does not enhance mutagenicity.
Ptaquiloside shows no mutagenicity if examined by the conventional methods. 
Mutagenicity occurs at high alkaline pH, or after preincubation at pH 7.4. The longer the 
preincubation period the higher the mutagenic response.
Rat hepatic fractions cannot be used to activate ptaquiloside mutagenicity in bacterial 
systems because mutagenicity is completely eradicated by such fractions. This is a further 
demonstration that activation and inactivation processes performed by hepatic fractions 
occur simultaneously. Therefore, a lack of mutagenic response to a compound in the 
presence of an activation system does not necessarily imply that the compound is non- 
mutagenic or non-genotoxic.
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_______________________ CHAPTER 4_________________________
GENOTOXICITY STUDIES OF QUERCETIN, SHIKIMATE AND 
CYCLOHEXANECARBOXYLATE IN THE BONE MARROW
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4.1 INTRODUCTION
Quercetin (Pamucku et al., 1980b) and shikimate (Evans and Osman, 1974) have 
been shown to be carcinogenic but information on the in vivo genotoxicity of these bracken 
constituents is scanty. There are a few reports on the induction of micronuclei in the bone 
marrow of mice by quercetin (Sahu et al., 1981; Aeschbacher et a l, 1982; MacGregor et 
al., 1983) but none on shikimate. In addition to the carcinogenic property, bracken fern 
causes acute poisoning with severe depression of bone marrow in cattle. Hence, a study of 
the effect of quercetin and shikimate when administered separately or in combination to 
laboratory animals may demonstrate the roles that each of them plays as genotoxins with 
relevance to carcinogenesis, or as depressants of bone marrow activity. Genotoxic effects 
are recognized by micronuclei formation (Schmid, 1975; Schmid, 1976), and depression of 
marrow activity which is characterised by infiltration of the bone marrow by red blood 
cells.
The micronucleus test is a cytogenetic test conducted in rodents (mouse) using the 
bone marrow erythroid cells (Schmid, 1976). The test allows the assessment of 
chromosomal damage in the bone marrow cells following exposure of a whole animal to a 
test compound. The test is closer to ‘real life’ genetic toxicology than in vitro tests using 
mammalian cells, yeast or bacteria because the processes of absorption, distribution, 
metabolism and excretion are retained. Bone marrow cells are somatic, but the type of 
events scored [chromosomal aberrations or damage (clastogenesis)], in addition to 
extrapolation to other tissues to predict carcinogenic risk (Schmid, 1975; Heddle and 
Carrano, 1977; Frank et al., 1978; Kinsella and Radman, 1978; Wild, 1978; Jenssen and 
Ramel, 1980; Cairns, 1981; Emerit and Cerutti, 1981; Salamone and Heddle, 1983) can 
give a good assessment of the genetic risk of a compound.
Studies on the absorption, distribution and elimination of quercetin are scarce and 
have mainly involved administration of radiolabelled compounds to animals (Booth et aL, 
1956; Petrakis et aL, 1959; Nakagawa et al., 1965; Griffiths and Smith, 1972a; 1972b; 
Ueno et aL, 1983b) for identification of urinary metabolites. The radiolabel method has the
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disadvantage of not being able to distinguish between the parent compound and its 
metabolites and can therefore overestimate tissue concentrations. Gugler et a l (1975) used 
a fluorimetric method to determine plasma concentrations of quercetin after oral and 
intravenous administration in man. The fluorimetric method (Gugler and Dengler, 1973b; 
Gugler et aL, 1975) may lack specificity and give an overestimation of the amounts 
absorbed due to interfering compounds present in the plasma. High performance liquid 
chromatography (HPLC) is currently one of the most preferred methods for qualitative and 
quantitative analysis of compounds in tissues and excreta of animals because of its high 
specificity and sensitivity.
It is the purpose of this study to determine whether quercetin, shikimate and its 
major metabolite cyclohexanecarboxylate, are genotoxic in vivo in the bone marrow cells, 
and whether the effect of quercetin may be influenced by combination with either shikimate 
or cyclohexanecarboxylate. Since quercetin has been reported to be both genotoxic (Sahu et 
al.t 1981) and non-genotoxic (MacGregor and Jurd, 1983) in vivo in the micronucleus 
assay, it was felt necessary to conduct pharmacokinetic studies to determine if the reported 
differences may be partly accounted for on the basis of poor absorption of the administered 
dose. An extraction and HPLC assay method was, therefore, developed for the purpose.
4 .2  MATERIALS AND METHODS
4.2.1 REAGENTS AND CHEMICALS
Foetal calf serum was obtained from Gibco Ltd. (Renfrew Road, Paisley); giemsa 
stain was purchased from Raymond A Lamb (North Acton, London); mitomycin C was 
from Sigma Chemical Co.Ltd (Poole, Dorset); methanol of HPLC grade was obtained from 
FSA Laboratory Supplies (Loughborough, Liecs); acetic acid, citric acid and DPX were 
from BDH (Poole, Dorset); and diethyl ether was from May & Baker Ltd (Dogenham).
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4.2.2 ANIM ALS AND TREA TM EN T FOR BONE MARROW  
MICRONUCLEUS ASSAY
Adult male outbred mice (10 weeks old) with an average weight of 25 - 27 g were 
assigned to groups each containing 3 mice. Each group was kept separately. Food 
(Laboratory animal diet No.l, LAD No.l) and water were given ad libitum. Test 
compounds were administered by the intraperitoneal route. The positive control groups 
received mitomycin C (MMC) which has already been shown to be genotoxic in the bone 
marrow cells (Salamone et al., 1980), while solvent control groups received the equivalent 
amounts of DMSO (5 ml/kg bwt.) which was used as a vehicle for test compounds. 
Distilled water was used as a vehicle for shikimate. Two treatments were given at an 
interval of 24 h. The animals were sacrificed by cervical dislocation 30 h after the first 
injection.
4.2.3 ANIMALS AND TREATM ENT FOR PERIPH ERA L BLOOD 
MICRONUCLEUS ASSAY
In most animals, the spleen removes micronucleated cells, but this does not seem to 
occur in mice (MacGregor et a l, 1980). Schlegel and MacGregor (1982) have shown that 
micronucleated normochromatic erythrocytes (MNNCE) entering peripheral blood have a 
life span similar to normal erythrocytes. Hence, in this species, increases in micronuclei 
formation in the bone marrow may be monitored in the peripheral blood, and the assay 
may, therefore, be complementary to the bone marrow micronucleus test.
Mice were treated as for the bone marrow micronucleus assay except that following 
the first intraperitoneal injection, further injections (shikimate and cyclohexanecarboxylate) 
were made at 24 h intervals for three days. Two injections of quercetin were administered, 
the second after 3 days. Blood smears, as described below, were prepared at intervals of 
24 h after the first injection until day 7 post-treatment. Animals were killed by cervical 
dislocation on the eighth day, and bone marrow smears prepared.
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4.2.4 PREPARATION OF SMEARS
Smears were prepared by the method of Schmid (1976). The femora of the mice 
were removed in toto by excision through the pelvic bones and below the knees. The bones 
were freed from the surrounding tissues by means of thumb forceps, scissors and gauze. 
The proximal and distal ends of the femora were similarly freed to leave the marrow 
cavities closed. The proximal ends of the femora were shortened with scissors to expose 
small holes to the marrow canal.
A centrifuge tube was filled with fetal calf serum. About 0.2 ml of serum was 
aspirated into a syringe mounted with a needle. The needle was inserted into the bone 
marrow through the opening in the proximal end of the femur. The femur was then 
submerged in the test tube containing serum, aspirated and flushed repeatedly until all the 
marrow was forced out through the opening around the needle. This procedure was 
repeated for all the mice. Tubes were then centrifuged at 100 ipm for 5 min. The 
supernatant was discarded using glass pipettes (long types with rubber bulbs). After 
carefully mixing the sediment, smears were made on microscope slides and air dried.
For peripheral blood smears, the ventral tail vein was pricked with a sterile 
disposable 25-Gauge needle (G25). Blood was transferred with a disposable 10 |il- 
capillary tube to a precleaned slide containing 3 - 5 pi of foetal calf serum, mixed quickly, 
and smears made.
4.2.5 STAINING OF SMEARS
The method used to stain smears was that described by Gollapudi and Kamora 
(1979): Smears were left overnight and then immersed in absolute methanol for 5 min 
before staining for 10 min with Giemsa (1: 6 Gurr’s R-66 giemsa in deionized distilled 
water). Smears were rinsed thoroughly in three changes of deionized distilled water, air 
dried and mounted in DPX.
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4.2.6 MOUNTING OF SLIDES
All operations in this procedure were conducted in a fume cupboard. Slides were 
immersed in xylene. After 3 min they were put, in turns, on a soft tissue paper with the 
smear surfaces uppermost, and DPX (about 2 drops per slide) applied onto the smear. 
Polished coverslips were then applied and glued onto the smears by firm application of 
pressure until all the air was expelled. Slides were left for several days to dry before 
scoring for micronucleated cells.
4.2.7 MICROSCOPIC STUDY OF THE SMEARS
Micronuclei arise primarily from chromosomal fragments which lack a centromere 
and therefore not incorporated into daughter nuclei at the time of cell division. The 
fragments may not be caught up in the cytoplasmic flow as the chromosomes are drawn to 
the poles of the daughter cells and so appear in the cytoplasm as a micronucleus i.e. a 
small, round, chromatin positive body which stains like the nucleus (Schmid, 1976). 
Chromosomal damage is a cause of micronuclei formation and may be chemically induced 
in the erythrocyte precursor (blast) cell stage. In erythropoiesis, the blast stage consists of 6 
- 7 cell divisions each lasting approximately 10 h, followed by extrusion of daughter cell 
nuclei (lasting 10 h) after the final cell division. Therefore, in the micronucleus test, the 
frequency of micronuclei is monitored in the descendent cell population, the polychromatic 
erythrocyte (PCE), which is a transient stage of erythrocyte development that lasts for 10 - 
20 h in the bone marrow to form mature erythrocytes (RBC) (Salamone and Heddle, 
1983). The test takes advantage of the fact that PCE have no nuclei and do not divide and 
can easily be distinguished from other bone marrow cells (Sanderson and Phillips, 1981).
Microscopic study of the bone marrow smears was, therefore, initially conducted at 
low power magnification (x 10) to spot areas of suitable technical quality. Such areas 
contained cells which were well spread, undamaged and well stained. Mature erythrocytes 
(normochromatic erythrocytes, NCE), were stained reddish, whereas, PCE were stained 
bluish. A total of 2,000 cells of each type, PCE and NCE, were scored from five slides at
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x 1000 magnification. Polychromatic erthrocytes with micronuclei (micronucleated 
polychromatic erythrocytes, MNPCE) were counted. The incidence of micronuclei with 
their relative percentages were calculated and used as a measure of the clastogenic property 
of the test compound(s). The proportion of PCE in the bone marrow was determined by 
screening 1000 erythrocytes as a measure of the cytotoxicity of the test compound(s). The 
ratio P (PCE : NCE) was then calculated.
Blood smears were similarly examined and the total number of micronucleated cells
scored.
4.2.8 ANIMALS AND TREATMENT FOR KINETIC STUDIES
Wistar albino rats with an average weight of 500g were alloted into 2 groups each 
with 21 rats. They were kept in cages each with three rats. Food (Laboratory animal diet 
No.l, LAD. 1) and water were given ad libitum. Rats of Group 1 were treated with a 5% 
(w/v) suspension of quercetin in water at an oral dose of 200 mg/kg bwt using an 
intragastric tube while rats of Group 2 were treated with a solution of quercetin in DMSO 
(0.25 ml/kg bwt) at the same dose rate. Blood samples were collected intra-cardially by 
terminal bleeding of three rats from each group at time intervals post-treatment. Blood (~20 
ml) in heparinised tubes was immediately centrifuged and plasma stored at -20o C for 
HPLC analysis of quercetin.
4.2.9 DETECTION OF QUERCETIN AND METABOLITES
A Waters Associate Model 440 fixed wavelength (254 nm) liquid chromatograph 
detector was used fitted with a 20-jj.I valve loop injector; the delivery pump was from 
Applied Chromatography Systems Ltd, supplying a pressure of 2,000 p.s.i, at a flow rate 
of 1.5 ml per min; the chromatographic column, 30 cm x 3.9 mm I.D., was purchased 
from Bondclone Ltd (England) prepacked with jiBondapak C%g, particle size 10 |im. 
Loading into the loop injector was accomplished by delivering 20 jil of samples in 
methanol using a graduated 50-jil microsyringe. The solvent system consisted of methanol,
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water, acetic acid (40:55:5) Samples and solvents were degassed using an ultrasonic 
vibration. A Perkin Elmer Recorder Model 56 was used to record detector signals.
4.2.10 EXTRACTION PROCEDURE AND HPLC ANALYSIS
Aliquots (2 ml) of plasma samples or spikes (prepared by adding known volumes 
of a 5 |ig/ml stock solution of quercetin in methanol to blank plasma to give concentrations 
ranging from 0.01 to 0.5 pg/ml) were transferred into 50-ml glass stoppered thick walled 
tubes using glass pipettes. Citric acid (1 ml of a 1M solution) was added into each sample 
followed by ‘peroxide free’ ether (20 ml). The mixtures were shaken in a rotary mixer for 
20 min after which 15 ml of the ether extract was transferred into clean 50-ml thin walled 
glass tubes. Fresh ether (20 ml) was transferred to the tubes for further extaction and the 
contents shaken for 20 min. All extracts (20 ml) were combined and evaporated to dryness 
in a water bath set at 50° C under a slow nitrogen stream to leave volumes of 
approximately 5 ml which were then transferred to 10-ml conical glass tubes. The walls of 
the 50-ml tubes were rinsed with about 1ml ether and transferred to the 10-ml tubes. 
Rinsing was repeated once more. The ether extracts were evaporated to dryness. The walls 
of the tubes were washed down with about 0.5 ml of ether and evaporated to diyness. The 
washing down process and re-evaporating to dryness was repeated and the resulting 
residue dissolved in 100 pi methanol with the aid of an ultrasonic water bath. Greater or 
smaller volumes of methanol were added to the residues if high or low plasma 
concentrations were expected. Alternatively, smaller or greater than 2 ml aliquots of plasma 
samples were analysed.
Aliquots (20 pi) of the extract were loaded into the loop injector for HPLC analysis 
(see Section 4.2.9). Quercetin standard solutions in methanol at a concentration range of 2 
to 10 pg/ml, spikes, and blank plasma extracts were injected between sample injections at 
frequent intervals to monitor possible column deterioration that may result from extracted 
plasma constituents. Spikes were run through the extraction procedure every time an 
extraction was made to take care of day to day variations in experimental conditions.
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4.2.11 RECOVERY FACTOR (R) IN THE KINETIC STUDIES
The concentration of quercetin (S) of the unknown sample was calculated using the 
following formula:
c _ H2 x C x V2
where S is concentration (pg/ml) of quercetin, %  is peak height expressed as % of full 
scale deflection (f.s.d), Vi is volume (ml) of sample analysed, V2 is volume (ml) of 
methanol in which residue was suspended, Hi is peak height of the standard, C is 
concentration of the standard. For the spikes, the reciprocal of the concentration S as a 
proportion of the known concentration gives the value R (recovery factor).
For the extracts from rat plasma, the adjusted concentration (S) of quercetin in the 
samples was calculated from the following formula:
S = H2 x C x V2 x R 
Hi x Vi x K
where R is the recovery factor based on spikes conducted concurrently with the samples, K 
is the correction value which accounts for differences in volumes of ether extracts. K was 
0.95 since, theoretically, 15 ml of the first extract removed quercetin at a proportion of 
0.75, and 0.20 of the remaining proportion (0.25) was removed in the second (20 ml) 
extract. The value of K varied depending on the volume of ether used for extraction. 
Flavonoids can easily be oxidized, resulting in the opening of the pyrone ring (Gottlieb, 
1975), hence processing of samples was conducted quickly.
4.2.12 STATISTICAL ANALYSIS
Micronucleus frequencies in erythrocytes of test groups were compared with 
control values using the binomial comparison described by Kastenbaum and Bowman 
(1970) at 95% confidence level.
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4 .3  RESULTS
4 .3 .1  INDUCTION OF BONE MARROW  M ICRO N U CLEI BY 
COMPOUNDS
Mice were treated with various doses of quercetin, shikimate and 
cyclohexanecarboxylate, or combinations of these compounds, as presented in Table 4.1. 
The results of the incidence of MNPCE in the different groups of mice is also presented in 
Table 4.1. The mean incidence of micronucleated erythrocytes per 10,000 PCE (five slides 
were assayed per animal to present a total of 10,000 PCE) in the control (untreated) mice 
was 14±1. The solvent system, DMSO, did not significantly influence the number of 
MNPCE. There was no significant increase in the mean number of MNPCE in animals 
treated with quercetin, shikimate or cyclohexanecarboxylate. Although mice treated with 
cyclohexanecarboxylate at 250 mg/kg bwt gave a slightly higher number of MNPCE, this 
increase was not significant.
The results of the effect of treatment of mice with a combination of quercetin with 
either shikimate or cyclohexanecarboxylate on the incidence of MNPCE are also presented 
in Table 4.1. Although there was a slight increase in the incidence of MNPCE in mice 
treated with a combination of quercetin and cyclohexanecarboxylate at 200 and 250 mg/kg 
bwt respectively, the increase was not significant.
Mitomycin C was used as a positive control compound. Mice were treated with this 
compound at 2.5 and 5.0 mg/kg bwt. The results revealed a marked increase in the 
incidence of MNPCE in animals after treatment. Mitomycin C at 5 mg/kg bwt caused 
greater than a 50-fold increase in the incidence of MNPCE. The response at 2.5 mg/kg bwt 
was significantly lower than that observed after administration of 5 mg/kg, indicating that 
there was a dose-response effect. Furthermore, Mitomycin C caused severe depression of 
the bone marrow at the 5 mg/kg bwt dose rate, as revealed by a lowered ratio of 
polychromatic erythrocytes to total number of erythrocytes (PCE : E). The bone marrow of 
affected animals was infiltrated with red blood cells, giving PCE/NCE value of 0.3 which 
was significantly lower than contol value.
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Table 4.1: The incidence of micronucleated erythrocytes in the bone marrow of mice 
after treatment with some bracken constituents.
Compound Dose+ MNPCE per 104 PCE MNNCE per 104 PCE PC Eperl03E P
DMSO - 10±2.2 (0.11) 612.1 (0.06) 541139 1.2 1
Quercetin 200 14±5.3 (0.14) 913.1 (0.09) 521+47 1.1 1
Quercetin 400 Î5+4.4 (0.15) 712.0 (0.07) 489+28 10 1
SA 100 17±3.4 (0.17) 1114.7 (0.11) 609149 1.0 1
SA 500 12+2.7 (0.12) 712.3 (0.07) 544122 1.2 1
SA 1000 11±2.5 (0.11) 10+4.6 (0.10) 514133 1.1 1
CCA 50 11±3.3 (0.11) 1112.0 (0.11) 536150 1.2 1
CCA 100 12±1.4 (0.12) 1312.5 (0.13) 527116 1.1 1
CCA 250 22±5.6 (0.22) 1013.5 (0.10) 478137 0.9 1
Quercetin* 200 15±4.0 (0.15) 10+3.3 (0.10) 455+43 0.8 1
Quercetin** 200 18±4.1 (0.18) 1615.8 (0.16) 497+35 1.0 1
Quercetin3 200 20+3.0 (0.20) 1414.2 (0.14) 485129 0.9 1
Quercetinb 200 21±3.4 (0.21) 12+3.0 (0.12) 508127 1.0 1
Mitomycin 2.5 397±24 (39.7) 1114.3 (0.11) 267121 0.4 1
Mitomycin 5.0 7581109 (76) 1313.2 (0.13) 238+34 0.3 1
Control - 1411.0 (0.14) 913.6 (0.09) 520+35 1.1 1
+ - denotes dose in mg/kg bwt; * - Shikimate at 500 mg/kg bwt.; ** - Shikimate at 50 
mg/kg bwt; a - Cyclohexanecarboxylate at 250 mg/kg.; b - cyclohexanecarboxylate at 100 
mg/kg bwt. Data in parentheses is the number of micronucleated cells in percentage. P is 
PCE /  NCE, (103 erythrocytes screened). Compounds were administered by the 
intraperitoneal route at the indicated doses (dissolved in DMSO except shikimate which was 
dissolved in water). The results are mean±SD of triplicate samples. All results not 
significantly different from controls except the mitomycin C treatment groups.
The value PCE / NCE i.e. (P) varied from 0.8 to 1.2 in animals treated with quercetin, 
shikimate or cyclohexanecarboxylate or a combination of these compounds. These values 
were, however, not significantly different from control values (1:1 - 1.2:1). There was no 
significant difference between the PCE : NCE ratio in mice treated with test compounds in 
the different treatment regimens compared with control mice.
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Quercetin was not completely absorbed from the injection site. When administerd at 
dosages of 200 mg/kg and 400 mg/kg bwt, quercetin was found deposited in the 
peritoneum near or close to the injection site during postmortem examination.
4.3.2 INFLUENCE OF COMPOUNDS ON PERIPH ERA L BLOOD 
MICRONUCLEI
The results of the micronucleus study using peripheral blood are presented in Table 
4.2. The mean number of micronucleated erythrocytes at various time intervals up to 168 h 
after treatment with quercetin (400 mg/kg bwt) was not significantly different from the 
mean pre-treatment values. Likewise, cyclohexanecarboxylate at 50 and 250 mg/kg bwt 
caused no significant increase in the mean number of micronucleated cells above the mean 
pre-treatment value. However, mice which were administered with cyclohexanecarboxylate 
at 250 mg/kg bwt died after 72 h; the incidence of micronucleated cells in the blood could 
not, therefore, be followed after this period.
The influence of quercetin and shikimate on the incidence of micronuclei in the 
peripheral blood is also presented in Table 4.2. No significant increase in the mean number 
of micronucleated erythrocytes above the mean pre-treatment level was observed. The 
results of the effect of combined treatment with quercetin and cyclohexanecarboxylate show 
no significant increase in the mean number of micronucleated cells above the pre-treatment 
count. However, all the mice which were treated with quercetin and 
cyclohexanecarboxylate at 200 and 250 mg/kg bwt, respectively, died after 48 h. 
(Necropsy studies, which included histopathology examination did not give significant 
findings). The incidence of micronucleated cells in the peripheral blood could not, 
therefore, be followed after this period. Nevertheless, there was no significant difference in 
the mean number of micronucleated cells up to this time following treatment.
Mitomycin C was administered to mice at either 0.5 or 5 mg/kg bwt, respectively, 
as positive controls. There was no significant increase in the number of micronucleated
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cells in mice treated with the high dose of mitomycin C. Blood smears derived from mice 
treated with mitomycin at 5 mg/kg bwt showed a significantly lower number of white blood 
cells compared with the other groups, indicating depression of bone marrow activity. Mice 
treated with the lower dose of mitomycin C developed a significantly greater number of 
micronucleated cells 48 h post-treatment and the high levels were sustained thereafter for 
the whole duration of the sampling period. Post-treatment number of micronucleated cells 
in the controls was not significantly different from the pre-treatment value. The number of 
micronucleated erythrocytes in 104 cells in the pre-treatment samples varied from 9 - 1 4  
(0.09% to 0.14%).
Table 4.2: The incidence of micronucleated cells among circulating erythrocytes in the 
peripheral blood of mice treated with compounds.
Compound Dose
Micronucleated cells among 104 circulating erythrocytes
0a 24 48 72 96 120 144 168
DMSO - 12±2 12±1 13±1 12±2 13±2 14±3 12±2 11±3
Quercetin 400 9±2 10±2 12±2 10+2 17±5 13+2 12±2 11+1
CCA 50 11±3 10±2 15±3 16±3 13+2 16+3 20±5 13±3
CCA 250 13±3 12±1 11±3 14±2 ND ND ND ND
Quercetin* 200 12±2 9±3 11±5 12±3 12±2 11±1 12±2 11±1
Quercetin** 200 14±3 14±3 12±4 15+6 19+4 17±2 11±3 11±3
Quercetin^ 200 10±1 10±1 9+3 ND ND ND ND ND
Quercetin0 200 12±1 12±2 13+2 10±1 14+3 14±0 11+3 10+2
Mitomycin C 0.5 9±3 12±2 32±10 46±11 44+11 41±14 44±15 39+Î4
Mitomycin C 5 14+3 15±2 14+3 10±2 18+5 18+5 15±3 13±2
* - Shikimate at 500 mg/kg bwt; ** - Shikimate at 50 mg/kg bwt.; ND - not determined; a - 
Time in h; b - Cyclohexanecarboxylate at 250 mg/kg.; c - Cyclohexanecarboxylate at 100 
mg/kg. Compounds were administered by the intraperitoneal route at the indicated doses
(dissolved in DMSO except shikimate which was dissolved in distilled water). Compounds 
were administered at 24 h intervals for 7 days, except quercetin which was administered on 
day 1 and day 4 only. Results are presented as mean±SD of triplicate samples.
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4.3.3 KINETIC STUDIES
Quercetin eluted well in the solvent system consisting of methanol, water, acetic 
acid (40:55:5). At a flow rate of 1.5 ml/min, which gave a column pressure of 2,000 psi., 
quercetin had a retention time of 13 min, as shown in Figure 4.1.
Standard solutions of the major metabolites of quercetin, p-hydroxyphenylacetic 
acid and m-hydroxyphenylacetic acid were eluted each with a retention time of 2 min. 
Hence, their concentrations in the plasma could not be quantified because of the interfering 
peaks resulting from other extracted plasma constituents that could not be separated even 
after changing the solvent composition.
Table 4.3 shows the concentration of quercetin in the plasma samples of rats after 
oral and intraperitoneal administration of quercetin at 200 mg/kg bwt. Peak plasma 
concentrations of 0.04 and 0.11 p,g/ml occurred at 8 and 4 h after oral and intraperitoneal 
administration respectively. Plasma concentrations were detectable up to 12 and 96 h after 
oral and intraperitoneal administration respectively. Mean as well as individual 
concentrations after intraperitoneal administration were significantly higher than those after 
oral administration. Plasma samples were assayed up to 96 h. It is possible, though, that 
quercetin persisted in the plasma for much longer because rats killed at 96 h still contained 
precipitated quercetin in the peritoneal cavity.
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Table 4.3: Plasma concentrations of quercetin after oral and intraperitoneal
administration of quercetin to rats at 200 mg/Kg bwt.
Sampling 
time (h)
Plasma concentrations of quercetin (pg/ml)
Oral Route Intraperitoneal Route
0 0 0
4 0.01±0.01 0.1110.01
8 0.0410.01 0.0610.02
12 0.0310.02 0.1010.01
24 ND 0.0610.02
48 ND 0.0910.01
96 ND 0.0710.02
Rats were treated with quercetin at 200mg/kg bwt and plasma samples taken at the indicated 
intervals assayed by the HPLC method.
ND - not detected.
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4.4 DISCUSSION
Quercetin, shikimate and cyclohexanecarboxylate were administered to mice by the 
intraperitoneal route to determine the toxic effect of these compounds in vivo in the bone 
marrow. The results show that quercetin failed to cause any significant increase in the 
incidence of the number of MNPCE in mice. These observations are in agreement with 
those reported by MacGregor et a l  (1983), but contradicted the findings of Sahu et a l  
(1981) who reported that quercetin caused a significant increase in the number of MNPCE 
after intraperitoneal administration in mice. The effect of shikimate and 
cyclohexanecarboxylate on the incidence of MNPCE has not previously been studied. The 
results obtained in the present study clearly demonstrate that shikimate and its major 
metabolite cycohexanecarboxylate do not influence the incidence of MNPCE in mice.
Mixed application of the bracken constituents to screen for synergistic effects as 
bone marrow clastogens has not previously been reported. Combined administration of 
quercetin with either shikimate or cyclohexanecarboxylate did not significantly affect the 
incidence of micronucleated erythrocytes, indicating that the constituents have no 
potentiation or synergistic effect as bone marrow clastogens in mice.
The use of peripheral blood in mice as an in vivo assay method for screening 
compounds for clastogenic effects was first reported by MacGregor et a l  (1980) who 
demonstrated that micronucleated erythrocytes accumulated in the peripheral blood of 
animals treated with bone marrow clastogens. Previously it had been suggested that 
MNPCE formed in the bone marrow could not be found in increased frequency in the 
peripheral blood of animals because such cells were abnormal and were removed very 
quickly from the circulation by the spleen (Von Ledebur and Schmid, 1973). In the present 
study, none of the bracken constituents tested caused significant increase in the mean 
number of micronucleated cells in the blood at any time up to 168 h. These observations are
dth the bone marrow assay results.
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Low (0.5 mg/kg bwt) doses of mitomycin C cause significant increases in the 
incidence of micronucleated cells in the blood (Table 4.1). Lack of an increase in the 
incidence of MNNCE in the peripheral blood in mice treated with the high (5 mg/kg bwt) 
dose of mitomycin C is probably the result of almost complete suppression of bone marrow 
activity as revealed by respective marrow smears in which there was either complete 
absence of cells, or veiy low P values. The number of micronucleated erythrocytes in the 
peripheral blood of mice treated with high doses of mitomycin C were, therefore, not 
significantly different from the controls because any increases must come from an active 
bone marrow. Mitomycin C, which acted as a positive control in the study, is carcinogenic 
in rodents and the present results are in agreement with reports that it also induces 
micronuclei in animals (Matter and Grauwiler, 1974; Heddle and Brace, 1977; Salamone 
et aL, 1980). Mitomycin C is reported to be activated by the widely distributed NADPH- 
dependent quinone reductase to alkylating derivatives which damage DNA by alkylation of 
guanine, and by formation of DNA-cross links (Waring, 1968).
The absorption of quercetin into systemic circulation in rats is demonstrated in the 
present study, although the concentrations achieved were lower than 0.1 pg/ml (Table 4.3). 
Reasons for higher systemic availability after intraperitoneal administration compared to 
the oral route seems to be due to precipitated drag in the peritoneum, which probably acts 
as a depot or reservoir for absorption and therefore maintaining persistent plasma 
concentrations. Quercetin is a highly insoluble compound and probably precipitates as the 
solvent is absorbed and metabolized. The initial high concentrations may have resulted 
from facilitated absorption due to DMSO used as a solvent for intraperitoneal 
administration.
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Based on the present results, and assuming that the pharmacokinetics of quercetin in 
mice are not significantly different from those in rats, a single intraperitoneal treatment 
appears to be sufficient for the purposes of the micronucleus tests because of the 
persistence of the plasma concentrations. Schmid (1976) recommended 2 treatments at 24 h 
interval with animals being sacrificed 6 h after the second treatment. Although this 
treatment schedule is identical to the one used by Sahu et al. (1981) and MacGregor et al. 
(1983) to determine the clastogenic property of quercetin in bone marrow cells, Salamone 
and Heddle (1983) suggest that the sampling period is too near the second injection to take 
advantage of the kinetics of erythropoiesis. In erythropoiesis there are 6 - 7 blast cell 
divisions before the daughter cells of the final division extrude their nuclei, about 10 h 
later, and become PCE. In theory, since each cell division lasts for about 10 h, and 
extrusion of the nuclei of the daughter cells of the final division lasts about 10 h, then 
approximately 20 h is required before a treatment can induce micronuclei formation 
(Salamone and Heddle, 1983). In the method by Schmidt (1976) animals are killed 6 h 
after the second injection. Hence cells exposed to this injection would not have sufficient 
time (20 h) to develop to PCE that may contain micronuclei. Data in Table 4.3 show that a 
single treatment with quercetin provides plasma concentrations which persist for longer 
than the duration (20 h) of one cell division plus maturation to PCE. Hence cell populations 
are continuously exposed as they divide. Thus, sampling 30 h after treatment with 
quercetin provides PCE arising from several, and not from a single exposed cell 
population, as would be the case for compounds which are rapidly absorbed and 
eliminated. The depot of quercetin that forms in the peritoneum, as seen during postmortem 
following treatment of rats seems to make a second treatment unnecessary.
Gugler et al. (1975) reported on the absorption, distribution and elimination of 
quercetin in man after oral and intravenous administration. Their results showed that 
quercetin was quickly cleared from the body with an elimination half life (T1/2) of 2.4 h 
and that plasma levels after oral administration were below the limit (0.1 fig/ml) of 
detection of the method used (spectrofluorimetric). Detection of quercetin in the plasma of
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rats after oral as well as intraperitoneal administration in the present experiment is due to the 
high sensitivity of the HPLC method.
In in vitro tests, such as the Salmonella /  mammalian microsome mutagenicity test, 
the mutagenicity of quercetin is detected in the top agar at concentrations of about 2 jig/ml 
or more. Assuming that quercetin is evenly distributed in the total body water after 
absorption, the maximum concentration of about 0.1 Jig/ml that occurred following 
intraperitoneal administration (Table 4.5) appears to be too low for mutagenicity in 
Salmonella typhimurium tester strains (Aeschbacher et al, 1982). Hence, it is unlikely that 
such concentrations would be genotoxic to mammalian cells in vivo, except possibly after 
prolonged exposure.
The extraction efficiency of quercetin from the plasma was high (115%). The small 
volumes (50-100 |il) of methanol used to dissolve the residue, followed by sonication for 1 
min, may have resulted in the evaporation of some of the solvent, leading to a concentrating 
effect. The plasma samples from control rats contained no compounds with the same 
retention time as quercetin that could be detected under the conditions of the experiment.
4.5 CONCLUSION
It is concluded that the mutagenicity of quercetin which has been demonstrated 
unequivocally in the Salmonella / mammalian microsome mutagenicity test (Chapter 1; 
Chapter 2; Bjeldanes and Chang, 1977; MacGregor and Jurd, 1978; Brown and Dietrich, 
1979; Rueff et a l, 1992) is not demonstrated by the micronucleus test showing that the 
compound is not a genotoxin in the bone marrow cells.
It is further concluded that lack of demonstrable clastogenicity in the bone marrow 
cells may be due to low plasma concentrations after either oral or intraperitoneal 
administration.
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The low bioavailability is possibly, among other factors, due to the 
physicochemical properties of quercetin. Quercetin is an extremely insoluble compound in 
water and only that fraction existing in solution is available for diffusion across biological 
membranes.
Shikimate was not genotoxic in the bone marrow cells. Since 
cyclohexanecarboxylate was not genotoxic either, it is concluded that the further 
metabolism of cyclohexanecarboxylate in mice produces metabolites which may possibly 
have no toxicity effects in the bone marrow.
Furthermore quercetin, shikimate and cyclohexanecarboxylate demonstrate no 
depression of bone marrow when determined by normochromatic erythrocytes to 
polychromatic erythrocytes ratio. Since blood smears of animals administered these 
compounds repeatedly for up to 7 days showed no abnormalities it seems unlikely that 
these compounds play any role in bracken poisoning. Bracken poisoning is characterised 
by severe depression of bone marrow activity (Naftalin and Cushnie, 1951; 1954; Guilhon 
et al., 1955).
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CHAPTER 5
GENOTOXICITY STUDIES OF QUERCETIN, SHIKIMATE AND 
CYCLOHEXANECARBOXYLATE IN VIVO IN THE RAT GASTRIC
MUCOSA CELLS
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5.1 INTRODUCTION
Although the micronucleus test (Chapter 4; Schmid, 1976) has been shown to be a 
suitable test for genotoxins in many cases, its application may be limited, depending on 
the physicochemical properties of the test compound(s). Compounds which are weak 
genotoxins and not well absorbed and distributed would invariably give false-negative 
results. Furthermore, systemic absorption, distribution, detoxification, and excretion can 
play a big role in modifying the behaviour of mutagens (Ashby, 1983b) and assessment 
of one organ / tissue may not necessarily extrapolate to events in other organs (De Serres 
and Ashby, 1980).
In bracken fern poisoning, besides the urinary bladder and the bone marrow, as 
target organs (Evans, 1968; Pamukcu et al., 1972), the alimentary tract is the most 
frequently affected system by neoplasia especially in laboratory animals (Evans and 
Mason, 1965; Evans and Osman, 1974; Pamukcu et al., 1980b; Evans, 1984). 
Evaluation of genotoxicity using the gastrointestinal system may, therefore, in addition to 
being complementary to the micronucleus test, provide reliable and useful information 
especially if the test compounds have localised gastrointestinal effects or if they are 
particularly unstable or degraded in the gastrointestinal tract, (as is the case with quercetin 
and shikimate) to form small concentrations of mutagenic /  carcinogenic metabolites that 
may fail to reach systemic circulation, while having localised effects. Interestingly, the 
carcinogenicity of shikimate (Evans and Mason, 1974) has been suggested to be 
associated with possible microbial formation of small amounts of lactones in the 
gastrointestinal tract (Jones et al., 1983). Small concentrations of such metabolites may 
evade detection by the micronucleus test due to inactivation and dislocation processes.
The purpose of the present study was to determine whether quercetin, shikimate 
and cyclohexanecarboxylate were genotoxic in vivo in the gastric mucosa cells and to 
further determine if combined administration of these compounds would enhance their 
separate activities. In this study, the unscheduled DNA synthesis (UDS) assay described 
by Burlinson (1989) was used. The method is based on extraction of DNA followed by
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determination of incorporation of pH]thymidine in the isolated DNA. The method has the 
advantage that incorporation of the radiolabel occurs in vivo. The amount of DNA 
extracted is measured spectrophotometrically using diphenylamine reagent; the amount of 
the radiolabel is measured using a scintillation counter. The technique is adequately 
sensitive for genotoxic compounds (Burlinson et a l, 1991), although doubts have been 
cast on the assay in terms of (a) its ability to distinguish UDS from scheduled DNA 
synthesis and (b) the variation in the types of gastric cells isolated (Ekman et a l, 1990).
5 .2  MATERIALS AND METHODS
5.2.1 CHEMICALS
Tritiated thymidine (pH]thymidine) was purchased from Amersham (Little 
Chalfont, Buckinghamshire); perchloric acid, sodium citrate, and sodium hydroxide were 
purchased from BDH Chemicals Ltd. (Poole, Dorset); chloroform was from FSA 
Laboratory Supplies (Loughborough, Leicester); Ham’s F10 mixture was obtained from 
Gibco (Renfrew Road, Paisley); OptiPhase ‘safe’ was from LKB Scintillation Products 
(Loughborough, Liecs); and glacial acetic acid, calf-thymus DNA, diphenylamine, N- 
methyl-N’-nitro-N-nitrosoguanidine (MNNG), paraldehyde, and proteanase E were 
purchased from Sigma Chemical Co. (Poole, Dorset).
5.2.2 PREPARATION OF REAGENTS
Saline Sodium Citrate (IX) (SSC). This solution was prepared by dissolving
sodium citrate (1.0 g) and sodium chloride (2.15 g) in deionized water (250 ml).
Perchloric acid. Perchloric acid solutions of 2% , 5%, 10% and 15% (v/v) in
deionized water were prepared from a 60% (v/v) solution of perchloric acid.
Diphenylamine reagent. The reagent was prepared by transferring 25 |il of 
paraldehyde [4% (v/v) solution in deionized water] to glacial acetic acid (250 ml) 
followed by diphenylamine crystals (10 g). Paraldehyde was always added before 
diphenylamine. The preparation was conducted in a fume cupboard. The reagent was 
stored at room temperature in the dark in a black bottle wrapped in black tape.
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Calf-thymus DNA standard solutions. Calf-thymus DNA standard solutions were 
prepared as follows: about 2.5 mg of calf-thymus DNA was weighed accurately. Saline 
sodium citrate (5 ml) was added to the DNA followed by 1 drop of chloroform and the 
mixture maintained at 37° C in a water bath until dissolved, to give a 500 pg/ml DNA 
solution. This was diluted 1 : 5 to give 100 gg/ml solution using 15% (v/v) perchloric 
acid, and then hydrolysed in a water bath at 70° C for 30 min. The solution was cooled 
and stored at 4° C until needed for the preparation of DNA diphenylamine standards. It 
was discarded after 2 months.
5.2.3 ANIMALS
Wistar Albino rats, 8 -1 4  weeks old and weighing about 300 g, were used. They 
were kept in groups of 3 animals. Food (Laboratory Animal Diet, LAD No. 1) and water 
were given ad libitum. They were dosed orally with either quercetin, shikimate, 
cyclohexanecarboxylate or MNNG. After 14 h pH]thymidine was administered 
subcutaneously at a dose rate of 0.75 ml/kg of a solution of radioactive concentration of 
37 MBq/ml (specific activity 925 GBq/mmol) before killing 1 h later. Negative controls 
were administered DMSO or water. Control samples were obtained from untreated rats.
5.2.4 DOSE LEVEL SELECTION
Preliminary studies on micronuclei induction in mice had established that quercetin 
(as a solution in DMSO) was not acutely toxic when administered at 400 mg/kg by the 
intraperitoneal route, or at 800 mg/kg by gavage (as a suspension in water). 
Cyclohexanecarboxylate, whose acute toxicity data is still not available, caused death of 
some mice when administered at doses greater than 500 mg/kg bwt by the intraperitoneal 
route. Oral doses of 1000 mg/kg bwt were without acute toxic effects. Hence, 1000 
mg/kg was chosen as the highest oral dose for cyclohexanecarboxylate. Similarly, 
shikimate was administered at a maximum dose of 1000 mg/kg bwt. MNNG which was 
used as a positive control was administered at 10 mg/kg up to 50 mg/kg bwt. Quercetin 
was administered as a suspension in water not exceeding 2.5 ml per rat while shikimate
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was administered as a solution in 1 ml of water. Cyclohexanecarboxylate and MNNG 
were administered in DMSO (0.5 ml). The number of animals for each dose ranged from 
2 to 4.
5.2.5 ISOLATION OF THE GASTRIC MUCOSAL CELLS
Gastric mucosal cells were isolated as described by Kurokawa et a l, (1975). Rats 
were killed by cervical dislocation and placed on a dissection board. A midline abdominal 
incision was made to expose the stomach. The oesophagus was ligated off close to the 
cardiac orifice and the stomach cut free with a small piece (5 mm) of duodenum. The 
forestomach was removed by cutting along the cardiac ridge with a pair of scissors. The 
gastric stomach was then thoroughly washed with physiological saline and the cut edge 
sealed with artery forceps. The stomach was then cannulated through the duodenum 
using Gauge-14 catheter. Proteinase E (50 U/ml in F10 medium, supplemented with 10% 
[v/v] fetal calf serum) (1-2 ml) was introduced into the stomach via the cannula. The 
stomach sac was incubated statically in F10 medium at 37° C for 45 min. The cell isolate 
was collected by releasing the artery forceps and flushing through with F10 medium (~ 8 
ml).
5.2.6 DNA EXTRACTION AND HYDROLYSIS
DNA was extracted by the method of Mitchell and Mirsalis (1984). The cell isolate 
was centrifuged in stoppered 15-ml conical tubes at 800 rpm for 3 min using a Beckman 
Model J-B6 centrifuge and the supernatant discarded. To the tubes was added 1M NaOH 
(2 ml), and mixed with the aid of a rotor mixer at room temperature for 40 min. Tubes 
were kept on ice and the contents neutralized with 10% (v/v) perchloric acid (PCA) (2 ml) 
at 4° C and then acidified with 5% (v/v) PCA (1 ml) at 4° C. DNA was allowed to 
precipitate (insoluble in mineral acids) for 30 min and the tubes were then centrifuged at 
1650 rpm for 10 min. The supernatant was discarded. After this step, the tubes 
containing the pellets were stored in a freezer (-20° C) for assay at a later time.
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The pellets were re-suspended in chilled (4° C) 2% (v/v) PCA (2 ml), using a glass 
rod and a vortex mixer to break them up, and centrifuged at 1650 rpm for 10 min. The 
supernatant was aspirated and discarded. The washing process was repeated twice more; 
the pellets, between washings being re-suspended using a vortex mixer. PCA (1 ml) 
(15% v/v), at room temperature, was added to each tube, the contents resuspended using 
a vortex mixer, and heated in a water bath at 70° C for 30 min to hydrolyse the DNA. 
The tubes were cooled to room temperature and centrifuged at 2700 rpm for 15 min and 
the supernatant decanted into scintillation minivials in 3 x 0.20-ml aliquots for 
scintillation counting. For DNA content determination, 2 x 0.20-ml aliquots were 
decanted into 15-ml tubes.
5.2.7 MEASUREMENT OF [3H]THYMIDINE INCORPORATION
Hydrolysed DNA (0.2-ml aliquots) was added to 5.0 ml of scintillation fluid 
(OptiPhase ‘safe’(R)) in a scintillation minivial. Minivials containing test samples and 
blanks were vigorously shaken. All the minivials were placed in minivial holders and 
stored in the dark for 1 h before transferring to a liquid scintillation counter (Wallac 
1410 Scintillation Counter). Each minivial was counted for 10 min.
5.2.8 DETERMINATION OF DNA CONTENT
The DNA content of the extracts was determined by a modification to the method of 
Richards (1974).
Aliquots (0.2 ml) of the hydrolysed DNA extract in 10-ml screw-cap tubes were 
combined with 15% (v/v) PCA (0.55 ml) at room temperature. Blanks, each containing 
only 15% (v/v) PCA (0.75 ml), and duplicate sets of DNA standards containing 0.75 ml 
of 2 to 100 jig calf thymus DNA / ml were also conducted.
To each of the samples, blanks and DNA standards, diphenylamine reagent (0.45 
ml) was added and shaken vigorously. The tubes were wrapped in aluminum foil and 
stored in the dark at room temperature. To determine the required storage /  incubation
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period, a preliminary study was conducted in which standards were placed in the dark 
and the absorbance of aliquots determined at intervals in a Kontron Uvikon Model 860 
spectrophotometer. Maximum absorbance occurred after 30 h to 48 h, as shown in 
Figure 5.1. The blanks were used to ‘auto-zero’ the spectrophotometer before reading the 
samples.
5.2.9 CALCULATIONS AND STATISTICAL ANALYSIS
A standard curve was drawn of the absorbance of the resulting solution of DNA- 
diphenylamine reagent against the amount of DNA in the reaction mixture (1.2 ml). The 
amount of DNA in the samples was then determined from the standard curve, and was 
the amount of DNA in the 0.2 ml extract.
The amount of radiolabel in the DNA samples was determined in 0.2 ml aliquots of 
the extracts using the liquid scintillation counter (LSC), and expressed as dpm per fig 
DNA. The effeciency of counting was automatically determined by the counter, and 
varied from 29% to 31%. The results were analysed statistically using students’ t-test. A 
chemical is considered to have induced UDS if the control values are within known 
ranges from the laboratory and incorporation of pH]thymidine per unit of DNA is 
significantly elevated, at the 95% confidence level.
5 .3  RESULTS
5.3.1 ABSORPTION SPECTRU M  AND RATE OF COLOUR 
DEVELOPMENT
A blue colour developed following incubation of hydrolysed DNA with 
diphenylamine reagent. The resultant solution had an absorbance maximum at a 
wavelength of 600 nm. This wavelength was therefore used to assay the samples.
Standard DNA solutions of varying concentrations were incubated with 
diphenylamine reagent and the absorbance of the resulting solution determined at time 
intervals as demonstrated in Figure 5.1. Maximum absorbance occurred after
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approximately 30 h of incubation in the dark. The increase in absorbance after this period 
proceeded very gradually.
The relationship between the concentration of the standards and the absorbance of 
the resulting solution after incubation with diphenylamine reagent for 48 h is as shown in 
Figure 5.2 (at low DNA concentrations) and Figure 5.3 (at high DNA concentrations). A 
good correlation coefficient (0.997) existed at all concentration ranges up to 75 pg. The 
standard curve was used to determine the concentration of DNA in the unknown samples. 
There was no significant difference between the absorbance of the standards of similar 
concentrations when assayed on different occassions, although in every assay a set of 
standards was run concurrently.
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Figure 5.1: Influence of incubation time on the absorbance of the resulting solution of 
DNA and diphenylamine reagent. Aliquots (0.75 ml) of 10, 20, or 50 pg/ml solutions of 
hydrolysed DNA in 15% (v/v) perchloric acid were mixed with 0.45 ml of diphenylamine 
reagent to give 7.5,15.0 and 37.5 |ig DNA/1.2 ml of the mixture, and left in the dark. At 
time intervals the absorbance of the resulting solution was determined at 600 nm.
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Figure 5.2: Correlation between low DNA concentrations and the absorbance resulting 
from incubation with diphenylamine reagent. Aliquots (0.75 ml) of 2 to 15 |ig/ml of 
standard DNA solutions in 15% (v/v) perchloric acid were mixed with 0.45 ml of 
diphenylamine reagent and left in the dark for 48 h, and the absorbance of the resulting 
solution determined. The amount of DNA (mean, n = 3) in 1.2 ml of the test mixture was 
plotted against absorbance.
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Figure 5.3: Correlation between high DNA concentrations and the absorbance resulting 
from incubation with diphenylamine reagent. Aliquots (0.75 ml) of 20 - 100 jig/ml of 
DNA (dissolved in 15% perchloric acid solution) were mixed with 0.45 ml of 
diphenylamine reagent and incubated in the dark at room temperature for 48 h. The 
absorbance of the resulting solution was determined. The amount of DNA (mean, n = 3) 
in the 1.2 ml of the incubation mixture is plotted against absorbance.
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5.3.2 DNA YIELDS AFTER DIGESTION WITH PROTEINASE E
The recovery of DNA, as presented in Figure 5.4, for a group of 33 rats, varied 
widely and ranged from 34 to 120 gg per rat, with a mean of (81.8±25.8). The variation 
is likely to be mainly due to differences in the size of sacs during preparation. Large sacs 
yielded more cells and therefore more DNA, and vice versa. However, the differences in 
DNA yields are unlikely to have affected the results as the final results for comparison of 
different treatment groups have been expressed in disintegrations per minute (dpm) per 
jig DNA.
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Figure 5.4: Amount (gg) of DNA extracted from the stomachs of individual rats.
Each bar represents the total amount of DNA extracted from each rat. DNA recovery 
varied from 34 to 120 gg per rat, with a mean of 81.8±25.8.
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5.3.3 INFLUENCE OF TIME INTERVAL BETWEEN TREATMENT AND 
SAMPLING ON INCORPORATION OF LABELLED THYMIDINE
The results of a study conducted to determine whether time interval between 
treatment of rats with MNNG and sampling influenced incoiporation of pH] thymidine 
are illustrated in Figure 5.5. The results show that the amount of thymidine incorporated 
into DNA increased sharply with increasing time interval between treatment and sampling 
up to an interval of 15 h. Although samples representing a 20 h interval showed a 
significantly higher level of incorporation than that at 5 h, the observed incorporation was 
significantly lower than that at 15 h interval.
The exact time for maximum incorporation of pH] thymidine cannot be deduced 
from the data because of the large sampling interval (5 h), though it seems to be at about 
15 h. Nevertheless, 14 h was chosen as the best interval between treatment with MNNG 
and administration of pH]thymidine, based on the present results and those of Burlinson 
(1989).
5.3.4 EFFECT OF DOSAGE OF [3H ]T H Y M ID IN E  ON TH E 
INCORPORATION OF THE LABEL BY GASTRIC CELLS
Incorporation of tritiated thymidine at different dose levels was examined in rats 
treated with MNNG at 50 mg/kg bwt to determine the minimum amount of 
pH]thymidine that need be administered to test animals. The results of this study are 
given in Figure 5.6. Incorporation of the label increased with increasing doses of 
pH]thymidine. The rate of increases was, however, small at 0.5 and 1 ml/kg bwt. In 
spite of the high cost of pH] thymidine, a dose of 0.75 ml/kg was chosen to ensure best 
results.
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Figure 5.5: Effect of time interval between treatment with MNNG and pH]thymidine 
on the incorporation of the label by rat gastric cells. Rats were treated initially with N- 
methyl-N’-nitro-N-nitrosoguanidine (50 mg/kg bwt orally), and then later at 0, 5,10,15, 
and 20 h with a solution of pH] thymidine (37 MBq/ml, specific activity 925 GBq/mmol) 
at 0.75 ml/kg bwt by the subcutaneous route. Rats were killed 1 h after treatment with 
pH]thymidine. DNA was extracted and hydrolysed as outlined in Section 5.2.6. 
Hydrolysed DNA (0.2 ml) was combined with 5 ml of scintillation liquid and counted for 
10 min, to give the amount of radiolabel (dpm). Results (mean of triplicate samples) are 
presented as dpm/jig DNA and plotted against time interval.
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Figure 5.6: Effect of pH]thymidine dose on its incorporation into gastric mucosal 
DNA of rats treated with N-methyl-N’-nitro-N-nitrosoguanidine. Rats were treated with 
MNNG (50 mg/kg bwt orally), and 14 hours later with a solution of pH]thymidine (37 
MBq/ml, specific activity 925 GBq/mmol) at 0, 0.15, 0.35, 0.5 and 1.0 ml/kg by the 
subcutaneous route. Rats were killed 1 h after treatment with pH]thymidine. DNA was 
extracted and hydrolysed as outlined in Section 5.2.6. Hydrolysed DNA (0.2 ml) was 
combined with 5 ml of scintillation liquid and counted for 10 minutes to give the amount 
of radiolabel in dpm. Results (mean of triplicate samples) are presented as dpm/jJ-g DNA, 
and plotted against amount of pHjthymidine administered.
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5 .3 .5  E F F E C T  OF Q U E R C E T I N ,  S H I K I M A T E  AND 
CYC L OH EX AN E CA R B O XY L AT E  ON I N C O R P O R A T IO N  OF 
[3H]THYMIDINE INTO GASTRIC MUCOSAL DNA OF RATS
Studies were conducted to determine the effect of quercetin, shikimate and 
cyclohexanecarboxylate on incorporation of [% ]thymidine in gastric mucosal DNA as 
shown it Table 5.1. Ptaquiloside was not used because sufficient amounts of the 
compound were not available for this experiment. None of the compounds tested had any 
significant effect on the incoiporation of pH]thymidine into DNA although shikimate and 
cyclohexanecarboxylic acid caused slight dose dependent increases. MNNG (positive 
control) produced a statistically significant (P < 0.001) increase on the incorporation of 
pH]thymidine into DNA at 25 and 50 mg/kg bwt, but not at 10 mg/kg bwt.
5.3.6: EFFECT OF COMBINED TREATMENT OF QUERCETIN AND 
SHIKIMATE ON INCORPORATION OF pH]THYMIDINE IN MUCOSAL 
DNA OF RATS
Quercetin and shikimate were administered to rats simultaneously to determine if 
this treatment could enhance the incorporation of pH]thymidine in the rat gastric mucosal 
DNA. Quercetin was administered at 100 mg/kg bwt whereas shikimate was administered 
at 250 to 750 mg/kg bwt, in the combinations indicated in Table 5.2. The results, as 
presented in Table 5.2, show that combined treatment with quercetin and shikimate 
produced no significant increase in the incorporation of the label.
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Table 5.1: Incorporation (dpm/jig DNA) of [3H] thymidine after treatment of rats with 
compounds.
Compound Dose (mg/kg) Response (dpm/jig DNA)
DMSO3 1129±507
MNNG 50b 7048±1609*
25c 3224±1596*
10c 1038±257
0 1295±216
Quercetin 800 789±41
400c 1179±269
100 475±180
50 1006±193
0C 1131±289
SA 1000 1704±418
750c 1580±772
500C 12371327
250 10961336
0 10541396
CCA 1000 18471386
500 17751384
200 16991241
0 12921213
a - denotes n = 9; b - denotes n = 4; c - denotes n = 3; All the others are in duplicate. 
Rats were treated with the indicated compounds. 14 h after treatment, pHjthymidine was 
administered subcutaneously and animals killed 1 h later. Gastric mucosa cells were 
isolated and DNA content assayed. The amount of radiolabel was determined as outlined 
in section 5.2.5 - 5.2.8, and results expressed as dpm/jig DNA.
* - significantly higher than the controls (DMSO).
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Table 5 2: Incoiporation of [3H]thymidine into gastric mucosa cell DNA after treatment 
of rats with quercetin and shikimate.
Compound Dose (mg/kg) Response (dpm/jig DNA)
DMSO 933±301
MNNG 50 55431978
Quercetin 400 11441608
SA 750
Quercetin 200 15461484
SA 750
Quercetin 100 13031264
SA 750
Quercetin 400 13181443
SA 250
Quercetin 400 10571497
SA 500
Rats were treated with a combination of quercetin and shikimate at the indicated doses. 14 
h after treatment [3H]thymidine (0.75 ml/kg) was administered subcutaneously and 
animals killed 1 h later. Gastric mucosa cells were isolated and DNA content assayed. 
The amount of radiolabel was determined as outlined in section 5.2.5 - 5.2.8, and results 
expressed as dpm/jig DNA. There was no significant difference (as determined by the 
students’ t-test) between cells obtained from control and test animals. Results are 
presented as meartizSD (n=3).
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5 .4  DISCUSSION
Administration of radiolabelled thymidine to rats leads to incorporation of 
radioactivity into the DNA. When there is damage to DNA increased uptake and 
incorporation of thymidine occurs (Rasmussen and Painter, 1966; Furihata and 
Matsushima, 1982; Furihata et a l, 1984) as the cells undergo unscheduled DNA 
synthesis to repair the damage. DNA repair is a normal process in organisms and occurs 
over the entire genome (Smerdon et al., 1978). Some chemicals have the ability to 
damage DNA (Furihata and Matsushima, 1982; Furihata et al., 1984), an event which 
leads to increased incorporation of thymidine (Mitchell and Mirsalis, 1984; Burlinson et 
a l, 1991).
Quercetin, shikimate, and cyclohexanecarboxylate were administered to rats to 
determine whether they could influence incorporation of pH]thymidine in the gastric 
mucosal DNA. Quercetin (Brown, 1980; Pamukcu et a l, 1980) and shikimate (Evans 
and Osman, 1974; Jones et al, 1983) are the bracken constituents shown to be genotoxic 
and carcinogenic. The results demonstrate that quercetin, shikimate and 
cyclohexanecarboxylate did not significantly influence incorporation of pH]thymidine 
into rat gastric mucosa cell DNA. This indicates that these compounds have no genotoxic 
effect on those cells.
It was earlier proposed that the carcinogenicity of bracken might be due to some of 
its constituents acting as genotoxic cocarcinogens. Thus the compounds may show 
enhanced genotoxicity if administered together in animals. The results (Table 5.2) 
demonstrate that mixed application of quercetin with either shikimate or 
cyclohexanecarboxylate does not enhance their genotoxicity to the mucosal cells.
The investigation of possible quercetin genotoxicity in mammalian cells in vitro 
(Amacher et al, 1979; Maruta et al, 1979; Yoshida et a l, 1980; Meltz and MacGregor, 
1981; Carver et al, 1983; Terada et a l, 1983) and in vivo, as in the present experiment, 
is prompted by the possible role that it may play as a carcinogen especially following
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demonstration of bacterial mutagenicity in the Ames test (Bjeldanes and Chang, 1977; 
MacGregor and Jurd, 1978; Brown and Dietrich, 1979). However, the present results 
suggest that the in vitro genotoxicity findings for quercetin have no bearing in vivo in rat 
gastric mucosa cells. This is surprising since Pamukcu et al. (1980b) produced evidence 
to suggest that quercetin may be carcinogenic. Further to this report on positive quercetin 
carcinogenicity, Ito (1992) reported that the Board of Scientific Counsilors of the 
National Toxicology Program in USA had reviewed a draft Technical Report (TR409) on 
‘long-term Toxicology and Carcinogenesis Studies of Quercetin’. It was concluded that 
there was some evidence of carcinogenic activity for male F344/N rats which showed 
increased incidence of renal tubular cell hyperplasia and adenoma after administration of 
4% (w/w) in feed (Dunnick and Hailey, 1992) although others (Ambrose et al., 1952; 
Saito et ai., 1980; Hosaka and Hirono, 1981; Morino et al., 1982; Hirose et al., 1983; 
Takanashi et al., 1983; Stoewsand et al., 1984; Ito et al., 1989) have consistently 
demonstrated a negative carcinogenic effect for quercetin in animals.
For comparative purposes, the glandular stomach carcinogen MNNG was evaluated 
in this assay and produced a significant increase in the incorporation of [^H]thymidine in 
the gastric mucosa cells. The results are in agreement with the observations of Burlinson 
(1989) of increased incorporation of [% ]thymidine by MNNG, demonstrating that the 
compound is genotoxic in vivo. MNNG is also a proven carcinogen.
Several unscheduled DNA synthesis (UDS) techniques are available for the 
determination of chemical genotoxicity in gastrointestinal tissue in vivo (Freeman and 
San, 1980; Mitchell and Mirsalis, 1984; Butterworth et al., 1987; Burlinson, 1989). One 
of the most widely used techniques has been autoradiography (Stitch et a l,  1975; 
Ishikawa et al., 1978; Ashby et al., 1985). In this technique, cells are exposed to test 
compounds in vivo and the target cells isolated and assessed for UDS in vitro by 
treatment with [3H]thymidine, followed by autoradiography and determination of relative 
incidence of silver grains over the nucleus and cytoplasm (Mitchell and Mirsalis, 1984; 
Furihata and Matsushima, 1987; Bakke and Mirsalis, 1988). The technique offers less
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confidence when extrapolated to the in vivo environment. However, exposure to a 
mutagen / carcinogen and pH] thymidine may be done in vivo followed by in vitro tissue 
fixation, sectioning and processing for autoradiography. Tissue processing and 
sectioning is a delicate procedure and may result in sections with poor cell outline thereby 
making the process of distinguishing cytoplasmic from nuclear grains difficult, leading to 
unreliable results. The method used in the present experiment, which is a modification of 
the assay descibed by Mitchell and Mirsalis (1984) for in vitro studies, has the advantage 
that incorporation of the label occurs in vivo, and the sensitivity to mutagens is good 
(Burlinson et al., 1991).
Although many genotoxic compounds have been shown to be carcinogenic (Cairns, 
1975; Ashby, 1983a; DiGiovanni, 1990), it has nevertheless been demonstrated that 
chemical carcinogenesis is not necessarilly mediated by direct interaction of chemicals and 
/  or their metabolites with the genetic material (Miller and Miller, 1976; Ashby, 1983a; 
Salamone and Heddle, 1983; DiGiovanni, 1990). Hence, lack of genotoxic effect by 
quercetin and shikimate in the present experiment may not necessarily mean that they are 
without carcinogenic effects. Ptaquiloside was not tested for in vivo genotoxicity because 
enough amounts were not available for the studies.
5 .5  CONCLUSION
In conclusion, quercetin and shikimate appear to be non-genotoxic in the gastric 
mucosa cell DNA in rats. Treatment of rats with quercetin and shikimate simultaneously 
does not enhance their genotoxic effect.
Since quercetin (Booth et al., 1956; Petrakis et al., 1959) and shikimate (Brewster 
et al., 1977a; 1977b; 1977c) undergo extensive bacterial metabolism in the 
gastrointestinal tract, it would seem that metabolites of these compounds may have no 
genotoxic activity in the gastric mucosa cells of the rat.
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CHAPTER 6
CYTOTOXICITY STUDIES OF QUERCETIN, SHIKIMATE, 
CYCLOHEXANECARBOXYLATE AND PTAQUILOSIDE IN CHO, 3T3,
AND NRK CELLS
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6.1 INTRODUCTION
Since quercetin is a known bacterial mutagen (Bjeldanes and Chang, 1977; 
MacGregor and Jurd, 1978; Brown and Dietrich, 1979) and several reports exist of its 
genotoxicity in mammalian cells in vitro (Amacher et al, 1979; Maruta et a l, 1979; Carver 
et al., 1983), it could be inferred that it may have cytotoxic effects, for it has been 
suggested that because mutagens damage DNA they are also very effective at killing cells 
(Ames and Gold, 1990; Gold et al, 1989). Unlike quercetin, shikimate is not mutagenic in 
the Salmonella /  mammalian microsome test (Chapter 3). Cytotoxicity studies with 
shikimate have not previously been conducted, but reports are available of its positive 
carcinogenicity (Evans and Osman, 1974), mutagenicity and cell transforming activity in 
mammalian cells (Evans and Osman, 1974; Jones et al., 1983). Ptaquiloside too is reported 
to be mutagenic (Van der Hoeven, 1983; Matoba et al., 1987) and carcinogenic in animals 
(Hirono et al., 1984a, 1984b, 1987), but like shikimate its cytotoxicity is not yet 
established.
The present experiment was therefore conducted to determine whether quercetin, 
shikimate, cyclohexanecarboxylate and ptaquiloside have any cytotoxic effects in three 
different types of cell lines Chinese hamster ovary (CHO), mouse fibroblast (3T3) and 
normal rat kidney (NRK) cells, and to correlate the cytotoxicities with their genotoxic and 
carcinogenic properties.
6 .2  MATERIALS AND METHODS
6.2.1 CHEMICALS AND REAGENTS
L-glutamine, essential amino acids (50x), non-essential amino acids (lOOx), fetal 
calf serum, penicillin / streptomycin, sodium pyruvate, tylocin, sodium bicarbonate 
(7.5%), phosphate buffered saline without magnesium or calcium, Ham’s nutrient mixture 
(F10), and trypsin - EDTA [0.05% (v/v) : 0.02% (w/v)] were purchased from Gibco Ltd. 
(Renfrew Road, Paisley); acetic acid, 3-4, 5, dimethylthiazol-2, 5 diphenyltetrazolium 
bromide (MTT), crystal violet, glutaraldehyde, 2-[N-morpholino] ethanesulfonic acid 
(MeS), and ethanol were from Sigma Chemical Co. Ltd (Poole, Dorset).
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CHO cells were a generous donation by Dr.P.Goldfarb (School of Biological 
Sciences, University of Surrey, Guildford), and 3T3 and NRK cells were a gift from Dr. 
R.J.B.King (Head of The Imperial Cancer Research Fund, Breast Biology Unit, 
University of Surrey, Guildford).
6.2.2 GROWTH MEDIUM INGREDIENTS
All growth media constituents (Table 6.1) were sterile when purchased. Distilled 
water was sterilised by autoclaving for 20 min at 121° C, 15 psi. Strict aseptic /  sterile 
techniques were followed in all cell culture studies. All procedures were conducted in a 
sterile cabinet with laminar air flow.
Table 6.1: Culture medium constituents.
Constituent Volume (ml)
Distilled water 400
F10 (Ham’s Nutrient mixture) (lOx) 50
L-Glutamine (lOOx) (200mM) 10
Sodium pyruvate (100 mM) 10
Essential amino acids solution (50x) 10
Non-essential amino acids solution (lOOx) 10
Penicillin-streptomycin solution 2
Tylocine (Anti-PPLO agent)(100x) 5
Sodium bicarbonate (7.5%) 10
Sodium hydroxide (2M) ~2
Fetal calf serum 50
Anti-PPLO (lOOx) (6000 gg/ml); penicillin-streptomycin solution (5000 units penicillin and 
5000 fig streptomycin/ml in normal saline).
Essential amino acids (50x) solution: L-arginine HCL (1050 mg/L), L-cystine (1050 
mg/L), L-histidine (400 mg/L), L-isoleucine (1300 mg/L), L-leucine (1300 mg/L), L-lysine 
HCL (1823.50 mg/L), L-methionine (375 mg/L), L-phenylalanine (825 mg/L), L-threonine 
(1200 mg/L), L-tryptophan (200 mg/L), L-tyrosine (900 mg/L), L-valine (1175 mg/L). 
Non-essential amino acids (lOOx): L-alanine (890 mg/ml), L-asparagine H2O (1500 mg/L), 
L-aspartic acid (1330 mg/L), L-glutamic acid (1470 mg/L), glycine (750 mg/L), L-proline 
(1150 mg/L), L-serine (1050 mg/L).
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6.2.3 SOLUTIONS OF TEST COMPOUNDS
Quercetin, shikimate, cyclohexanecarboxylate, ptaquiloside, mitomycin C, and 
dinitrophenol were incorporated into the growth medium. They were diluted to give a wide 
logarithmic concentration range, in log increments, 1 x 10-7 M to 1 x 10-1M. Based on the 
observations on the effects of these concentrations, a narrower range (log or linear) was 
then used in the subsequent trials. Mitomycin C and dinitrophenol were used as positive 
controls. Cultures containing DMSO or ethanol (solvent control), at their highest 
concentrations used, were also conducted with the test samples.
6.2.4 CULTURE PROCEDURE
Cultures (in ampoules) were quickly thawed in a water bath at 37° C. Cells were 
transferred to a 75-cm2 culture flask. Complete growth medium [Ham’s F10 with 10% 
(v/v) fetal calf serum] (20 ml) was added to the cells. Cells were incubated at 37° C, 5% 
C02-95% air in a high humidity atmosphere. After 24 h the medium was replaced with 
fresh medium and the cells re-incubated. The growth medium was subsequently replaced 
every 2 days until a confluent monolayer was established. The monolayer of cells was then 
washed with about 5 ml trypsinizing solution [0.05% (v/v) trypsin and 0.02% (w/v) EDTA 
in PBS without calcium or magnesium] for about 10 sec. The washings were discarded and 
fresh trypsinizing solution (2 ml) added and the contents incubated for 5 min. F10 (Ham’s) 
medium (8 ml) was added to the cells to suspend them, and at the same time stop the action 
of trypsin. After pipetting up and down several times the cell suspension was transferred to 
20-ml sterilin tubes and centrifuged at 800 rpm for 3 min using a Beckman JB-6 centrifuge. 
The medium was decanted and cells re-suspended in fresh medium (10 ml). Portions (1 ml) 
were transferred (subculture) to fresh 75-cm2 culture flasks containing fresh medium (19 
ml) and incubated at 37° C. The medium was changed every 2 days and when cells became 
confluent, they were trypsinized and centrifuged as described above and re-suspended in 
fresh medium (5 ml). The concentration of cells was estimated using an improved Neubaur 
haemocytometer.
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6.2.5 ASSAY FOR CELL GROWTH
A traditional method for the determination of cell growth in culture involves manual 
counting of the live cells using a haemocytometer chamber. This method is inadequate 
when large numbers of samples are to be processed. Since this technique is also time 
consuming, colorimetric methods (Mosmann, 1983; Kueng et ah, 1989) were chosen for 
the present experiments.
6.2.5.1 THE TETRAZOLIUM DYE (MTT)-BASED COLORIM ETRIC 
ASSAY
The MTT assay described by Mosmann (1983) is based on the ability of viable cells 
to convert a soluble tétrazolium salt (3-4,5, dimethylthiazol-2,5 diphenyltetrazolium 
bromide; MTT) into insoluble formazan crystals (Slater et al., 1963). The amount of purple 
coloured formazan crystals formed is directly proportional to the number of surviving and /  
or proliferating cells (Mosmann, 1983). Hence, to determine cell growth and 
multiplication, the resulting crystals are dissolved in an organic solvent and the absorbance 
(Gillies et al., 1986) of the resulting solution measured on a multiwell spectrophotometer 
(ELISA plate reader).
Cells were taken from the 75 cm2 tissue culture flasks during the exponential phase 
of growth. Microtitration (96-well) plates were seeded with cells in 200 |il of culture 
medium. Plates were incubated for 24 h (unless otherwise stated) and then the medium 
removed from each well and replaced with one containing the appropriate amounts of drug. 
After a further incubation (48 h), 20 fil of MTT (5mg ml-1 in phosphate buffered saline) 
was added to each well. Plates were again incubated for 4 h and the medium aspirated from 
the wells as completely as possible. DMSO [200 p.1 containing 2.5% (v/v) F10 medium 
without fetal calf serum] was added to each well and plates vigorously agitated on a plate 
shaker for 5 min to dissolve the formazan crystals. The absorbance of the resulting blue 
solution was determined in a multiwell reader at a wavelength of 570 nm and a calibration 
setting of 1.00 - 1.99. A reference (blank) well without cells, but with the medium, was
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used as a blank (i.e. absorbance zero). The absorption wavelength of 570 nm was chosen 
although the formazan crystals absorbed maximally at 553 nm, determined in a Kontron 
Uvikon model 860 spectrophotometer, because the appropriate filter was not available. 
However, this has been shown not to significantly affect the results (Mosmann, 1983; 
Gillies era/., 1986).
6.2.S.2 THE CRYSTAL VIOLET-BASED COLORIMETRIC ASSAY
The Crystal Violet colorimetric assay, originally described by Gillies et al. 
(1986) and modified for 96-well plates by Kueng et al. (1989) is a quantitative assay for 
cells based on the staining of their nuclei with Crystal Violet The dye taken up by the cells 
is then dissolved in 10% (v/v) acetic acid, and the absorbance of the resulting solution 
recorded using a spectrophotometer.
Microtitration culture plates were prepared as described in Section 6.2.4. After the 
cells were incubated with the test compounds, glutaraldehyde solution [20 gl of an 11% 
(v/v) solution] was added to each well and the plates shaken at 500 cycles/min for 15 min 
using a Dynatech Microtiter shaker incubator. The plates were washed three times by 
submersion in deionized distilled water and air dried. Crystal Violet solution [100 JJ.1 of 
0.1% (w/v) solution in 200 mM MeS buffer pH 6.0] was transferred to each well and the 
plates shaken again for 20 min. Excess dye was removed by extensive washing with 
deionized water before the plates were air dried. The bound dye was then solubilized in a 
10% (v/v) solution of acetic acid (100 pi), solubilization being hastened by shaking for 10 
min. The absorbance was finally determined using a multiwell reader at 570 nm using a 
Kontron Uvikon 860 spectrophotometer. A reference well containing the solvent [10% 
(v/v) acetic acid] alone was used for blanking the plate reader (zero absorbance). Inhibition 
of growth by each concentration of compounds was calculated as follows:
Inhibition (%) = 100 X^° '
X„
where Xq represents absorbance of the resulting solution without test compounds, and Xi 
represents absorbance of the resulting solution with test compounds.
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6 .3  RESULTS
6 .3 .1  GROWTH CHARACTERISTICS OF CULTURE CELLS
Studies were conducted to correlate cell number (estimated by a haemocytometer) 
with the amount of formazan produced. Wells were seeded with different cell 
concentrations and plates incubated for 4 h to allow the cells to attach to the plates before 
quantitation. The resulting formazan solution absorbed maximally at 553 nm. The 
correlation coefficient between cell number, up to 5 x 10^ cells assayed, and the resultant 
absorbance was greater than 0.99 (Figure 6.1). The amount of formazan formed was 
directly proportional to the cell number.
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Figure 6.1: Relationship between cell number and the absorbance of the resulting 
formazan crystals solution. CHO cells were seeded at 625 - 50 x 103 cells per well and 
incubated for 4 h. Cell growth was determined by the MTT assay. The number of cells 
plated per well was plotted against the mean (n = 3) absorbance of the resulting formazan 
solution.
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Three pH ranges were compared in the Crystal Violet based colorimetric assay, and 
the correlation between cell number and the amount of Crystal Violet taken up by cell nuclei 
determined in CHO (Figure 6.2) and 3T3 (Figure 6.3) cells. The results demonstrate that
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Figure 6.3: Relationship between cell number and absorbance in the Crystal Violet assay. 
3T3 (a) and CHO (b) cells were seeded at 625 to 50 x 103 cells per well and incubated for 
4 h. Cells were assayed using Crystal Violet [0.1% (w/v) solution in 200 mM MeS buffer 
pH 6.0, or 3.5, or 2.2]. The number of cells plated per well is plotted against the mean (n 
= 3) absorbance of the resulting Crystal Violet solution.
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the pH of the staining solution affected the amount of dye taken up by the cells. The 
amount of dye increased with increasing pH in both CHO and 3T3 cells and was directly 
proportional to the cell number. The correlation coefficient between cell number and the 
resulting absorbance was greater than 0.99.
6.3.2 PROLIFERATION PROFILE OF CULTURE CELLS
The influence of incubation time on the proliferation of cultures was studied using 
the MTT and the Crystal Violet assays in order to determine the appropriate seeding 
densities that would produce absorbance within the range 1.0 to 1.99 after 72 h of 
incubation.
6.3.2.1 MTT assay
CHO and 3T3 cells were seeded at 625 to 5 x 104 cells per well, and incubated. At 
time intervals, CHO (Table 6.2) and 3T3 (Table 6.3) cells were assayed for growth. The 
amount of formazan formed by cultures increased significantly with incubation time. The 
increase was more marked at high seeding concentrations. At 72 h post-seeding, seeding 
densities of greater than 5 x 103 cells per well produced absorbance very close to 2.0,1250 
cells per well produced absorbance less than 0.6 in CHO (Table 6.2). Seeding at 2.5 x 103 
cells per well produced an absorbance within the range of 1.0 - 1.99,72 h post-seeding. In 
3T3 cell line seeding densities of 2.5 x 103 cells per well produced a significantly lower 
absorbance than CHO cell line after 72 h of incubation, but within the desired calibration 
range of 1.0 to 1.99 (Table 6.3).
6.3.2.2 Crystal Violet assay
CHO and 3T3 cells were assayed for growth at time intervals by the Crystal Violet 
assay using different pH ranges of the staining solution, to determine the suitability of the 
method and the appropriate pH in the subsequent studies. Tables 6.4 and 6.5 show the 
results of CHO and 3T3 cells respectively, after staining with Crystal Violet at pH 2.2. The 
absorbance at all sampling periods up to 144h was below 0.25 for all seeding 
concentrations of up to 5 x 103 cells per well.
167
CHO (Table 6.6) and 3T3 (Table 6.7) were assayed for growth using Crystal Violet 
at pH 3.5, at intervals after incubation. The absorbance after 72 h was below 1.0 in both 
CHO and 3T3 cells, at all seeding densities, up to 5 x 10  ^ cells per well. Incubation of 
cultures for longer than 72 h, however, resulted in higher absorbance.
Tables 6.8 and 6.9 show the results of CHO and 3T3 cells respectively, after 
assaying for growth with crystal violet at pH 6.0. Both CHO and 3T3 cells at seeding 
densities of 2.5 x 10  ^cells per well produced absorbance which was between 1.0 and 2.0 
72 h after incubation.
Table 6.2: Growth of CHO cells after incubation, based on MTT assay.
Number of
Absorbance
CHO cells* 0 h** 24 h 48 h 72 h 96 h
625 0.028+0.002 0.033±0.003 O.O65+O.O22 0.255+0.036 0.552+0.039
1250 O.O58±O.OO6 0.076+0.009 0.189+0.034 0.565+0.054 1.124+0.051
2500 0.110±0.008 0.177+0.066 0.400+0.082 1.250+0.107 N.D
5000 0.228+0.021 0.339±0.058 0.788+0.065 1.950+0.157 N.D
10000 0.472±0.054 0.742±0.039 1.670+0.098 N.D N.D
30000 1.289±0.049 N.D& N.D N.D N.D
50000 1.998±0.166 N.D N.D N.D N.D
* - Number of CHO cells seeded per well.
** - sampling time post-seeding.
a - Not determined (absorbance above the calibration range of the spectrophotometer). 
Plates were seeded at the indicated densities. At 24-h intervals samples were taken and cell 
growth determined by the MTT assay. Results are presented as mean±SD of triplicate 
samples.
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Table 6.3: Growth of 3T3 cells after incubation, based on MTT assay.
Number of
Absorbance
3T3 cells* 0 h** 24 h 48 h 72 h 96 h
625 0.022±0.001 0.02810.0 0.05110.014 0.16110.018 0.40610.024
1250 0.043±0.004 0.05010.003 0.11510.012 0.36110.025 0.90310.051
2500 0.090±0.010 0.12110.030 0.24010.029 0.93310.048 N.D
5000 0.184±0.007 0.26610.037 0.51910.055 1.77210.063 N.D
10000 0.374+0.020 0.60310.041 1.38810.061 N.D N.D
30000 1.10410.048 N.D3 N.D N.D N.D
50000 1.80410.103 N.D N.D N.D N.D
* - Number of cells seeded per well; ** - sampling time post-seeding; a - Not determined 
(absorbance above the calibration range of the spectrophotometer).
Plates were seeded at the indicated densities. At 24-h intervals cell growth was determined 
by the MTT assay. Results are presented as mean±SD of triplicate samples.
Table 6.4: Growth of CHO cells as determined using the Crystal Violet assay, pH 2.2.
Absorbance
Sampling
Time (h) 625* 1250* 2500* 5000*
0 0.00210 0.00510 0.01210.001 0.02210
24 0.00510 0.01110.002 0.02110 0.03610.003
48 0.01210.001 0.02910.001 0.04110.001 0.06710.002
72 0.02010.001 0.05410.004 0.08210.002 0.11910.001
96 0.05810.004 0.09810.007 0.13510.003 0.16110.010
120 0.08110.003 0.12610.005 0.18810.002 0.24010.003
144 0.12810.022 0.18110.013 0.21910.007 0.22310.004
* - Number of CHO cells seeded per well.
Plates were seeded at 625 - 5 x KP cells per well. At 24-h intervals cell growth was 
determined using the Crystal Violet method, pH 2.2. Results are presented as mean+SD of 
triplicate samples.
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Table 6.5: Growth of 3T3 cells as determined using the Crystal Violet assay, pH 2.2.
Sampling 
Time (h)
Absorbance
625* 1250* 2500* 5000*
0 0.003±0 0.00310 0.00510 0.01210.002
24 0.005±0 0.00310 0.01410.001 0.01310.002
48 0.007+0 0.00910 0.01910.002 0.03010
72 0.014±0.002 0.02610.003 0.05210.005 0.09310.009
96 0.04110.003 0.09010.006 0.12810.002 0.16510.004
120 0.05710.005 0.11310.006 0.15210 0.18810.006
144 0.13510.005 0.20110.002 0.22410.013 0.21510.011
* - Number of 3T3 cells seeded per well.
Plates were seeded at 625 - 5 x 103 per well. At 24-h intervals cell growth was determined 
using the Crystal Violet method, pH 2.2. Results are presented as mean±SD of triplicate 
samples.
Table 6.6: Growth of CHO cells as determined using the Crystal Violet assay, pH 3.5.
Absorbance
Sampling
Time (h) 625* 1250* 2500* 5000*
0 0.00710.001 0.01610.004 0.03310.002 0.06710.001
24 0.01210.001 0.02410.004 0.05110.003 0.18510.003
48 0.08110.006 0.08710.001 0.19810.003 0.39610.016
72 0.12710.008 0.22710.007 0.45210.025 0.74010.053
96 0.30110.006 0.54110.009 0.83510.020 1.11510.029
120 0.87010.024 1.20810.011 1.67210.038 1.98310.007
144 1.17710.037 1.38210.013 1.54110.008 1.88410.013
* - Number of CHO cells seeded per well.
Plates were seeded at 625 to 5 x 103 cells per well. At 24-h intervals cell growth was 
determined using the Crystal Violet method, pH 3.5. Results are presented as mean±SD of 
triplicate samples.
170
Table 6.7: Growth of 3T3 cells as determined using the Crystal Violet assay, pH 3.5.
Sampling
Time(h)
Absorbance
625* 1250* 2500* 5000*
0 0.01510 0.03810.010 0.08410.012 0.14510.001
24 0.02410.002 0.08210.003 0.13610.013 0.20410.003
48 0.09610.004 0.10110.005 0.21310.006 0.39210.004
72 0.15310 0.22610.008 0.46110.012 0.81410.010
96 0.62310.039 0.50510.015 0.81010.018 1.07110.010
120 0.81210.013 1.06610.059 1.31310.027 1.37510.042
144 0.84310.019 1.17710.035 1.38810.033 1.37710.017
* - Number of 3T3 cells seeded per well.
Plates were seeded at 625 to 5 x 103 cells per well. At 24-h intervals cell growth was 
determined using the Crystal Violet method, pH 3.5. Results are presented as mean±SD of 
triplicate samples.
Table 6.8: Growth of CHO cells as determined using the Crystal Violet assay, pH 6.0.
Absorbance
Sampling
Time (h) 625* 1250* 2500* 5000*
0 0.01310.001 0.02410.004 0.05010.002 0.13110.008
24 0.02410.004 0.07110.006 0.19510.008 0.43210.007
48 0.14510.011 0.31510.019 0.69810.013 1.34710.070
72** 0.51810.037 1.07410.019 1.99310.031 N.Da
* - Number of CHO cells seeded per well; ** - Cultures produced absorbance reading 
higher than the calibration range (2.0) after 72 h of incubation; a - Not determined.
Plates were seeded at 625 to 5 x 103 cells per well and at 24-h intervals cell growth 
determined using the Crystal Violet method, pH 6.0. Results are presented as mean±SD of 
triplicate samples.
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Table 6.9: Growth of 3T3 cells as determined using the Crystal Violet method, pH 6.0.
Sampling
Time(h)
Absorbance
625* 1250* 2500* 5000*
0 0.020±0.001 0.040+0.002 0.080±0.002 0.201+0.001
24 0.032+0.005 0.101+0.004 0.217±0.003 0.495±0.002
48 0.135+0.006 O.3O6+O.OÎ7 0.671+0.027 Î.3O9+O.OO4
72** 0.350+0.008 0.979±0.040 1.902+0.045 N.D3.
* - Number of 3T3 cells seeded per well; ** - Samples produced absorbance reading higher 
than the calibration range after 72 h of incubation; a - Not determined.
Plates were seeded at 625 to 5 x 1Q3 cells per well and at 24-h intervals cell growth was 
determined using the Crystal Violet method, pH 6.0. Results are presented as mean±SD of 
triplicate samples.
6.3.3 QUERCETIN CYTOTOXICITY
In the MTT assay, a bluish colouration occurred immediately after adding the dye to 
wells containing quercetin. This was possibly the result of a chemical reaction between 
quercetin and/or its degradation products with the dye. The Crystal Violet assay was 
therefore used for all the studies involving quercetin. The use of MTT and the Crystal 
Violet assays interchangeably did not affect the results because in every experiment 
appropriate controls were included. The similarity of these two assays in terms of cell 
culture technique, that involved 96-well plates, and scoring for growth using a plate reader 
at the same calibration range of 1.00 -1.99, reduced the error further.
Incorporation of quercetin into the growth medium at concentrations higher than 0.5 
x 10-4 M significantly inhibited cell growth in all three cell lines (Table 6.10). 
Concentrations lower than 0.25 x 10"4 M had no significant effect on cell growth. The low 
water solubility of quercetin meant that concentrations higher than 1.0 x 10-4 M could not 
be produced.
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Table 6.10: Cytotoxicity of quercetin in cell cultures.
Quercetin
oncentration
(x H H m )
Absorbance
CHO 3T3 NRK
0 l.73O±O.Oll 1.88410.067 0.68410.039
0.10 1.68210.038 (3) 1.92710.044 0.68210.042
0.25 1.56710.027 (9) 1.76710.026 (6) 0.66610.015 (3)
0.50 1.18710.003 (31)* 1.56710.033 (17)** 0.44210.022 (38)**
0.75 1.02510.109 (41)* 1.11710.032 (41)* 0.26810.013 (61)*
1.00 0.77010.012 (55)* 0.98710.014 (48)* 0.18610.018 (73)*
Statistically significant inhibition: * - (p < 0.001), **- (p< 0.01). 
Data in parenthesis is percent growth inhibition.
Plates were seeded with CHO, 3T3 and NRK cells at 2.5 x 103» 2.5 x 103» and 4.0 x 103 
cells per well respectively, and incubated for 24 h. The growth medium was replaced with 
one containing the indicated concentrations of quercetin, and incubated for a further 48 h. 
Growth inhibition was determined by the Crystal Violet assay, pH 6.0.
6 .3 .4  S H IK IM A T E  AND C Y C L O H E X A N E C A R B O X Y L A T E  
CYTOTOXICITY
Unlike quercetin, shikimate inhibited cell growth at relatively higher concentrations 
of the compound as shown in Table 6.11. No significant inhibition was observed at 
concentrations lower than 0.5 x 10'^ M. Cyclohexanecarboxylate was similarly tested for 
cytotoxicity in cell cultures as shown in Table 6.12. Inhibition of cell growth occurred at 
concentrations higher than 0.25 x 10'2 M.
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Table 6.11: Growth of CHO, 3T3 and NRK cells in the presence of shikimate.
Shikimate
concentration
(x 10-2 M)
Absorbance
CHO 3T3 NRK
0 1.514+0.012 1.016+0.181 1.08610.011
0.5 1.402+0.045 ( 7) 1.061±0.024 1.073+0.015 (8)
1.0 1.385+0.022 ( 8)** 0.855+0.074 (16)** 0.965+0.004 (11)**
2.5 1.216+0.075 (20)** 0.651+0.051 (36)* 0.816+0.016 (25)**
5.0 0.821+0.071 (46)* 0.455+0.024 (55)* 0.571+0.018 (47)*
7.5
id
(61)* 0.299±0.032 (71)* 0.37110.004 (66)*
10 O.435±O.O35 (71)* O.242+O.OÎ2 (76)* 0.27710.017 (74)*
Statistically significant inhibition: * - (p < 0.001), ** - (p < 0.01); Data in parenthesis is 
percent growth inhibition. CHO and 3T3 cells were seeded at 2.5 x 103 cells per well, and 
NRK cells at 4.0 x 103 cells per well, and incubated for 24 h. The growth medium was 
replaced with one containing the indicated concentrations of shikimate, and incubated for a 
further 48 h. Cultures were assayed for growth inhibition by the MTT assay. Results are 
presented as mean±SD of triplicate samples.
Table 6.12: Growth of cell culture in the presence of cyclohexanecarboxylate (CCA).
CCA
concentration 
(x 10"2 M)
Absorbance
CHO 3T3 NRK
0 1.513+0.015 1.10110.044 1.05710.035
0.25 0.84310.025 (44)* 0.48310.059 (56)* 0.45710.027 (57)*
0.50 0.73310.020 (52)* 0.34110.023 (66)* 0.33010.011 (69)*
0.75 0.61310.011 (60)* 0.26910.016 (76)* 0.25510.008 (76)*
1.0 0.37710.020 (75)* 0.17610.004 (84)* 0.14210.005 (87)*
inhibition. Plates were seeded with CHO and 3T3 cells at 2.5 x 103 cells per well, and 
NRK cells at 4.0 x 103 cells per well and incubated for 24 h. The growth medium was 
replaced with one containing die indicated concentrations of cyclohexanecarboxylate, and 
incubated for a further 48 h. CHO and 3T3 cells were assayed for growth by the MTT 
method, and NRK cells by the crystal violet method. Results are presented as mean±SD of 
triplicate samples.
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6.3.5. CYTOTOXICITY OF PTAQUILOSIDE
Ptaquiloside caused a significant inhibition of growth and proliferation of the three 
cell lines at concentrations greater than 5 x 1(M M in the culture medium, as demonstrated 
in Table 6.13.
Table 6.13: Inhibition of growth of cell cultures by ptaquiloside.
Ptaquiloside
concentration
Absorbance
(x 10-3 M) CHO 3T3 NRK
0 Î.Î56+O.O35 O.963+O.O32 1.076±0.076
0.25 1.069±0.019 (7) 0.854±0.006 (11) O.864±O.O3l (20)
0.5 0.974+0.020 (16)** 0.622±0.015 (35)** 0.763+0.060 (29)**
1.0 0.499±0.023 (57)* O.322+O.O2O (67)* 0.52710.011 (51)*
1.5 O.222+O.OÎ8 (81)* 0.210±0.014 (78) * 0.22610.016 (79)*
2.0 0.054±0.003 (95)* O.O95±O.O28 (90) * 0.08710.034 (92)*
Statistically significant inhibition: * - (p < 0.001), ** - (p < 0.01). Data in parenthesis is 
percent growth inhibition. Plates were seeded with CHO and 3T3 cells at 2.5 x 103 cells 
per well, and NRK cells at 4.0 x 10  ^cells per well and incubated for 24 h. The growth 
medium was replaced with one containing the indicated concentrations of ptaquiloside and 
incubated for a further 48 h. Cultures were assayed for growth inhibition by the Crystal 
Violet method. Results are presented as mean±SD of triplicate samples.
6.3.6 CYTOTOXICITY OF DINITROPHENOL AND MITOMYCIN C
Mitomycin C (Table 6.14) and dinitrophenol (Table 6.15) were used in this study 
as positive controls. As expected these compounds produced marked inhibition of cell 
growth.
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Table 6.14: Cytotoxicity of mitomycin C on cell cultures.
Mitomycin C 
concentration
Absorbance
(x 10-6 M) CHO 3T3 NRK
0 1.487±0.030 1.020+0.129 1.080+0.017
1.5 0.980+0.036 ( 34)* 0.467+0.032 ( 54)* O.5O6+O.OO8 ( 53)*
3.0 0.391+0.034 ( 74)* 0.124+0.013 ( 88)* O.Î2Î+O.OO6 ( 89)*
6.0 0.033+0.013 (100)* 0.031+0.007 (100)* 0.024+0.002 (100)*
Statistically significant inhibition: * - (p < 0.001). Data in parenthesis is percent growth 
inhibition. Plates were seeded with CHO and 3T3 cells at 2.5 x 103 cells per well, and 
NRK cells at 4.0 x 103 cells per well and incubated for 24 h. The growth medium was 
replaced with one containing the indicated concentrations of mitomycin C and incubated for 
48 h. Cell growth was determined using the Crystal Violet method. Results are presented 
as mean±SD of triplicate samples.
Table 6.15: Cytotoxicity of dinitrophenol in cell cultures.
Dinitrophenol 
concentration 
(x 10"4 M)
Absorbance
CHO 3T3 NRK
0 1.172+0.025 0.886+0.006 1.086±0 015
0.5 0.981±0.019 (16)** 0.801±0.018 (12)** 1.043±0.025 (4)
1.0 0.923+0.018 (21)* O.737+O.ÎO4 (16)** 0.826+0.050 (24)*
2.7 0.385+0.018 (67)* 0.406+0.036 (53)* 0.459+0.027 (58)*
5.4 0.278+0.015 (76)* 0.189+0.026 (78)* O.274+O.OÎ6 (75)*
Statistically significant inhibition: * - (p < 0.001), ** - (p < 0.01). Data in parenthesis is 
percent growth inhibition. Plates with CHO and 3T3 cells at 2.5 x 103 cells per well, and 
NRK cells at 4.0 x 103 cells per well were incubated for 24 h. Growth medium was 
replaced with one containing the indicated concentrations of dinitrophenol and incubated for 
48 h. Growth was determined using the Crystal Violet method. Results are presented as 
mean±SD of triplicate samples.
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6.3.7 IC5o AS AN INDEX OF CYTOTOXICITY
The cytotoxic activity of quercetin, shikimate, cyclohexanecarboxylate and 
ptaquiloside were compared. Cytotoxic activity was expressed in terms of the concentration 
which produced a 50% inhibition of cell growth (inhibitory Dose 50, IC50) as shown in 
Table 6.16. The concentrations required for 50% inhibition of growth were obtained 
graphically. The mean reciprocals of the IC50 were calculated to give an index of 
cytotoxicity and, as presented in Table 6.16, show that quercetin was the most cytotoxic of 
the bracken constituents tested. Shikimate was the least cytotoxic.
Table 6.16: IC50 concentrations of quercetin, shikimate, cyclohexanecarboxylate (CCA) 
and ptaquiloside against CHO, 3T3 and NRK cell cultures.
IC5o(M)
Compound CHO 3T3 NRK
Quercetin 0.8 x IO-4 (12500) 1.2 x 10-4 (8330) 0.7 x 10-4 (14280)
Ptaquiloside 0.8 x 10-3 (1250) 0.7 x 10-3 (1430) 1.0 x ID"3 (1000)
CCA 0.4 x 10-2 (250) 0 .2 x l0 -2 (500) 0.2 x IQ"2 (500)
Shikimate 0.6 x 10-1 (17) 0.6x10-1 (17) 0.6  x 10-1 (17)
IC50 - concentrations (M) inhibiting cell growth by 50% after 48 h of incubation.
Data in parenthesis is the reciprocal of the IC50 as an index of cytotoxicicity.
The IC50 concentrations were determined graphically by plotting concentrations of test 
compounds in the growth medium against the resulting growth inhibition.
6.3.8 CYTOTOXICITY OF SOLVENT CONTROL
Three solvent systems DMSO, ethanol and water were used. The concentrations of 
DMSO and ethanol in the growth medium were maintained at less than 0.5% (v/v). At this 
concentration, DMSO (Table 6.17) and ethanol (Table 6.18) were not toxic to cultures. 
Concentrations higher than 0.5% (v/v) caused solubilization of formazan crystals into the 
medium.
1 7 7
Table 6.17: Effect of dimethylsulphoxide on the growth of cell cultures.
DMSO Absorbance
concentration _______________________________________________
[% (v/v)] CHO 3T3 NRK
0 1.546+0.026 1.093+0.045 1.103±0.033
0.1 1.541±0.049 1.056+0.040 (4) Î.O86+O.OÎ5
0.5 Î.522+O.O5Î 1.023+0.034 (6) 1.094+0.046
1.0 1.120+0.044 (28)* O.87O+O.O55 (20)** 0.911+0.052(17)**
2.0 0.346±0.053 (78)* O.544+O.O68 (50)* O.62Î+O.O34 (44)*
4.0 0.051+0.012 (97) O.O67+O.OO2 (94)* 0.062+0.004 (94)*
Statistically significant inhibition: * - (p < 0.001), ** - (p < 0.01). Data in parenthesis is 
percent growth inhibition. Plates were seeded with CHO and 3T3 cells at 2.5 x 10  ^cells 
per well, and NRK cells at 4.0 x 103 cells per well and incubated for 24 h. The medium 
was replaced with one containing the indicated concentrations of DMSO and incubated for a 
further 48 h. Growth inhibition was determined using the MTT assay. Results are 
mean±SD of triplicate samples.
Table 6.18: Effect of ethanol on the growth of cell cultures.
Ethanol 
concentration 
[% (v/v)]
Absorbance
CHO 3T3 NRK
0 1.546+0.026 1.118+0.011 1.098+0.051
0.1 1.522±0.033 1.12610.081 1.086+0.015
0.5 1.503±0.077 (3) 1.092+0.055 (2) l.O9l±O.O46
1.0 1.45010.037 (6) 1.027+0.023 (8) 1.017+0.039 (7)
2.0 1.329+0.083 (14)** 1.012+0.028 (9) 1.009+0.042 (8)
4.0 1.182+0.064 (23)* 0.812+0.044 (27)* 0.835+0.028 (24)*
8.0 0.058+0.012 (96)* 0.092+0.020 (92)* 0.094+0.022 (91)*
Statistically significant inhibition: * - (p < 0.001), ** - (p < 0.01). Data in parenthesis is 
percent growth inhibition. Plates were seeded with CHO and 3T3 cells at 2.5 x 103 per 
well, and NRK cells at 4.0 x 103 cells per well and incubated for 24 h. The medium was 
replaced with one containing the indicated concentrations of ethanol and incubated for a 
further 48 h. Growth inhibition was determined using the MTT assay. Results are 
mean±SD of triplicate samples.
178
6.4 DISCUSSION
In order to establish the relative importance of the various bracken constituents in 
terms of acute toxicity, a cytotoxicity study of quercetin, shikimate, 
cyclohexanecarboxylate and ptaquiloside was carried out in vitro in CHO, 3T3 and NRK 
cells. The four compounds inhibited the growth and multiplication of cell cultures, but at 
relatively high concentrations as demonstrated by their IC50 values (Table 6.16). It was 
anticipated that ptaquiloside would induce a higher cytotoxicity than quercetin on the basis 
of its greater carcinogenic potency. Ames and Gold (1990) suggest that carcinogenic 
compounds are effective at killing cells. Positive carcinogenicity for quercetin is supported 
by only one report in rats (Pamukcu e ta l, 1980b) while ptaquiloside carcinogenicity has 
been reproduced several times in laboratory animals (Niwa et a i, 1983a; Van der Hoeven 
etal., 1983; Hirono etaL, 1984a; 1984b; Hirono, 1987).
Unexpectedly, quercetin was 5 to 14 times more cytotoxic than ptaquiloside. One 
possible explanation may be suggested for this observation. Ptaquiloside is unstable, and 
both acidic and basic conditions (Figure 1.7) facilitate degradation to the non toxic 
compounds pterosin B and pterosin O (Niwa et a l, 1983a; Van der Hoeven et a l, 1983). 
Hence, the microenvironment of the culture medium, which is slightly alkaline (pH 7.4 - 
7.7) (Benford and Hubbard, 1987), may facilitate degradation of the compound thereby 
shortening the duration of exposure of cultures to active ptaquiloside concentrations, and 
contribute to the low cytotoxic effect. A shorter exposure period or repeat treatment may 
possibly have revealed a higher cytotoxic activity. It was pertinent, though, that the 
cytotoxicity of the constituents be determined under identical conditions for a better 
assessment of their relative in vivo activities, as recommended by Wilson (1983).
There is limited published information on the biochemical reactions for 
ptaquiloside. Nevertheless, it is proposed that the induced cytotoxic activity may result 
from binding to DNA of the dienone degradation product since induction of transformation 
of Chinese hamster cells by ptaquiloside increases significantly if cells are cultured in an 
alkaline medium (Niwa et a l, 1983b; Van der Hoeven et a l, 1983).
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By contrast, quercetin is relatively more stable (Kuhnau, 1976) and its high 
cytotoxicity, compared with ptaquiloside or shikimate, appears to be due to several factors 
which are possibly inherent of the compound. Quercetin autoxidizes (Figure 2.7) and in the 
process forms superoxide and hydroxyl radicals which may mediate its toxicity (Ueno et 
al., 1984; Hodnick et al, 1986; Rueff et a l, 1989). The superoxide radical may be toxic 
through its effect as an oxidant or through production of hydroxyl radicals (Fridovich, 
1975; Graham et a l, 1978; Brunmark and Cadenas, 1989) by interacting with its 
dismutation product H2O2, as shown below:
O2' + H2O2  ►- OH- + OH" + O2
The hydroxyl radical is very reactive and highly toxic, and damages DNA and cell 
membranes (Fridovich, 1975; Brunmark and Cadenas, 1989). Furthermore, autoxidation 
produces quinone species which may cause deleterious effects to cells through inhibition of 
sulfhydryl enzymes and reaction with other nucleophilic groups within the cells (Brunmark 
and Cadenas, 1989).
Although superoxide and hydrogen peroxide are removed by defence mechanisms 
such as superoxide dismutase and catalase to protect cells from injury (Fridovich, 1975; 
Rueff et a l, 1986; Brunmark and Cadenas, 1989), at high quercetin concentrations, 
increased amounts of the toxic species may overwhelm the protective mechanisms. In 
addition, quercetin inhibits the transport properties of the plasma membrane at 
concentrations as low as 0.5 x 10~4 M (Suolinna et a l, 1974; Fewtrell and Gomperts, 
1977a; Graziani and Chayoth, 1979). Interference with membrane properties may inhibit 
protein synthesis and hence growth and/or proliferation of cells. Quercetin affects the 
activity of many enzyme systems such as those involved in regulation of secretion, 
contractile and motility processes (Section 1.3.1.5). This effect may further contribute to 
the reduction in cell growth (Graziani and Chayoth, 1979; Middleton and Drzewiecki, 
1982; Havsteen, 1983).
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The concentrations of quercetin that inhibited cell growth in the present experiment 
are in the micromolar (about 100 pM) range and compares well with those that inhibit 
growth and proliferation of LI 210 Leukemia cells (Suolinna et al, 1975), HeLa cells (Kim 
et a l, 1984) and ovarian cancer cell line OVCA 433 (Scambia et a l, 1990a) in culture. At 
such concentrations interaction with adenosine triphosphatase (Lang and Racker, 1974; 
Kuriki and Racker, 1976; Shoshan and MacLennan, 1981), phosphodiesterase (Monahan 
et a l, 1975; Nishino et a l, 1983), hexokinase (Graziani, 1977), phosphorylase kinase and 
tyrosine protein kinase (Graziani et a l, 1983) has been shown to occur.
Apparently, the pharmacokinetic data describing absorption, distribution, 
metabolism and excretion of ptaquiloside are still unknown. However, in the present 
circumstance if one considers a hypothetical case in which ptaquiloside undergoes 
instantaneous absorption and distribution, throughout the total body fluid compartment, the 
maximum plasma concentrations achieved in a six-month-old calf treated with 2.9 to 11.7 
mg/kg daily for 32 days (Hirono et a l, 1984b) would be between 4.1 pg/ml (after lowest 
dose) to 16.7 Jig/ml (after highest dose). Since the calf showed no classical clinical 
symptoms of acute cattle bracken poisoning (Evans, 1985b), and the present results show 
that 2.5 x 10'4 M concentration is not inhibitoiy to cell growth and multiplication, then it is 
likely that plasma concentrations achieved were too low for any acute toxicity effects. 
Considering that ptaquiloside was administered to the calf by the oral route, its 
bioavailability may have been greatly reduced through degradation by gastrointestinal 
factors such as pH and microbial metabolism.
It is unlikely that shikimate undergoes metabolism in the culture to any significant 
extent because it has been shown that mammalian cells are unable to metabolize it (Brewster 
et a l, 1978). Shikimate has previously been tested for acute toxicity in vivo in mice by 
Evans and Osman (1974) who reported an LD5 dose of Ig/kg bwt after intraperitoneal 
administration. This compares well with the IC50 of 0.06 M (Table 6.16) in the culture in 
the present study. It is known that shikimate is converted to cyclohexanecarboxylate in the 
gastrointestinal tract by microbial metabolism (Brewster, 1977). Cyclohexanecarboxylate is
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further metabolized after absoiption. The present findings thus suggest that shikimate may 
result in a higher in vivo toxicity if administered by the oral than the intraperitoneal route, 
but this may depend on the rate of the further bacterial metabolism of the 
cyclohaxanecarboxylate.
The biochemical or molecular mechanisms by which shikimate causes cell 
transformation in mammalian cells have not been reported. Since cytotoxicity occurs at 
extemely high concentrations (Table 6.16) it is possible that multiple biochemical processes 
are interfered with leading to multiple effects that are injurious to cells.
Trypsinization is known to cause a variety of effects including membrane damage 
(Hebb and Chu, 1960; Waymonth, 1974; Barranco et al., 1980). There is thus a possibility 
that the toxicity of the compounds tested in the present study may have been enhanced by 
trypsin, especially quercetin as its mode of action may partially be mediated by membrane 
effects. This problem was overcome by preincubating cells in untreated media for 24 h after 
seeding to allow them to attach to the plate and regenerate membrane constituents.
A blue colour appeared immediately on addition of MTT to wells containing 
quercetin. It is possible that the colour was a result of a chemical reaction between MTT 
and quercetin (or its reactive species) because spontaneous autoxidation of quercetin 
produces superoxide radical (Ueno et al., 1984; Hodnick et al., 1986; Rueff et al., 1989) 
which has been shown to reduce nitro-blue-tetrazolium (NET) (Slater et al., 1963; Rueff et 
al., 1989). NET and MTT are tétrazolium salts which form formazan crystals (Slater et al., 
1963). The Crystal Violet assay method was therefore used in all the tests involving 
quercetin.
6.5 CONCLUSION
It is concluded that quercetin and ptaquiloside possess low cytotoxic activity in 
CHO, 3T3 and NRK cell cultures at concentrations in the order of x 10-4 M, at their IC50 
value. This cytotoxic effect is extremely low in comparison with mitomycin C whose
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cytotoxic effect occurs at concentrations as low as 10-7 M. Ambrose et al. (1952) similarly 
concluded that quercetin possessed a low order of toxicity after administration of quercetin 
at a level of 1% (w/w) in feed to rats for 410 days. This conclusion is in agreement with 
more recent findings of Dunnick and Hailey (1992) who have reported that rats fed a ration 
containing quercetin at a concentration of 0.1 - 4% (w/w) in feed for up to 2 years 
developed no acute effects regarding clinical signs, mortality, blood biochemistry or any 
histopathological lesions. Only the 4% (w/w) dose level in male rats caused a mild form of 
nephropathy, hyperplasia and adenoma of renal tubular epithelium. However, Ito (1992) 
concludes that the kidney changes reported by Dunnick and Hailey (1992) may have been a 
result of involvement of ccap.- globulin. It has been suggested that aag- globulin, which is 
secreted into the glomerular filtrate, plays some role in chemically induced renal 
carcinogenesis in male rats. It is unlikely that humans would demonstrate a similar 
response since much lower amounts of 0C2jj.- globulin are secreted. Secondly, Dunnick and 
Hailey (1992) re-evaluated tissue sections in the 4% (w/w) dose group by additional step 
sections thereby increasing the incidence of renal adenomas to 16%. This re-evaluation may 
not statistically be appropriate because comparison and evaluation was conducted with 
control groups which were not handled in a similar manner. A more suitable approach 
would be to compare the number of tumours per unit area of histological section in both test 
and control groups (Ito, 1992).
It is further concluded that shikimate possesses extremely low cytotoxic effect in 
comparison with either quercetin or ptaquiloside. It is not surprising, therefore, that 
shikimate has traditionally been viewed as a harmless compound (Evans and Osman, 
1974). Any possible cytotoxic effect of shikimate in vivo may be mediated by its major 
metabolite the cyclohexanecarboxylate per se, or after further metabolism of this metabolite 
following absorption in animals.
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_________________ CHAPTER 7______________
GENERAL DISCUSSION AND CONCLUSION
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Since bracken fern causes chronic toxicity in the form of carcinogenesis in animals 
(Evans, 1984; 1985a; Hirono, 1987), and is used as a human food (Hirono et al., 1972; 
1980; Hirayama, 1979), it was necessary to examine the genotoxic properties of some of 
its constituents in vitro using the Salmonella / microsome mutagenicity test, and in vivo 
using bone marrow micronucleus assay in mice and unscheduled DNA synthesis assay in 
the rat gastric mucosa. The effect of simultaneous application of the constituents was also 
examined because, so far, none of the toxic bracken constituents isolated have reproduced 
all the disease syndromes typical of the plant, and therefore there was the possibility that 
the carcinogenicity of the plant may be due to such factors acting in combination as 
comutagens /  cocarcinogens.
Three constituents were chosen, namely quercetin, shikimate and ptaquiloside 
because they are the only compounds so far isolated from the plant that have been 
implicated as carcinogens (Evans, 1984; 1985a; Hirono, 1987). Cyclohexanecarboxylate, 
which is a gastrointestinal metabolite formed by microbial metabolism of shikimate was 
also tested because the further metabolism of shikimate in mammalian systems depends on 
this metabolite after absoiption (Brewster et a l, 1977a; 1977b; 1977c; 1978).
Data presented in Chapters two and three confirm previous reports (Bjeldanes and 
Chang, 1977; MacGregor and Jurd, 1978; Brown and Dietrich, 1979; Hatcher and Bryan, 
1985; Rueff et a l, 1986; Vrijsen et al., 1990; Rueff et al., 1992) that quercetin exhibits 
ffameshift and base pair substitution mutagenicity in Salmonella typhimurium both in the 
absence and presence of rat liver S9, microsomal and cytosolic (SI00) fractions. 
Additionally, the present work and that of others (Hatcher and Bryan, 1985) shows that 
quercetin mutagenicity may also be influenced by various other factors such as pH and 
compounds of different chemical classes such as norharman, menadione, 
cyclohexanecarboxylate and metal salts.
These inhibitors of quercetin mutagenicity are unrelated structurally. The 
mechanism of inhibition of mutagenicity by menadione, as proposed in Chapter 1, may
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involve facilitated degradation of quercetin by superoxide radicals generated by 
autoxidation of menadione. It is unlikely that norharman or cyclohexanecarboxylate would 
inhibit quercetin mutagenicity by the same mechanism since neither undergo autoxidation or 
generates radical species. However, norharman is a comutagen of certain compounds and 
this comutagenic activity is enhanced by superoxide dismutase (SOD) (Nagao et al., 1986). 
Since SOD present in rat hepatic cytosolic fraction enhances the mutagenicity of quercetin 
by protecting it from degradation by superoxide radicals (Chapter 2; Ueno et al., 1984; 
Rueff et al., 1989), it is possible that inhibition of mutagenicity by norharman may partly 
involve interaction with quercetin-superoxide pathways. Norharman intercalates into the 
DNA helix and this may also play a role in inhibition of mutagenicity because, quercetin, 
by virtue of possessing a planar molecule, may cause mutation by intercalation into the 
DNA helix (Bjeldanes and Chang, 1977).
Enhancement of quercetin mutagenicity by shikimate and its metabolite 
cyclohexanecarboxylate, or ptaquiloside, as originally envisaged, did not occur in the 
Salmonella typhimurium strains TA 100 or TA98. Nor did quercetin enhance the 
mutagenicity of either shikimate, cyclohexanecarboxylate, or ptaquiloside in comutagenicity 
studies (Chapter 3), indicating that these constituents have no synergistic effects in this 
system. Hence, on extrapolation to the in vivo environment, the results suggest that each of 
the three compounds possibly act independently in bracken induced carcinogenesis.
Data presented in Chapter four and five show that quercetin did not induce 
micronuclei in the bone marrow of mice or UDS in the rat gastric mucosa cells in vivo, 
even after administration of doses more than 103-fold greater than the estimated average 
total intake of about 0.7 mg/kg bwt per day (Brown, 1980) in man. The bacterial 
mutagenicity of quercetin and its positive genotoxicity in mammalian cells in vitro is well 
documented (Bjeldanes and Chang, 1977; MacGregor and Jurd, 1978; Brown and 
Dietrich, 1979; Brown, 1980). There are several explanations to non-genotoxicity in vivo. 
The sensitivity of bacterial strains to mutagens / carcinogens has been increased by various 
manipulations, such as alteration of target sequences, specific defects in DNA repair and
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introduction of plasmids (pKMIOl) into tester strains (Ames et al., 1975; Langer et al., 
1981). For example, plasmid pKMIOl (Langer et al., 1981) which has been introduced 
into strains TA100 and TA98 makes these strains more sensitive to mutation. TA102 and 
TA104 have been specially prepared and are hypersensitive to oxidative mutagens 
(peroxides, aldehydes, and free radicals) (Levin etal, 1982a; 1982b). Since the sensitivity 
of mammalian cells has not been altered in any way, it might be that they (mammalian cells 
in vivo) are inherently resistant to quercetin genotoxicity. In the future bacterial strains may 
be produced showing activating and detoxifying enzyme activity towards promutagens and 
procarcinogens so that it may no longer be necessary to use rat liver activating systems. It 
is also possible that in the future cytochrome P-450 genes will be introduced into 
Salmonella. All this will, however, not be a representation of the in vivo condition. The 
second explanation to non-genotoxicity of quercetin in vivo may result from low 
bioavailability after administration. This is evident from the results of the pharmacokinetic 
study (Chapter 4) in which quercetin achieved very low plasma concentrations after both 
oral and intraperitoneal administration. The peak plasma concentration of 0.07 fig/ml (Table 
4.3) after administration of quercetin at 200 mg/kg bwt is 120-fold lower than the quercetin 
detection level (5 |ig) for TA98 in the Ames plate incorporation test. Aeschbacher et al.
(1982), using the host-mediated in vivo test, reported that quercetin administered orally to 
mice at doses of up to 500 mg/kg bwt at intervals of 0 - 12 h before application of 
Salmonella typhimurium TA98 induced no significant mutagenic effect These results are in 
agreement with the conclusion that insufficient amounts of quercetin are absorbed from the 
gastrointestinal tract or peritoneum to cause a genotoxic effect.
Inhibition of mutagenicity by environmental factors might also contribute to lack of 
quercetin mutagenicity in vivo if the results of the Ames test in the present study are 
extrapolated to the situation in vivo. Cycohexanecarboxylate inhibited quercetin 
mutagenicity. Considering the widespread and natural occurence of shikimate in food 
plants, it is possible that an inhibitory role by shikimate and derivatives of this compound 
such as those arising from the further metabolism of cyclohexanecarboxylate may play a
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role in inhibition of quercetin genotoxicity in vivo. Quinones of the benzo-, naphtho-, and 
anthraquinone type form a large group of compounds that are widely distributed in nature 
(Thomson, 1987). Quinones are also found naturally in many foods eaten by man (Brown, 
1980, Ames, 1983). Some antitumour agents such as mitomycin containing the quinone 
nucleus (Begleiter, 1983) are widely used. Although these compounds do not normally 
occur in food plants, inhibition of quercetin mutagenicity by menadione is evidence of 
interaction that may occur between quercetin and quinones or similar compounds because 
of similarities in the mechanism of action that exist between them (Thompson, 1987; 
O’Brien, 1991). Inhibition of quercetin mutagenicity was further demonstrated by 
norharman, a p-carboline derivative. Several p-carboline derivatives occur in charred 
proteinaceous and other foods that are consumed by man (Sugimura et ai., 1976; Adachi et 
ai., 1991). Beta-carbolines also occur in tissues of man and rats as body constituents (in 
plasma at about 0.1 to 0.7 nmol/L) (Fekkes et a l, 1992). Thus the genotoxicity of 
quercetin in vivo may depend on the balance between antimutagenic and mutagenic 
enhancing effects.
That quercetin is cytotoxic to established cell lines, CHO, 3T3 and NRK has been 
established (Chapter 6). The IC50 values of 8 x lO"5 M, 12 x lO"5 M, and 7 x 10-5 m  in 
CHO, 3T3 and NRK cells respectively, are higher than those found to inhibit proliferation 
of cancer cell lines (Markaverich et a l, 1988; Scambia et a l, 1990a; 1990b) and acute 
lymphoid and myeloid leukemic cells (Larocca et a l, 1990; Teofili et al., 1992). The 
leukemic cell blasts AML-M5 and ALC-common are sensitive to quercetin with IC50 value 
of 8 x 10-8 M and 2 x 10“9 M respectively. AML-M1, which exhibits some resistance, is 
known to show an IC50 at about 1 x 10 ^ M. It is, therefore, not surprising that quercetin 
did not suppress bone marrow activity, because the peak plasma concentrations of 0.1 
M-g/ml (Table 4.3), which are assumed to be in equilibrium with those in the central 
compartment after oral or intravenous administration, are lower than those that failed to 
inhibit growth and progression of cancer cells (Markaverich et a l, 1988; Scambia et a l.
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1990a; 1990b), leukemic cells (Larocca et a l, 1990; Teofili et a l, 1992) and CHO, 3T3 
and NRK cells (Chapter 6).
Although quercetin has been identified as a carcinogen in rats by the Board of 
Scientific Councelors of the National Toxicology Program of USA (Dunnick and Hailey, 
1992; Ito, 1992) and by Pamukcu et a l  (1980b) its in vivo genotoxicity or clastogenicity 
could not be detected. The mechanism of carcinogenicity may not, therefore, be entirely 
genetic and may involve an epigenetic mechanism. For example, the reported increase in 
the incidence of hyperplasia and adenomatous lesions in male rats fed a ration containing 
quercetin at 4% (w/w) for 2 years is possibly a result of interaction with o^u-globulin (Ito, 
1992). Female rats, which excrete less of this globulin, did not develop such kidney 
lesions under identical conditions (Dunnick and Hailey, 1992). The reported induction of 
ileal tumours in rats (Pamukcu et a l, 1980b) may also be explained on the basis of 
nitrosation via the formation of nitrosamides as suggested by Ogunbiyi (1987). 
Polyphenols are good catalysts for nitrosating compounds. The effect of quercetin would, 
therefore, depend on the availability of nitrosatable compounds.
It seems, however, that ‘quercetin containing foods’ may not present a mutagenic 
risk based on the negative genotoxicity effects in vivo. Since the major route of exposure to 
mutagenic compounds is through the mouth, it is even less likely that internal organs would 
be in any mutagenic risk at all considering that the small amounts consumed would lead to a 
negligible bioavailability. The present findings support those by MacGregor and Jurd 
(1983) that quercetin is not genotoxic in vivo, but contradict those reported by Sahu et a l 
(1981), thus necessitating further genotoxicity studies.
Quercetin remains an important compound in bracken carcinogenesis because of its 
potential to interact with compounds of different chemical structures. Only shikimate and its 
metabolite cyclohexanecarboxylate, and ptaquiloside were tested for comutagenicity with 
quercetin. Search for the toxin must, therefore, continue by screening for possible
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comutagenic /  cocarcinogenic activity of the numerous compounds already identified from 
the plant (Section 1.3).
Quercetin is one of the most common members of the flavonoid class of 
compounds. Its wide range of biological activities has been of concern as the toxic 
constituent of bracken fern especially following induction of tumours in rats (Pamukcu et 
a l, 1980). On the other hand, the wide range of biological activities are of concern as a 
beneficial dietary constituent and therapeutic agent (Kuhnau, 1976; Havsteen, 1983). 
Increased understanding of quercetin toxicity may therefore be of importance both in 
toxicological and public health perspectives. Future studies could evaluate the mechanisms 
involved in the inhibition of mutagenic activity by norharman (and related compounds such 
as harman, 3,4-dihydronorharman, 1,2,3,4-tetrahydronorharman, and 1,2,3,4- 
tetrahydroharman). No investigations have been conducted on structure-activity (inhibition) 
relationships following chemical substitution of either norharman or quercetin. Because 
structure and mechanisms of action are inseparable it may be appropriate to determine the 
effect of chemical substitution of quercetin on inhibition of mutagenicity by norharman For 
example the effects of norharman on the mutagenicity of quercetin derivatives, e.g. at 3,5, 
7- positions of ring A, and 3 \  and 4’- positions of ring B, would establish the sites on the 
structure of quercetin that are important for the activity of norharman. Such compounds 
include galangin, kaempferol, myricetin, morin, rhamnetin, tamarixetin, 3 -0- 
methlquercetin, and 7,4’-di-0-methylquercetin, as shown in Figure 7.1. It may also be 
interesting to examine the effect of norharman on compounds related to quercetin that are 
known to be non-mutagenic, to determine whether activity would be enhanced. Such 
compounds include the methylated derivatives: 3-O-methylquereetin, 5-O-methylquercetin, 
3,5-di-O-methylquercetin, 3,7-di-O-methylquercetin, 5,7-di-O-methylquercetin, 3 \4 ’-di- 
O-methylquercetin and pentamethylquercetin. The role of SOD and catalase on the 
inhibitory effect of norharman on quercetin would constitute part of this proposed 
investigation.
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Future studies may also be directed towards identification of the specific 
microsomal enzymes involved in enhancing quercetin mutagenicity. Specific cytochrome P- 
450 chemical inhibitors (Murray and Reidy, 1990) could be used for this purpose in 
mutagenicity studies using Salmonella tester strains TA100 and TA98. The present studies 
have demonstrated that quercetin can interact with environmental compounds such as 
menadione. There is a need to determine whether other members of the quinoid compounds 
behave similarly towards quercetin mutagenicity. In conjunction with this study, 
elucidation of the mechanisms involved need examining.
The results of Chapter 3 have clearly demonstrated that shikimate and its 
metabolites are not mutagenic in Salmonella typhimurium TA97, TA98, TA100, TA102 
and TA 104 even after preincubation and /  or incorporation of rat liver activating system and 
norharman which are known to enhance the mutagenicity of otherwise non-mutagenic 
compounds. Thus, further to the observations of Jacobsen et al. (1978) and Jones et al.
(1983) who tested the mutagenicity of shikimate and some of its major metabolites using 
S.typhimurium strains TA98, TA100, TA1535, TA1537 and TA1538, the present results 
additionally show that strains TA97, TA 102 and TA 104 do not undergo reversion by 
shikimate and cyclohexanecarboxylate. TA102 and TA104 are known to be highly sensitive 
to oxidative mutagens (Levin et al.t 1982a; 1982b). This work has further demonstrated 
that shikimate and cyclohexanecarboxylate are not genotoxic in mouse bone marrow cells 
(Chapter 4) or rat gastric mucosa cells in vivo, and this activity is not enhanced by 
quercetin (Chapter 5). Hence the results are not in support of the notion that shikimate is of 
mutagenic / carcinogenic risk to animals and man. This does not, necessarily, mean that 
interactions with other constituents may not occur to produce deleterious effects. For 
example an epidemiological study in Japan not only indicated that daily intake of bracken 
fern significantly elevates oesophageal cancer risk, but also that when combined with the 
intake of hot tea-gruel (Chagayu) the risk increases (Hirayama, 1979). Hence, bracken fern 
constituent(s) may act as initiator(s) and Chagayu components as promotor(s) of 
carcinogenesis. Ogunbiyi (1987) investigated the tumour promoting and initiating
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properties of quercetin and shikimate and found that tissue ornithine decarboxylase 
activities (ODC) were enhanced when shikimate was fed alone or in conjunction with 
MNNG (as initiator) and with cyclophosphamide, saccharine and lithocholate (as 
promoters), suggesting that shikimate acted as a tumour promotor. Furthermore, quercetin 
enhanced ODC activities when fed in conjunction with cyclophosphamide and MNNG as 
initiators, and with cyclophosphamide, saccharine and lithocholate as promoters.
The carcinogenicity of ptaquiloside has been reproduced several times by others 
(Hirono et al., 1984a; 1984c; 1987). However, in vivo mutagenicity studies have not yet 
been conducted, and its acute toxicity in vivo is largely unknown (Hirono et al., 1984b). 
Furthermore, it is not clear whether ptaquiloside would be bioavailable particularly after 
oral administration in animals. Studies on the absorption, distribution, metabolism and 
excretion of ptaquiloside may therefore constitute an important component of future 
investigation, in conjunction with in vivo genotoxicity studies. Future studies may also be 
directed towards identification of the factors in the rat liver fraction that inactivates 
ptaquiloside. Ptaquiloside is not yet available in the commercial market. Since studies of 
this nature require large amounts of the compound, initially synthesis or extraction from 
bracken fern need to be performed as described by Ojika et a/.(1987) and Saito et û/.(1989)-
SUMMARY
In summary, the results derived from comutagenicity studies with quercetin, 
shikimate (and its major metabolite cyclohexanecarboxylate) and ptaquiloside in Salmonella 
typhimurium suggest that these compounds do not potentiate the activity of each other. 
Besides ptaquiloside, which was not tested, these compounds are not genotoxic in vivo in 
the bone marrow or gastric mucosal cells.
The results derived from the cytotoxicity studies and assay of bone marrow cells 
after intraperitoneal administration show that the compounds are of low order of toxicity 
and suggests that they are probably not directly the aetiological agents of ‘acute cattle 
bracken poisoning’.
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Figure 7.1: Quercetin derivatives which may be used to further determine the 
mechanisms involved in inhibition of mutagenicity by norharman. All the compounds 
shown are mutagenic in the Ames test (MacGregor and Jurd, 1978).
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Appendix 1. Compounds tested for their antimutagenic effects on quercetin.
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